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MAYA EL-SABBAN. Elucidating the contribution of the BAF A12T mutation to cellular 
mechanisms of premature aging. (Under the direction of PAULA TRAKTMAN) 
Abstract  
The nuclear envelope is a dynamic structure and organizing hub for cell structure 
and function. The underlying nuclear lamina is composed of a thick network of 
intermediate filaments, Lamin A/C and B, and inner nuclear membrane-associated 
proteins such as Lap2, Emerin and Man1. BAF, a central organizing protein, is a small, 
dimeric, essential protein that binds to dsDNA, proteins of the inner nuclear membrane 
and Lamin A. Cells with perturbations of the nuclear lamina display dysmorphic nuclei 
which have the potential to lead to altered gene expression, increased DNA damage 
events, and premature cellular senescence. In this study, we address a single amino acid 
substitution from Alanine 12 to Threonine (A12T) in BAF that gives rise to a nuclear 
morphology defect. At the clinical level, patients who inherit a homozygous BAF A12T 
mutation have a rare premature aging syndrome called Nestor Guillermo Progeria 
Syndrome (NGPS) with symptoms such as osteolysis, adipolysis and craniofacial defects 
that present at approximately two years of age and progress rapidly, ultimately shortening 
patient lifespan significantly. Tissues of mesenchymal origin appear to be most severely 
impacted in this disease, leading to the hypothesis that mesenchymal stem cells are 
preferentially affected. To address the cellular and organismal pathology of NGPS, we 
used CRISPR/Cas9 technology to establish BAFA12T/BAFA12T human induced pluripotent 
stem cells (hiPSCs). A12T BAF iPSCs appeared normal, however when differentiated to 
induced mesenchymal stem cells (iMSCs), A12T BAF cells exhibited a marked increase 
in cellular senescence and an elevated cellular stress response. The mechanism of A12T 
BAF’s contribution of this cell-type specific pathology was not well understood. Our data 
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indicate that A12T BAF ‘s binding to Lamin A is greatly diminished, thereby weakening the 
Lamin A network of the nuclear lamina and the structural integrity of the nuclear envelope. 
Mechanosensitive iMSCs are unable to withstand this weakened network and the nuclei 
appear to rupture, thereby causing cellular stress and ultimately, senescence. Our results 
indicate that the A12T BAF mutation is necessary but not sufficient to cause premature 
cellular aging. All cell types expressing BAFA12T/BAFA12T have dysmorphic nuclei, however 
cells derived from BAFA12T/BAFA12T mice are viable and primary dermal fibroblasts are not 
senescent, nor do they demonstrate elevated levels of DNA damage. Furthermore, A12T 
BAF mice do not have shortened lifespans nor do they have defects in mesenchymal 
derived tissue. These data highlight the nuances of this mutation’s effect both at the 
cellular and organismal level and elucidates a new role for BAF at the nuclear envelope 
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Chapter 1: Introduction  
As early as the first microscopic observations in the 18th century, the nucleus was 
described as a central feature of the eukaryotic cell. Over 100 years later, Robert Brown 
coined the term nucleus in 1831 and suggested that the nucleus played a key role in the 
fertilization and development in plant cells (Brown, 1833). The late 1800’s saw a spike in 
the study of the nucleus and its role in the heredity and development. By the early 1900s 
there were extensive studies and observations about the discrete entities within the cell, 
including the nucleus, and in 1964 Gall described the nuclear envelope using electron 
microscopy. This final observation established the division between the nucleus and the 
cytoplasm (Gall, 1964; Wilson, 1900). As time continues to press on, studies continue to 
uncover the complexities of this organelle, revealing the intricate relationships between 
chromatin, the nuclear envelope, the nuclear lamina and the nuclear substructures.  
Overview of the Nucleus and its Substructures 
The nucleus is one of the defining feature of eukaryotic cells. It encloses and 
sequesters the entire genome and is delimited by two concentric lipid bilayers that are 
punctuated by nuclear pores, which facilitate selective transport between the nucleus and 
cytoplasm. The nucleus is the site of the major metabolic activities of the cell including 
DNA replication and repair, gene transcription, RNA processing and ribosome maturation 
and assembly. The limited nuclear space must contain within it: DNA, RNA, histones, non-
histone proteins, regulatory and processing enzymes, stable elements of the nuclear 
envelope and nuclear pores, structural proteins, and the nuclear lamina. Spatio-temporal 
regulation of this crowded nucleus is managed through the non-stochastic 3-D architecture 
of chromatin into distinct territories determined by the association of chromatin domains 
with other nuclear structures such as the nuclear envelope (Dekker & van Steensel, 2013).   
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DNA Organization in the Nucleus 
 The majority of the nuclear volume is occupied by genetic material packaged into 
high-order DNA-histone complexes called chromatin (Wolffe, 1998). The building blocks 
of chromatin are discrete entities called nucleosomes, which consist of 160-200bp 
stretches of DNA wrapped around an octamer of histones folded into a condensed 
structure (Felsenfeld & McGhee, 1986; Kornberg & Lorch, 1999). Compacted chromatin 
is transcriptionally repressed and chromatin is remodeled during replication and 
transcription (Adams & Workman, 1993; Alexiadis, Varga‐Weisz, Bonte, Becker, & Gruss, 
1998; Beato & Eisfeld, 1997; Kornberg & Lorch, 1991).  
Histones:  
Core histones are the main components of the nucleosome and are comprised of 
histones H2A, H2B, H3 and H4. Core histones are regulated through post translational 
modifications such as acetylation, methylation and phosphorylation which influence the 
accessibility and remodeling of chromatin (Davie & Chadee, 1998; Wu, Panusz, Hatch, & 
Bonner, 1986). The post translational modifications of histones are carried out by histone 
modifiers, which are organized into subfamilies such as histone acetyltransferases (HATs) 
and histone deacetylases (HDACs), histone methyltransferases (HMTs) and histone 
demethylases (HDMs) and protein kinases. (Gilbert, Gilchrist, & Bickmore, 2004). The 
function of the nucleosome is not only to act as a structural component but also as a 
modulator of gene expression. Precise positioning across genes allows differential access 
to transcription factors and are repositioned by chromatin remodeling complexes (Längst 
& Becker, 2001; Simpson, 1991).  Linker histones H1, H5 and H1° are located outside of 
the nucleosome and are responsible for the condensation and the stabilization of the 
chromatin fiber (Pruss, Hayes, & Wolffe, 1995; Thoma & Koller, 1977). Histone acetylation 
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is correlated with transcriptional activity, while methylation is correlated with transcriptional 
repression (Hebbes, Thorne, & Crane‐Robinson, 1988) 
Chromatin Compaction: 
Interphase nuclei have two distinct chromatin organizations: heterochromatin and 
euchromatin. Heterochromatin is highly condensed and euchromatin adopts an open 
conformation. Heterochromatin is further subcategorized into: i) constitutive 
heterochromatin, which is comprised of tandem repeats that remain condensed 
throughout the cell cycle, ii) facultative heterochromatin, which changes throughout 
development and as a result of signaling and is therefore regulated in a temporal manner 
and iii) senescence associated heterochromatin foci (SAHF) which accumulate throughout 
the genome as cells undergo cellular aging (Gilbert et al., 2004). Interphase chromatin is 
organized spatially into territories. Territories are discrete entities delimited by the 
interchromatin domains (ICD) and their structured organization influences gene 
expression  (Cremer & Cremer, 2001; Leitch, 2000). Chromosomes return to the 
configuration in which they were found preceding anaphase, which is fixed during cell 
cycle and can be arranged into similar patterns among similar species or cell type (Leitch, 
2000).  These data highlight the non-random positioning of chromatin within the nucleus.  
Lamina Associated Chromatin: 
An important substrate for the tethering of chromatin to specific localizations in the 
nucleus is the nuclear envelope (Chubb, Boyle, Perry, & Bickmore, 2002; Heun, Laroche, 
Shimada, Furrer, & Gasser, 2001). The regulation of transcription through chromatin 
conformation is facilitated by long range interactions which form intrachromosomal loops 
and contacts. The development of chromosome conformation capture allowed the 
identification of subdomains within chromatin that associate spatio-temporally (Dekker, 
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Rippe, Dekker, & Kleckner, 2002). These interacting domains are called topology 
associated domains, or TADs. Discrete TAD organization is subdivided into two major 
compartments: the “A” compartment which correlates with proteins and histone 
modifications that are involved with active transcription; and the “B” compartment which 
correlates with repression of gene transcription (Dixon et al., 2012). Within the “B” type 
compartment is a subset of TADs which associate with the nuclear envelope and the 
underlying nuclear lamina, called lamina-associated domains (LADs) (Guelen et al., 2008; 
Pickersgill et al., 2006).  
The nucleolus: 
The nucleolus is a nuclear body that forms around rRNA enriched gene loci called 
“nucleolar organizer regions” (NORs). The function of the nucleolus is the synthesis of 
rRNA and processing and assembly of the ribosomal subunits which are then exported 
from the nucleolus to the cytoplasm to carry out their function of mRNA translation. The 
nucleolus is divided into three subcategories: the fibrillary center, the dense fibrillary 
component and the granular component. Each step of rRNA synthesis and maturation 






Figure 1-1. The 3-D Organization of Chromatin in the Nucleus. Taken from 
(Gonzalez-Sandoval & Gasser, 2016). Chromatin is highly organized within the cell, and 
chromosome territories are conserved throughout the lifespan of the cell and across cell 
type and species. Long rage chromatin interactions facilitate chromatin organization within 
the nucleus. Topology associated domains are classified as transcriptionally active or 
repressed (Compartment A or B respectively) and TADs associated with the nuclear 
lamina, termed Lamina Associated Domains, LADs are generally associated with 
transcriptional repression.  
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The Nuclear Envelope and Nuclear Lamina 
The nuclear envelope (NE) is a dynamic structure that determines the overall 
shape, size, and integrity of the nucleus. The NE is comprised of two lipid bilayers giving 
rise to an outer nuclear membrane (ONM) and inner nuclear membrane (INM). The ONM 
is continuous with the endoplasmic reticulum which allows for direct insertion of NE 
proteins and the translocation of proteins into the perinuclear space; the INM contains 
within it a population of stable membrane proteins that interact with chromatin and the 
nuclear lamina (Schirmer, Florens, Guan, Yates, & Gerace, 2003; Schirmer & Gerace, 
2005). The INM acts as the scaffolding for the intermediate filaments of the nucleoskeleton 
which, in turn, provide critical stability, elasticity, rigidity, and organization to the structure 
of the nucleus.   
The INM and ONM fuse at the sites of nuclear pore complexes (NPC) which are 
involved in the selective trafficking between the nucleus and cytoplasm. Pore density and 
distribution varies greatly between different cell and tissue types and across development. 
The membrane delimiting each pore is highly curved and studded with specific pore 
proteins called Poms which facilitate the anchoring of nucleoporins (Nups), thus 
generating a series of interactions contributing to the formation of the complex structure 
of the NPC (Rout et al., 2000). High resolution structures for the Nups and their interaction 
partners reveal a 9mm aqueous central channel that allows for the diffusion of small 
molecules (<40kDa). Large proteins, RNA and other macromolecules are transported 
across the membrane using facilitated transport  
 The NE further contains of the nuclear lamina (NL). The NL is comprised primarily 
of type V intermediate filament proteins, termed lamins, which form a meshwork of 
filamentous structures. They feature a central α-helical rod that is flanked by non-helical 
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head and tail domains organized in an Ig-like-β -fold that contains a nuclear localization 
sequence, see Figure 1-3 (Brian Burke & Stewart, 2013). There are two major families of 
lamins: Lamin A/C and Lamins B1 and B2. Lamin A and Lamin C are isoforms of the LMNA 
gene that arise due to alternative splicing and that are only expressed in differentiated 
cells. Lamins B1 and B2 are encoded by the LMNB1 and LMNB2 genes respectively, and 
one or the other are expressed in all cells throughout development and differentiation 
(Thomas Dechat et al., 2008). Lamin A and Lamins B1 and B2 contain a C-terminal CaaX 
motif (Cys, aliphatic residue, aliphatic residue, and X, usually a Met), that defines the site 
of farnesylation and carboxymethylation (Beck, Hosick, & Sinensky, 1990; Kitten & Nigg, 
1991). Newly synthesized lamins are targeted to the nuclear envelope through 
farnesylation and are associated with the INM. Once incorporated, Lamin A undergoes 
proteolytic cleavage by ZMPSTE24 after Tyr646 to remove 15 amino acids from the C-
terminus to give rise to mature Lamin A, whereas B-type Lamins remain farnesylated at 
the INM (Pendás et al., 2002). The proper expression and processing of both A-type and 
B-type lamins are critical to cell function and will be discussed in more detail later. Lamins 
are integral to the organization of chromatin at the nuclear periphery. Analysis of NE and 
NL-associated DNA indicates that for the most part, transcriptionally silent chromatin is 
concentrated at the nuclear periphery, and genes move towards or away from the NP 
based on repression or expression respectively, providing a mechanism for the spatial 
control of DNA replication and transcription.  
 Resident proteins of the INM and underlying NL contribute to the regulation of 
nuclear functions. A family of INM proteins that contain a 40 amino acid bi-helix motif, 
LAP-2, Emerin, Man1 domain (LEM-D), share the ability to bind lamins and BAF at the 
NP. LEM-D proteins interact with a diverse array of substrates, implicating them in 
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mechanotransduction, cellular and nuclear architecture, transcriptional regulation and 
chromatin tethering (Barton, Soshnev, & Geyer, 2015). LEM-D proteins represent the most 
studied subset of INM proteins and contribute to the organization of chromatin within the 
nucleus by tethering genomic regions to the NP through direct interactions or through their 
interactions with BAF and Lamin. LEM-D proteins also play a role in gene regulation 
through histone mark regulation by interacting with histone deacetylases, or by direct 
association with transcription factors (Barton et al., 2015). The mammalian genome 
encodes 7 LEM-D proteins: LAP2α, Emerin, MAN1, LEM2, LMD1, Ankle1 and Ankle2 
most of which contain transmembrane domains that tether them to the INM (Brachner & 
Foisner, 2014).  
 Lamina associated peptide (LAP) 2α arises from the LAP2 gene which gives rise 
to 6 LAP2 isoforms. The LAP isoforms share the first 187 N-terminal residues that contain 
within them the LEM domain and a LEM-like motif which allows for direct DNA binding. 
LAP2α differs from other LAP2 isoforms in that it is not stably anchored into the INM at its 
C-terminal tail, whereas LAP2β, for example contains a C-terminal transmembrane 
domain. LAP2α is distributed within the nucleoplasm and binds Lamin A, chromatin and 
pRb (Gesson, Vidak, & Foisner, 2014). LAP2α’s association with the cell cycle regulator 
pRb is suggestive of a role in cell cycle regulation. LAP2α preferentially interacts with 
hypophosphorylated pRb and anchors it in the nucleus, thereby inhibiting the expression 
of E2F target genes and inhibiting cell proliferation (Dorner et al., 2006). LAP2α is highly 
dynamic and localizes throughout the nucleoplasm during interphase. During NEBD and 
prophase, it disperses into the cytoplasm, and during late anaphase and telophase it 
interacts with sub-telomeric regions and TRF1, a member of the Sheltrin complex (T. 
Dechat et al., 2004). Furthermore, LAP2α plays a role in DNA repair pathways through its 
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association with DNA repair machinery, such as the Werner helicase (WRN) and Ku86, in 
the context of non-homologous end joining (NHEJ), and with PARP to generate a docking 
site for DNA damage repair proteins (Gagné et al., 2012; Lachapelle et al., 2011).  
 Emerin is an integral membrane protein that localizes to the INM and directly binds 
BAF and lamins.  Emerin is encoded by the EMD gene, which was identified during the 
genetic mapping of Emery-Drifuss muscular dystrophy (EDMD) (Emery & Dreifuss, 1966). 
EDMD is characterized by the progressive wasting of skeletal muscle and dilated 
cardiomyopathy, which results in cardiac arrest (Dalton, Goldman, & Sampson, 2015). 
The identification of Emerin as a nuclear membrane protein gave rise to the new category 
of diseases termed laminopathies that are involved in the binding to and regulation of the 







Figure 1-2. Structure and processing of Lamin A, C and B1/2. Taken from (Thomas 
Dechat et al., 2008). (A) Conserved structure between LMNA and LMNB1/2. Lamins are 
type V intermediate filaments which contain an α-helical rod, nuclear localization signal 
(NLS), an Ig-fold domain and a C-terminal CAAX domain. (B) The processing of pre-Lamin 
involves farnesylation, trimming and carboyxymethylation, as shown. Lamins B1 and B2 
remain farnesylated in their mature form, whereas pre-Lamin A is cleaved internally by 
Zmptse24 to give rise to non-farnesylated, mature Lamin A. (C) Comparison of the nuclear 
lamins structure at the C-terminus. 
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The Nucleoskeleton and Mechanotransduction 
The shape of the nucleus is regulated by the mechanical properties of the NE and 
NL, but also by the attachments it makes to the cytoskeleton. Cellular and extracellular 
mechanical forces are transduced at the cell periphery into signaling cascades that directly 
affect cell function. Mechanical changes at the cell periphery can arise as a result of 
changes to the extracellular matrix (ECM), changes in cell-cell junctions, or sheer and 
mechanical forces. Membrane-bound mechanosensitive proteins, such as integrins and 
cadherins, induce the reorganization of actin filaments, triggering downstream signaling 
pathways (Bouzid et al., 2019). The nucleus and cytoskeleton are coupled through a 
complex termed the Linker of Nucleoskeleton to the Cytoskeleton, or LINC complex. 
 The LINC complex is composed of two protein families that span the nuclear 
envelope: Nesprin and SUN proteins. Nesprins are found at the nuclear envelope and 
contain a variable N-terminal domain, a C-terminal transmembrane KASH domain and a 
rod domain composed of a series of spectrin repeats (Lombardi & Lammerding, 2011). 
Nesprin binds actin at the N-terminus and SUN proteins in the preinuclear space at the C-
terminus. A SUN monomer is made up of Unc-84 and Sad1 homology domains and 
assembles in a homotrimer (Malone, Fixsen, Horvitz, & Han, 1999). SUN interacts with 
Lamin A at its nucleoplasm domain thereby linking the perinuclear space and the 
nucleoplasm. The tethering of actin to Nesprin, Nesprin to SUN, and SUN to Lamin A, 
therefore, connects the cellular periphery to the nucleus and integrates the forces of the 
cytoskeleton and the nucleus. Cells require the LINC complex for migration and to 
establish nuclear structure, function, shape and position (Lombardi & Lammerding, 2011). 
Changes in nuclear shape affect gene expression and protein synthesis, and lamins are 
upregulated and reorganized in response to mechanical stress (Lammerding et al., 2005). 
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Nuclear shape is dependent on the rigidity of the underlying extracellular substrate: the 
nucleus assumes a spherical shape on soft surfaces due to smaller actomyosin tension 
and becomes flattened and ellipsoid on rigid substrates where the extracellular forces on 
the cell are greater (Lovett, Shekhar, Nickerson, Roux, & Lele, 2013). Lamin A levels are 
proportional to substrate rigidity, implicating Lamin A as a stabilizer for the nucleus under 
mechanical stress (Swift et al., 2013).  
 The coupling of the nucleus with the surrounding cytoskeleton indirectly connects 
the nucleus with the extracellular matrix and the surrounding cells. Mechanical 
deformations within the tissue are transduced along the cytoskeleton to the nucleus and 
influence nuclear function and gene expression. The interphase nucleus is a rigid, but 
deformable structure and is 2-10 fold stiffer than the remainder of the surrounding cell 
(Caille, Thoumine, Tardy, & Meister, 2002). The nuclear lamina and chromatin impart the 
nuclear stiffness and cells deficient in Lamin A/C are softer and more fragile (Lammerding 
et al., 2006). The interior of the nucleus can be characterized as being an aqueous, 
compressible viscoelastic material that increases in stiffness when compressed (Dahl, 
Engler, Pajerowski, & Discher, 2005). During cellular migration, the movement of the 
nucleus is coordinated with the motile cytoskeleton, which results in complex changes in 
both position and shape. Through the LINC complex, the nuclear lamina absorbs the 
mechanical stresses and tensile forces acting on the nucleus (Broers et al., 2005). As 
mentioned previously, the vast majority of the volume of the nucleus is comprised of 
genetic material. An increase in the proportion of heterochromatin restricts chromatin 
mobility and stiffens the nucleus (Pajerowski, Dahl, Zhong, Sammak, & Discher, 2007). 
The nuclear lamins also contribute to the rigidity of the nuclear interior and provide 





Figure 1-3. Nuclear deformations as a result of mechanical stress. Adapted from 
(Ungricht & Kutay, 2017). The NE responds to force stiffening of the nuclear lamina which 
results in the transduction of the signal from the cytoskeleton to the LINC complex, and in 
turn the nucleoskeleton. (B) The balance between nuclear rigidity and flexibility is crucial 
for cells to withstand mechanical forces on the nucleus. (C). Cells deform their nuclei to 
migrate, or mechanosensitive cells under mechanical strain, can results in the loss of the 
NE integrity and subsequent NE rupture and chromatin herniation. BAF is a component of 
the nuclear rupture repair complex and acts by binding dsDNA at the site of rupture and 
recruiting LEM-D proteins of the INM through the ESCRT-III machinery.  
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Structure and Function of BAF 
The Discovery of BAF 
The integration of viral DNA, synthesized by reverse transcription, into the host 
genome is essential for the retrovirus life cycle. Integration is carried out by a nucleoprotein 
complex which directs viral DNA to integrate into the host chromosome rather than 
undergoing self-destructive, self-integration. Viral nucleoprotein complexes isolated from 
Moloney Murine Leukemia Virus (MoMLV) featured a host cellular component that 
inhibited auto-integration (M. S. Lee & Craigie, 1994). Analysis of this host component 
revealed a single protein that was termed Barrier to Autointegration Factor, or BAF. 
Sequencing revealed an 89 amino acid protein highly conserved across species (Figure 
1-4) 
Structure Resolution of BAF 
In 1998, the structure of BAF was solved by nuclear magnetic resonance (NMR), 
which revealed that BAF is a globular shaped protein composed of 5 helices and a small 
helical turn. The core is tightly packed and composed of hydrophobic residues. BAF forms 
a stable dimer in solution with Gly 47 of each monomer in helix 3 forming the dimeric axis 
(Cai et al., 1998). Importantly, helices 4 and 5 of BAF were thought to constitute a helix-
turn-helix (HTH) motif, where the small turn between helix 4 and helix 5 is three residues 
in length beginning with a Gly, typical to HTH domains that recognize DNA. The N-
terminus of helix 5, the DNA recognition helix of the HTH, appeared to readily fit into the 
major groove of DNA, aligning the residues along the DNA and orienting residues of helix 
1 to position along the phosphate backbone. These DNA-interacting residues comprise a 
patch of positively charged residues on the surface of the protein and are highly conserved 
between human, mouse and zebrafish. These NMR data were mostly validated by x-ray 
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crystallography, confirming and refining the structure solution. The high-resolution 
structure however, replaced the theory of an HTH domain facilitating DNA binding with 
evidence of a helix-hairpin-helix (HhH), sequence-independent, DNA binding motif. An 
HhH motif is defined as containing two helices connected by a reverse turn. DNA binding 
occurs via hydrogen bonds formed between two adjacent phosphate groups of the DNA 
backbone with the residues of the reverse turn and second helix of the HhH (Umland, Wei, 
Craigie, & Davies, 2000). The dimerization of BAF at the third helix using the Gly47 notch 
frees the HhH on either side of the dimer to bind distinct DNA strands, foreshadowing 
BAF’s ability to cross-bridge DNA for the first time. Using 21-mer oligonucleotides, BAF 
was observed to form discrete complexes with DNA and, extending the study of the role 
of BAF from viral integration, revealing BAF’s extremely high affinity to dsDNA (Harris & 
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Figure 1-4. BAF’s structure and Binding Surfaces. (A) The structure of the BAF dimer 
(Red= BAF monomer 1 Blue=BAF monomer 2) creates a binding surface for the 
interaction with LEM-D proteins (Green=LEM domain). Each BAF monomer binds dsDNA 
in a sequence independent manner. BAF A12T mutation occurs on the binding surface on 
the opposite pole of the LEM-D binding site (Pink Oval = surface of A12T mutation) (B) 
Sequence alignment reveals that BAF is highly conserved among species. Important 
resides are highlighted: Green box=sites of phosphorylation, red diamonds=interactions 
with dsDNA, cyan arrow=site of A12T mutation, maroon boxes and yellow ovals= residues 
that affect histone binding and chromatin compaction blue triangles= LEM-D binding, 
purple rectangles= Lamin A IgFold binding 
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BAF Protein Partners 
 In 1999, a yeast two-hybrid assay was performed to identify binding partners of 
Lap2.   An 89 aa protein that localized to the nucleus was retrieved as a top hit; further 
analysis revealed that the Lap2-binding protein was indeed BAF.  The binding site for BAF 
corresponded to the chromosome-binding site of Lap2.  These data suggested, for the 
first time, that BAF might play a role as an organizer of DNA within the nucleus. By 
interacting with both DNA and proteins within the INM, it was postulated that BAF might 
serve to tether DNA to the INM (Furukawa, 1999). Building on this, NMR analyses 
elucidated the complex formed between BAF, DNA and Lap2’s LEM domain, a domain 
shared, as discussed previously, with other components of the INM. A study in 2001 
analyzed the contribution of the Emerin-BAF binding complex to chromosome dynamics 
during mitosis and the reassembly of the nuclear envelope. BAF was implicated in the 
assembly of the lamina and nuclear envelope at the end of mitosis, including the 
recruitment of INM components to the newly forming nucleus (T. Haraguchi et al., 2001).  
 BAF has been shown to interact with pre-Lamin A and Progerin and influence 
chromatin organization in the nucleus (Loi et al., 2016). Pre-Lamin accumulation affects 
chromatin organization through HeK9me3 clustering. Furthermore, BAF was found to 
regulate the distribution of Lamin A during nuclear envelope assembly implying its direct 
interaction with it (Tokuko Haraguchi et al., 2008).  
 There is evidence that BAF interacts directly with transcriptional regulators to 
influence gene expression, such as Crx to repress target gene activation (X. Wang et al., 
2002), LAP2ζ to repress LAP2β-mediated transcriptional repression (Shaklai et al., 2008), 
and Sox2 to regulate stem cell fate in mouse embryonic stem cells (Mallanna et al., 2010). 
Furthermore, BAF is thought to regulate gene expression epigenetically. Mapping of LAD 
18 
 
sequences revealed that Lamins B1&2, Lamin A and BAF all interacted with the same 
genomic regions at the NP forming a structural complex that modulates LAD positioning 
(Kind & van Steensel, 2014). Furthermore, BAF interacts with a variety of histones 
including H4 and the nucleosome core histones (De Oca, Lee, & Wilson, 2005; Rocío 
Montes de Oca, Andreassen, & Wilson, 2011). BAF inhibits HAT-mediated acetylation of 
H3 and H4, consistent with its ability to bind H3 by sterically inhibiting access of chromatin 
regulators to the nucleosome (Rocío Montes de Oca et al., 2011). Furthermore, 3 specific 
post translational modifications (PTMs) increase in the presence of BAF overexpression: 
H3K4me2, H3K9me3 and H3K79me2. Paradoxically, H3K4me2 is associated with active 
chromatin and H3K9me3 with transcriptional silencing. It is unclear how BAF influences 
these PTMs and the downstream effects on gene expression (Rocío Montes de Oca et 
al., 2011) 
 Moreover, BAF was found to bind to regulators of the DNA damage response. 
PARP1 was found to bind to BAF and may implicate BAF in the repression of transcription 
during the DDR. Additionally, BAF binds to damage-specific DNA binding protein (DDB2) 
and CUL4A in a UV dependent manner. BAF is bound to DDB2 before the onset of DNA 
damage. Once DNA damage is induced, BAF is released from DDB2 and binds CUL4A 
until the damage process is complete (R. Montes de Oca, Shoemaker, Gucek, Cole, & 
Wilson, 2009). 
  BAF’s interactions with LEM-D proteins, dsDNA and the nuclear lamina, 
transcription factors, histones and other binding partners such as DNA damage effectors 
highlights BAF’s role as a nuclear organizing hub that bridges a myriad of components of 



















Figure 1-5. The Known Interactions of BAF. The BAF dimer is able to bind dsDNA in a 
sequence independent manner, proteins of the INM that contain a LEM domain and the 
Ig Fold of Lamin A. Furthermore, it has been show to play a role in the regulation of 
transcription factors, histones and effectors of the DNA damage response pathway. BAF 
is phosphorylated by VRK1 which regulates its interactions with its binding partners.  
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BAF/VRK1 Signaling Axis and Mitosis 
 Our lab showed that BAF is phosphorylated preferentially on Serine 4 by Vaccinia 
Related Kinase 1 (VRK1) which regulates its interactions and localization within the cell 
(Bengtsson & Wilson, 2006; R.J. Nichols, M.S. Wiebe, & P. Traktman, 2006). Threonine 
2 and 3 are weaker sites of phosphorylation. BAF is primarily localized at the INM but 
there is also a cytoplasmic pool (Tokuko Haraguchi et al., 2007). BAF’s localization and 
binding affinity to LEM-D proteins and DNA is reliant on its phosphorylation status: pBAF 
increases the cytosolic fraction, and decreases BAF’s affinity to its interacting partners 
(R.J. Nichols et al., 2006). In particular, the interaction between BAF and dsDNA is nearly 
abrogated by phosphorylation.   
The NE undergoes disassembly (NEBD) at the onset of mitosis. During NEBD, 
nuclear integrity and compartmentalization is completely lost. NEBD marks the transition 
from prophase to prometaphase and results in the retraction of the NE from chromatin, 
NPC disassembly, and the mixing of the contents of the nucleoplasm and cytoplasm. The 
components of the NE during this reorganization are released into the mitotic cytoplasm 
and endoplasmic reticulum, either as individual proteins or stable subcomplexes (Hetzer, 
Walther, & Mattaj, 2005; L. Yang, Guan, & Gerace, 1997). NEBD is regulated at multiple 
levels by phosphorylation of NE- associated proteins, NPC proteins, lamins and other INM 
proteins at the onset of mitosis (Anderson & Hetzer, 2008a). Cdk1/Cyclin B 
phosphorylates lamins directly to trigger lamina depolymerization, Nup phosphorylation 
initiates NPC disassembly, and other important phosphorylation events provide the 
temporal signal for NEBD. Phosphorylation-mediated disruption of protein-protein 
interactions at the NE leads to bulk disassociation (Buendia, Courvalin, & Collas, 2001; 
Dephoure et al., 2008). BAF is hyperphosphorylated, by VRK1 at the onset of mitosis, 
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which abrogates BAF binding to dsDNA and diminishes its interaction with the LEM-D 
proteins, thereby releasing the chromatin from the nuclear lamina during mitosis 
(Bengtsson & Wilson, 2006; T. P. Molitor & Traktman, 2014; R.J. Nichols et al., 2006). 
Chromosomes aligned on the metaphase plate are membrane free and the proteins of the 
NE reside in the mitotic ER, the precursor membrane of the interphase NE. At the end of 
mitosis, BAF is dephosphorylated by PP4, and PP2A phosphatases, which reestablishes 
its binding affinity to the LEM-D proteins of the INM to recruit membranes to chromosomes 
through its interactions with dsDNA and the LEM domain-containing proteins (Asencio et 
al., 2012; Gorjanacz, 2012; Gorjanacz et al., 2007). NE reformation and reconstitution 
occurs by chromosomes binding to and targeting ER tubules and immobilizing them on 
the chromosome surface which flattens and seals into a closed NE (Anderson & Hetzer, 
2008b). The formation of flat membrane sheets on chromatin is initiated by the recruitment 
of DNA-binding INM proteins or INM proteins containing a LEM domain bound to BAF 
(Anderson & Hetzer, 2008b; Puhka, Vihinen, Joensuu, & Jokitalo, 2007; Samwer et al., 
2017). Depletion of BAF causes defects in chromatin segregation during mitosis and 
subsequent nuclear envelope assembly (Furukawa et al., 2003; Gorjanacz et al., 2007), 
and the expression of BAF is required for the reformation of a single nucleus at the end of 
mitosis (Samwer et al., 2017).  
BAF and Nuclear Rupture 
 Ruptures in interphase nuclei can occur as a result of migration through confined 
spaces, weakening of the NE due to changes at the NP and mechanical strain and tension 
(N. Y. Chen et al., 2018; Denais et al., 2016; Hatch & Hetzer, 2016). Repetitive nuclear 
rupture causes loss of cellular compartmentalization and is a feature of laminopathies (De 
Vos et al., 2011). Following NE rupture there are cellular consequences such as DNA 
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damage, innate immune signaling, and mechanisms to functionally repair the rupture. 
BAF’s predominantly non-phosphorylated pool of cytosolic BAF localizes to sites of 
nuclear rupture to bind herniated dsDNA and recruits LEM-D with their associated 
membranes proteins to functionally repair the NE (Halfmann et al., 2019; Young, Gunn, & 
Hatch, 2020).  
Overview of Cellular Aging and Progerias 
The Hallmarks of Aging 
 Aging is characterized by the loss of physiologic integrity over time. The isolation 
of longevity mutants in C. elegans by Klass in 1983 launched the study of genes 
contributing to organismal aging (Klass, 1983). The study of the molecular basis of cellular 
aging has become a widely studied field and has helped inform different areas of research 
such as cancer biology and metabolism. There are nine hallmarks of aging that fill the 
criteria of: i) manifesting during normal aging ii) aggravation accelerates aging iii) 
amelioration retards the aging process and increases lifespan (both cellular and 
organismal) (Lopez-Otin, Blasco, Partridge, Serrano, & Kroemer, 2013) 
Genomic Instability: 
 The Disposable Soma model introduced the idea that aging is a consequence of 
the investiture of energy required only to maintain the soma only long enough to 
reproduce, and that the damage to cellular components is a consequence of this process 
(Kirkwood & Holliday, 1979). DNA damage accumulates throughout the lifespan of a cell 
and is likely one of the most critical contributors to the aging process (Moskalev et al., 
2013). The insults to DNA through exogenous damage, and endogenous stresses such 
as replication errors, result in DNA lesions that require DNA repair. Insults to DNA repair 
mechanisms cause premature aging syndromes, such as mutations in ATM, PARP-1, 
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Ku86, DNA-PKcs, XPF, WRN and BLM (Espejel et al., 2004; H.-W. Lee et al., 1998; 
Lombard et al., 2000).  
Telomere Attrition:  
Telomeric regions in the genome are highly susceptible to deterioration with each 
round of replication, due to the inability of DNA polymerase to prime synthesis at the end 
of linear DNA. Therefore, maintenance of telomere length during cellular DNA replication 
relies on a specialized polymerase called telomerase (Blackburn, Greider, & Szostak, 
2006). After birth, most somatic cells do not express telomerase, which causes the 
progressive loss of telomeric sequences and eventually culminates in the inability of the 
cell to replicate any further (Blackburn et al., 2006; Hayflick & Moorhead, 1961). Inducing 
the expression of telomerase rescues cells from senescence and imparts cellular 
immortality (Bodnar et al., 1998). Cells deficient in telomerase or components of the 
telomeric complex results in cellular senescence and organismal aging (Armanios et al., 
2009).  
Epigenetic Modifications:  
Histone modifications can modulate gene expression through the methylation of 
longevity-associated genes (Greer et al., 2010). Specifically, sirtuins, a family of histone 
deacetylases, have been studied extensively because Sir2 overexpression increases the 
lifespan of yeas, flies and worms (Guarente, 2011). In mammals Sirt1, Sirt3 and Sirt6 
overexpression results in genomic stability and enhanced metabolic efficiency (Nogueiras 
et al., 2012). Furthermore, DNA becomes hypermethylated with age and the patterns of 
physiologic aging-driven hypermethylation of the genome is mirrored in premature aging 
syndromes (Maegawa et al., 2010). Chromosome modifying proteins such as HP1α or 
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members of the Polycomb or NuRD complexes all contribute to overall epigenetic 
modifications that influence cellular aging (Pegoraro et al., 2009; Pollina & Brunet, 2011). 
Loss of Proteostasis: 
 Impaired protein homeostasis is linked to aging. Endogenous and exogenous 
insults to the cell leads to impaired protein folding during protein synthesis. The detection 
of unfolded proteins is usually met either with refolding by heat-shock proteins or targeted 
degradation through ubiquitin-mediated proteasomal or lysosomal pathways. Cells that 
fail to clear unfolded proteins accumulate unfolded protein aggregates, with resultant 
proteotoxicity (Powers, Morimoto, Dillin, Kelly, & Balch, 2009).  
Deregulated Nutrient Sensing: 
 The IGF-1 pathway has been famously linked to aging through the identification of  
C. elegans longevity mutants, and is one of the most conserved age-controlling pathway 
between multiple species (Klass, 1983). Inhibition of IGF-1 signaling through caloric 
restriction upregulates FoXO1, a tumor suppressor gene that mediates the observed 
longevity effects (Yamaza et al., 2010).  mTOR kinase downregulation also increases 
longevity and mimics the effects of caloric restriction (Johnson, Rabinovitch, & Kaeberlein, 
2013). The contributions of these two pathways indicate that reduced anabolic activity 
mediates longevity.  
Mitochondrial Dysfunction: 
The free radical theory states that progressive aging results in the production of 
reactive oxygen species (ROS) which leads to mitochondrial damage and global cellular 
stress (Harman, 1965). Reduced mitochondrial biogenesis can occur as a result of 
telomere attrition or p53 signaling but also occurs during physiologic aging (Bernardes de 
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Jesus et al., 2012). Furthermore, the SIRT genes discussed above also modulate 
mitochondrial biogenesis and can control the rate of ROS production by regulating the 
antioxidant enzyme manganese superoxide (Qiu, Brown, Hirschey, Verdin, & Chen, 
2010). Furthermore, the accumulation of mtDNA damage, the oxidation of mitochondrial 
proteins or the destabilization of the electron transport change may all result in a decrease 
in the proportion of healthy mitochondria and in turn contribute to cellular aging (K. Wang 
& Klionsky, 2011).  
Cellular Senescence: 
 Cellular senescence is the stable arrest of the cell cycle that is coupled with 
phenotypic changes (Campisi, 2013). Senescence was first described by Hayflick while 
culturing human fibroblasts, who noticed the inability of cells to progress past a certain 
number of passages, termed the Hayflick number (Hayflick & Moorhead, 1961). 
Senescence Associated β-Galactosidase is used to diagnose cellular senescence. 
Senescent cells have an altered secretome, referred to as the senescence associated 
secretory phenotype (SASP), which is a pro-inflammatory paracrine signaling pathway 
that contributes to cellular aging and senescence (Campisi, 2013).  
 The accumulation of DNA damage and cellular stress responses results in the 
induction of the p16INK4a/Rb and p19ARF/p53 pathways, which leads to cellular senescence 
and contributes to physiologic aging (Baker et al., 2011). It is argued that cellular 
senescence is a compensatory mechanism in response to the accumulation of damage, 




Stem Cell Exhaustion: 
 The loss of regenerative potential is an obvious characteristic of physiologic aging. 
Functional attrition of stem cells from nearly every adult stem cell reservoir is exhibited as 
aging progresses (Lopez-Otin et al., 2013). The accumulation of cellular damage, 
telomere shortening and induction of cell cycle inhibitory proteins such as p16 or p53 
contribute to the reduced self-renewal capacity of hematopoietic stem cells (HSCs) 
(Janzen et al., 2006; Rossi et al., 2007). Stem cell exhaustion is likely the integrative 
consequence of many age-related insults and is likely the definitive cellular defect that 
underlies tissue and organismal aging.  
Altered Intercellular Communication: 
 Alterations in intercellular communication modulate aging at a level beyond the 
individual cell. Pro-inflammatory intercellular communication arises from inflammatory 
tissue damage, chronic pathogen infection, dysfunctional immune signaling and the 
activation of SASP, and age-associated inflammation reinforces the aging program 
(Lopez-Otin et al., 2013; Salminen, Kaarniranta, & Kauppinen, 2012). The activation of 
SASP causes a bystander effect in which senescent cells induce senescence in 
neighboring cells through gap-junction mediating signaling, for example (Nelson et al., 
2012). 
Conclusions: 
The nine hallmarks of aging are divided into three subcategories: primary, 
antagonistic and integrative. Primary hallmarks are unequivocally deleterious to the cell, 
as is the case for DNA damage, telomere attrition, epigenetic alterations and defective 
proteostasis. Conversely, antagonistic hallmarks are dependent on intensity: at low levels 
they may be benign, but at high levels they impart damage to the cell. Examples of 
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antagonistic hallmarks include senescence, ROS accumulation and elevated nutrient 
sensing and metabolism. Lastly, integrative hallmarks such as stem cell exhaustion and 
altered intercellular communication integrate some of the primary or antagonistic 
hallmarks and in turn affect cellular and tissue homeostasis. Primary hallmarks are thought 
to be the initiating hallmarks, which in turn lead to the antagonistic hallmarks, eventually 
culminating in the integrative hallmarks that give rise to organismal aging (Lopez-Otin et 






Figure 1-6. The Hallmarks of Aging. Taken from (Lopez-Otin et al., 2013). The nine 
hallmarks of aging include: Genomic instability, telomere attrition, epigenetic alterations, 
loss of proteostasis, deregulated nutrient-sensing, mitochondrial dysfunction, cellular 








The Aging Nucleus & Nuclear Envelopathies and Premature Aging Syndromes 
They study of premature aging syndromes have been instrumental in elucidating 
the molecular mechanisms behind physiologic aging. Moreover, the examination of 
cellular aging is impossible without addressing the inextricable relationship between 
cellular aging and nuclear structure and integrity.   
Hutchinson Guilford Progeria Syndrome (HGPS) 
The organization within the nucleus non-stochastic, and highly regulated into 
functional neighborhoods of chromatin, subcompartments such as the nucleolus, and the 
nuclear lamina. As described previously, the nuclear lamina is thought to act as the shield 
that protects the genome from mechanical stress and as a regulator of chromatin 
organization and gene expression. In 2003, the Collins and Levy labs identified mutations 
in LMNA as the genetic cause for a premature aging syndrome termed Hutchinson-Gilford 
progeria syndrome (HGPS) (Annachiara De Sandre-Giovannoli et al., 2003; Eriksson et 
al., 2003). HGPS patients undergo normal embryonic development and appear normal at 
birth and during infancy; however during childhood they begin to exhibit severe 
degenerative symptoms such as failure to thrive, lipoatrophy, skeletal defects, osteolysis, 
and alopecia. HGPS patients also suffer cardiovascular defects that lead to heart attack 
and stroke, the ultimate cause of their extremely short lifespan. HGPS arises from the 
Mendelian inheritance of a spontaneous C→T transition at position1824 of the LMNA 
gene. Replacement of a single base produces a silent mutation which does not alter the 
amino acid sequence (G608G). However, the mutation reveals a cryptic splice site within 
LMNA; utilization of this splice site leads to an internal deletion of 50aa within the protein. 
This deletion spans the Zmptse24 cleavage site. The resultant protein, termed Progerin, 
therefore contains a 50 aa deletion and is permanently farnesylated at its C-terminus. 
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HGPS is inherited as a heterozygous trait; Progerin exerts a dominant, negative effect 
even in the presence of WT Lamin A (A. De Sandre-Giovannoli et al., 2003). Cells derived 
from HGPS patients display irregular nuclear morphology, designating HGPS as a 
laminopathy (Eriksson et al., 2003).   
The expression of Progerin render cells more susceptible to damage by physical 
stress because WT cells respond are thought to respond to mechanical stress by 
redistributing Lamin A (Zhang et al., 2011). Progerin is found exclusively at the periphery 
of the nucleus, unlike Lamin A. Moreover, HGPS nuclei exhibit a loss of LAD-associated 
heterochromatin, a loss of overall repressive histone modifications and changes at the 
level of chromatin-modifying complexes such as NuRD (Scaffidi & Misteli, 2005; Vidak & 
Foisner, 2016). Progerin expression also affects genome stability by negatively affecting 
DNA damage repair pathways. HGPS cells exhibit the accumulation of double strand 
breaks as a result of impaired recruitment of DNA repair machinery such as 53BP1 and 
Rad50/51. The accumulation and persistence of DNA damage leads to the induction of 
p53 and promotes senescence (Brachner & Foisner, 2014). 
HGPS preferentially targets tissue of mesenchymal origin, and evidence from the 
literature indicates that the regulation and function of mesenchymal stem cells (MSCs) are 
affected by Progerin expression (Gotzmann & Foisner, 2006). Low levels of Progerin are 
observed during normal cellular aging, however, MSCs derived from HGPS patients 
accumulate significant amounts of Progerin with passaging in vitro, and their self-renewal 
and differentiation capacity are impaired (Wenzel et al., 2012).  
Therapeutic treatment of HGPS was initially focused on repairing the mutant 
protein with farnesyltransferase inhibitors, which improved some disease parameters such 
as weight gain and bone structure (Cau et al., 2014; Gordon et al., 2012). Other 
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approaches have included treatment with Rapamycin, an inhibitor of mTOR, which 
relieves lobulated nuclei and clears DNA damage (Cao et al., 2011), Sulforaphane, an 
antioxidant which enhances protein clearing and reverses some of the hallmarks of HGPS 
(Gabriel, Roedl, Gordon, & Djabali, 2015), and Retinoids which showed promise by 
decreasing Progerin levels (Kubben, Brimacombe, Donegan, Li, & Misteli, 2016).  
Nestor Guillermo Progeria Syndrome (NGPS) 
The homozygous inheritance of a single amino acid substitution from Alanine12 to 
Threonine in BAF was identified as the cause of a novel progeria disease known as 
Nestor-Guillermo Progeria Syndrome (NGPS) (R. Cabanillas et al., 2011). NGPS patients 
share clinical features similar to those exhibited by HPGS patients, but lack cardiovascular 
disease (R. Cabanillas et al., 2011). The clinical manifestations of NGPS do not begin until 
approximately two years of age, when patients exhibit skin atrophy, general lipoatrophy 
and severe osteoporosis with marked osteolysis (Puente et al., 2011). Craniofacial 
abnormalities result from the atrophy of the facial subcutaneous fat and osteolysis of the 
maxilla and mandible and incomplete closure of the cranial sutures. Diverging from HGPS, 
NGPS patients retain eyebrows and eyelashes and, importantly do not exhibit cardiac 
dysfunction, ischemia, atherosclerosis or metabolic syndromes (R. Cabanillas et al., 2011; 
H. G. Fisher, N. Patni, & A. E. Scheuerle, 2020; Puente et al., 2011). The index patient 
suffered of severe secondary pulmonary hypertension and subsequent heart failure as a 
result of severe scoliosis (R. Cabanillas et al., 2011). Fibroblasts from NGPS patients 
exhibit aberrant nuclear morphology which can was rescued by exogenous expression of 
wild type BAF (R. Cabanillas et al., 2011; N. Paquet et al., 2014). A third NGPS patient 
was recently identified in the US (Heather G. Fisher, Nivedita Patni, & Angela E. 
Scheuerle, 2020)The literature has suggested that the A12T mutation in BAF does not 
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affect interactions with LEM-D proteins or histone H3 (N. Paquet et al., 2014). 
Interestingly, alanine12 is in close proximity to the BAF residues which have been 
previously shown to affect in vitro chromatin condensation and histone binding (De Oca 
et al., 2005), suggesting the possibility that A12T-expressing cells might exhibit defects in 
chromatin condensation and histone binding, which could have negative consequence for 
gene expression and eventual cellular dysfunction.  
 The ternary complex of BAF, a LEM-D domain and the IgF of Lamin A has shed 
significant light the implications of the BAF A12T mutation.  This report was the first to 
demonstrate a direct interaction between BAF and the IgF of Lamin A and showed that 
alanine12 is buried within the BAF: Lamin A interface. Moreover, this interface not only 
contains alanine12, but contains several residues on the BAF-binding IgF surface of Lamin 





Figure 1-7. The Structure of the Nucleus and Aging. Cells that have undergone 
physiologic aging or pathologic aging through the expression of progeria-associated 
mutant proteins both undergo structural changes at the level of the nuclear envelope. The 
integrity of the nuclear lamina is lost over time and nuclei develop dysmorphic nuclear 
envelopes. Furthermore, these changes are met with the accumulation of DNA damage, 
overall changes in the compaction of chromatin (including the formation of SAHF), and the 
accumulation of stress responses like ROS accumulation and p53 signaling. 
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Biochemical Characterization of BAF A12T  
 Dr. Aye Mon of the Traktman lab performed in depth biochemical comparison of 
WT BAF and A12T BAF. To begin with, she established a model system in MCF10a cells 
by expressing shRNA resistant 3XF-BAF or 3XF-A12T (discussed in Chapter 3) and then 
depleting endogenous BAF. This approach established a close-to homozygous 
expression system. In so doing, she observed that 3XF-A12T expressing cells exhibited 
aberrant nuclear morphology, an observation that was also reproduced in this study. She 
determined that 83% of 3XF-BAFexpressing cells exhibited normal nuclear morphology 
whereas only 53% of 3XF-A12T-BAF-expressing cells had normal nuclear envelopes 
(data not shown).  
 The first published study of the biochemical properties of A12T BAF noted that 
cells derived from NGPS patients had lower steady state levels of BAF as analyzed by 
immunoblot analysis (Puente et al., 2011). Based on this finding, the authors posited that 
the stability of A12T was diminished and that this contributed to the molecular mechanism 
behind the disease state. Using the model described above, Dr. Mon metabolically labeled 
cells with 35S-methionine and performed pulse chase experiments to analyze the half-life 
of the protein. BAF is an extremely stable protein with a half-life of 35h; importantly, the 
introduction of A12T did not alter the half-life (Fig 1-9 A).  
 The functional unit of BAF is a homodimer, through which it is able to associate 
with its binding partners. The next question that was asked was whether A12T is able to 
dimerize to the same efficiency of WT BAF. Recombinant BAF was purified and its 
dimerization state analyzed using a size exclusion column: BAF dimers elute at 
approximately 20 kDA, whereas monomers eluate at approximate 10 kDA. Analysis of the 
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gel filtration fractions that corresponded to these molecular masses indicated that the 
A12T mutation does not affect dimerization (Fig 1-9-B).  
 BAF is rapidly and efficiently phosphorylated by VRK1 at Serine 4 and more slowly 
at Threonine 2& 3 (R. J. Nichols, M. S. Wiebe, & P. Traktman, 2006). In vitro kinase assays 
performed with recombinant WT or A12 BAF and purified VRK1 indicated that A12T does 
not prevent the phosphorylation of BAF. In fact, A12T BAF appeared to be phosphorylated 
more rapidly than WT BA (Fig 1-9-C). This result was intriguing, and led us to question of 
whether threonine12 generated a novel phosphorylation site. To address this question, 
T2, T3 and S4 were mutated to Alanine to generate a BAF phospho-null mutant or a BAF 
A12T phospho-null mutant (R.J. Nichols et al., 2006). In vitro kinase assays indicated that 
neither of these mutants were phosphorylated by VRK1, thereby showing that the 
introduction of threonine as a result of the A12T mutation did not result in a novel 
phosphorylation site. It is possible that the A12T mutation leads to a slight alteration in the 
folding of the BAF protein that makes ser4 more accessible to VRK1.  
 The BAF homodimer binds dsDNA on either side with high affinity, and cross 
bridges DNA into higher order structures. Paquet et al. found that A12T bound to dsDNA 
with a lower affinity than WT BAF (Nicolas Paquet et al., 2014), as assessed by 
electrophoretic mobility shift assays (EMSAs). Dr. Mon performed similar assays using 
32P-radiolabeled dsDNA oligonucleotide probes and purified recombinant WT or A12T 
BAF dimers. In these experiments, BAF and A12T had comparable DNA binding activity 
in vitro (Fig 1-9 D).  Interestingly, a very recent 2021 paper (Marcelot et al., 2021) 
assessed DNA binding in another manner, and their work demonstrated that the dsDNA 
binding activity of WT and A12T BAF are indistinguishable. 
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 Cumulatively, these data indicate that the previously known biochemical functions 
of BAF were unperturbed by the introduction of the A12T mutation. Therefore, this study 
aimed to elucidate the molecular impact of the A12T mutation on BAF function in the 
context of the nuclear envelope, and the overarching effects that these effects would have 
























Figure 1-9. The Biochemical Characterization of BAF A12T. Aye Mon 2018- 
Unpublished. (A) Assessment of the stability of WT and BAF A12T. (Top) MCF10a cells 
that stably express 3XF-WTBAF and 3XF-A12TBAF were pulsed with 35S-met containing 
DMEM medium for 2 h. Cells were washed and chased with DMEM complete media for 8 
to 48 h. The 3XF-BAF proteins (WT and A12T) were retrieved by immunoprecipitation and 
analyzed by SDS-PAGE \ and phosphorimager analysis. Black diamond indicates the 
residual BAF protein during the chase. Bottom: Data were plotted; the half-lives of the two 
proteins were indistinguishable (n = 3). (B)  Dimerization of BAF is not perturbed by the 
A12T mutation. The elution profile of gel filtration standards is shown. Lanes 6 -10 




molecular weights of 670 kDa and 158 kDa respectively; Lanes 11 – 21 correspond to the 
ovalbumin protein standard with the molecular weight of 44 kDa; Lanes 22 – 36 
correspond to the myoglobin protein standard with the molecular weight of 17 kDa. Black 
diamond indicates the myoglobin with 17 kDa (bottom left and right) Size exclusion 
chromatography of WT BAF dimers (bottom left) and A12T BAF dimers (bottom right). 
Black diamonds indicate WTBAF and A12TBAF dimers. WTBAF and A12TBAF dimers 
have the molecular weight of approximately 20 kDa, and were resolved from the size 
exclusion column in the same fractions as the myoglobin standard (17 kDa). (C) VRK1 
phosphorylates BAF A12T at least as well as WT BAF, and threonine 12 is not a new site 
of phosphorylation.   VRK1 kinase (10 nM) was incubated with WT or A12T BAF dimers 
(1.5 μM) in the presence of [γ-32P] ATP for 0-10 min at room temperature. Reaction 
products were resolved by SDS-PAGE and analyzed by silver staining (top) and 
autoradiography (middle panel). In top panel, black diamond indicates the equal input of 
BAF dimeric protein. On autoradiography, gray triangle indicates the phosphorylated BAF 
proteins. Bottom panel: phosphorylated products were quantified and plotted; linear 
regression analysis was performed to determine the slopes of WTBAF and A12TBAF. The 
slope ratio 𝐴𝐴12𝑇𝑇𝑇𝑇𝐴𝐴𝑇𝑇 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
𝑊𝑊𝑇𝑇𝑇𝑇𝐴𝐴𝑇𝑇 𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠𝑠
 indicates the difference in the rate of phosphorylation of WTBAF 
and A12TBAF by VRK1. (n = 3) (D) BAF A12T and WT BAF exhibit comparable DNA 
binding. Top: EMSA was performed using 100 nM of a 21-mer dsDNA probe and purified 
recombinant WT and A12T BAF dimers at 66 nM, 100 nM, and 133 nM. Reaction products 
were resolved on 4-10% acrylamide gel; a representative gel is shown. Black diamond 
represents the free dsDNA probes, and gray triangle indicates dsDNA bound to BAF. 
Quantitation of BAF binding to dsDNA. Calculation was performed using the formula 
( 𝑏𝑏𝑠𝑠𝑏𝑏𝑏𝑏𝑏𝑏
𝑏𝑏𝑠𝑠𝑏𝑏𝑏𝑏𝑏𝑏+𝑓𝑓𝑓𝑓𝑠𝑠𝑠𝑠
 × 100), in which bound means dsDNA + BAF, and free means dsDNA.   
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Chapter 2: Materials and Methods 
Cell Culture Methods 
All cells were cultured at 37°C in the presence of 5% CO2. 
Harvest and Culture of Primary Mouse Dermal Fibroblasts 
48-well dishes for culture were prepared by coating with 0.1% Gelatin solution (Life 
Technologies #S006100) and incubating for 30-60min at room temperature. After 
incubation, the remaining gelatin was aspirated and replaced with 250uL of warm mPEF 
medium described in Table 2-1. Plates were left in the incubator while explants were 
harvested in the mouse facility. In order to harvest ear punches, each mouse was 
restrained in one hand and was placed inside the tissue culture hood. The ears, head and 
face were sterilized using 70% ethanol. After the ear was sufficiently dry from the ethanol, 
an ear puncher was used to generate a 1mm circular punch. Each individual punch was 
placed in 500uL of ice cold mPEF medium on ice. Instruments were heat sterilized and 
appropriately cooled between each mouse. After the harvesting was complete, the ear 
punches were brought back to the tissue culture room on ice. The collection medium was 
carefully aspirated and each punch was placed forcefully using sharp, sterile, forceps on 
the gelatin at the bottom of the well, ensuring that the forceps were heat sterilized and 
appropriately cooled between each ear punch 
The 48-well dish was placed in the incubator and monitored daily. 100uL of fresh 
media was added to each well every three to four days to compensate for evaporation. 
After approximately two weeks, the volume of media was increased to 500uL/well and the 
medium was carefully changed every three to four days without disturbing the ear punch.  
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Once fibroblasts were confluent in each well, they were detached using 0.05% 
Trypsin Ethylenediaminetatracetic acid (EDTA) (Life Technologies #15400054). They 
were passaged at a 1:2 ratio until cells were comfortably doubling every 24-48 hours. The 
subsequent passaging dishes did not need to be coated with gelatin. Once at least 5x107 
cells were obtained, at least three vials were frozen in 10% Dimethylsulfoxside (DMSO) 
with complete medium at a density of 1x106 cells/vial. Fibroblasts were kept relatively 
confluent and passaged at a ratio of 1:3 to 1:5.  
Stem Cell Culture 
Culture of Induced Pluripotent Stem Cells 
Induced pluripotent stem cells were cultured on human embryonic stem cell 
(hESC) qualified Matrigel (Corning #8774552). Culture dishes are prepared by diluting the 
Matrigel in DMEM/F12 (Life Technologies #1330057) at the appropriate ratio specified by 
the manufacturer based on lot number. Dishes were then left to incubate one hour at room 
temperature and stored for up to one week at 4°C. Coated dishes were then warmed for 
one hour at 37°C before use. iPSCs were subcultured at a ratio of no less than 1:5 and 
the medium was changed daily (see Table 2-1). iPSCs were subcultured by aspirating 
media, washing twice with PBS, and adding Versene (Life Technologies #15040066), 
formulated with 0.48mM EDTA in PBS, in order to gently lift the iPSCs in the absence of 
proteases. Cells were then allowed to gently lift for 2-3 minutes at room temperature, the 
Versene was aspirated and fresh media was added to the culture dish. Cells were gently 
scraped in the fresh media using a cell scraper and, without dissociating the intact 
colonies, transferred to a new Matrigel coated dish containing fresh medium. 
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Differentiation and Culture of Induced Pluripotent Stem Cells to Induced Mesenchymal 
Stem Cells 
In order to differentiate iPSCs into induced mesenchymal stem cells (iMSCs), 
iPSCs were plated on Matrigel coated dishes at a confluence of approximately 25%. Cells 
were cultured in iPSC media for three to five days before switching the media to iMSC 
media (see Table 2-1). Media was changed every three days for a total of 21 days. After 
the 21st day, cells were passaged on to dishes coated with 0.1% gelatin (Attachment 
Factor, Life Technologies #S006100) using 0.25% Trypsin EDTA (Life Technologies 
#15400054), a concentration five-fold higher than generally used in cell subculturing. The 
cells were subcultured at a ratio of 1:4 on gelatin for a total of three passages, each 
passage using 0.25% Trypsin to lift the cells. On the fourth passage after gelatin, cells 
were plated on uncoated tissue culture dishes, deemed passage zero. Subsequent 
passaging of the cells occurred using 0.025% Trypsin EDTA and cells were always 
subcultured at a ratio of 1:4. The success of this protocol is measured by the ability of the 
cells to continue to proliferate on uncoated culture dishes. 
Differentiation of Induced Mesenchymal Stem Cells to Lineage Cells 
In order to determine whether the iMSCs are functional, they must be differentiated into 
lineage cells such as osteoblasts and pre-adipocytes. To do this, iMSCs were plated in 
24-well dishes at a density of 1x104 cells/cm2. Cells are cultured for three days in MSC 
media, and then switched to either StemPro Osteogenesis Differentiation Medium (Life 
Technologies #A1007201) or StemPro Adipogenesis Differentiation Medium (Life 
Technologies #A1007001). The medium was changed every three days for a total of 28 
days. Every seven days, cells were assessed for lineage staining: Alizarin Red (abcam 
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#146374) for osteoblasts, and Oil Red O (Simga Aldrich #O0625) for pre-adipocytes 




Table 2-1 Table of Cell Culture Media 
Cell Line Cell Line 
Description 
Base Media Supplements Source 
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Established Cell Lines 
Previously established cell lines were cultured in media according to Table 2-1. 
Cells that were genetically manipulated to generate stable cell lines were cultured in the 
presence of antibiotic selection that corresponded to the gene of interest, see Table 2-2.  
Molecular Biology Methods 
Generation of lentiviral particles for transduction of shRNA 
A variant of the pHAGE lentiviral from containing a multiple cloning site (MCS) was 
used to generate replication-deficient viral particles for stable transduction of cDNA. 
pHAGE-PUROR-MCS (pPM), as described in Molitor & Traktman 2014 (T. P. Molitor & 
Traktman, 2014). pPM was used to generate replication deficient lentivirus for shRNA 
mediated depletion of target proteins were generated by transfecting HEK293T cells with 
2ug of helper plasmids pRRE and pRSV-REV, 4ug of pVSVG and 12ug of the target 
shRNA plasmid of interest using Lipofectamine 2000 transfection reagent (Life 
Technologies #11668019). 24h after transfection, the medium was replaced with a 
lentiviral harvest media containing: DMEM (Sigma Aldrich #5546), 10% Fetal Bovine 
Serum (FBS), 0.5% bovine serum albumin (BSA), 10mM HEPES (4-(2-hydroxyethyl)-1-
piperazineethanesulfonic acid) and 2.5mM sodium butyrate. Following a 24h incubation in 
harvest medium, the supernatant containing lentiviral particles was filtered using a 45um 
filter and then treated with 8ug/mL of polybrene. Target cells were transduced with 1mL 
of viral particles for 8-10h at 37°C, then media was replaced with the appropriate standard 
media. After approximately 48h, cells were placed under selection appropriate to the 
transfer plasmid at a concentration of 7.5ug/mL. Assays performed on these cell lines 




Table 2-2 Table of Generated Cell Lines 
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Generation of lentiviral particles for stable expression of transgenes 
To generate lentiviral particles for expression of transgenes, 0.5ug of helper 
plasmids pREV, pGAG/Pol, and pTAT, 1ug of VSVG and 12ug of a hygromycin-resistance 
cassette, pHAGE-HYGR-MCS (pHM) (T. P. Molitor & Traktman, 2014) containing the 
target gene of interest was used to transfect HEK293T cells at approximately 70% 
confluence. The harvest of viral particles was performed as described above. Stable cell 
lines were placed under selection using hygromycin at a concentration of 50ug/mL.  
Transient Transfection  
Cells were subjected to transient transfection using Lipofectamine 2000 (Life 
Technologies #11668019) according to the manufacturer’s instructions. Plasmids that 
were introduced to cells using transient transfection can be found in Table x.  
Biochemical Methods 
Purification of pGEX-Lamin A proteins 
pGEX-Lamin A Ig fold constructs were generously gifted to us by the Zinn Justin Lab 
(Institut de Biologie Intégrative de la Cellule, University of Paris) (Samson et al., 2018).  
BL21-DE3 cells expressing pGEX-Lamin A IG fold (WT, R453C or R527H) were grown to 
an OD550 of 0.5-0.7. in Luria-Bertani (LB) medium supplemented with 100ug/mL of 
ampicillin at 37°C. Cultures were induced by the addition of Isopropyl-b-D-1-
thiogalactopyranoside (IPTG) to a final concentration of 1mM for three hours at 37°C. Cells 
were harvested by centrifugation at 4,000xg for 30 minutes. Cells were suspended in PBS 
containing: 1ug/mL Leupeptin, 1ug/mL Pepstatin and 0.2mM PMSF and subjected to 
sonication 15 times per sample. After sonication, Triton-X 100 was added to a final 
concentration of 1% and gently mixed and incubated on ice for 30 minutes. Lysates were 
then clarified by centrifugation at 10,000xg for 20 minutes at 4°C. The resulting 
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supernatant contained the soluble fraction of the pGEX-Lamin fusion proteins. In Vitro 
Lamin-A and BAF binding assays were performed on the crude soluble lysate achieved in 
this step.  
Visualization of Proteins by Silver Staining of SDS-PAGE 
In order to visualize and quantify protein content after induction or purification of 
recombinant proteins, silver staining was performed on SDS-PAGE resolved protein 
samples. BSA was serially diluted to 50ng, 100ng, 200ng, 400ng and 800ng, and utilized 
as a protein standard for comparison. The gels were dehydrated by soaking in methanol 
then incubated with 10uM DTT and stained with 0.1% (w/v) Silver Nitrate solution (Sigma 
Aldrich #209139). Gels were placed in developer solution containing 6% sodium 
carbonate (w/v) until protein bands were detectable. The developing reaction was 
quenched by the addition of citric acid. Cells were then fixed using a solution of 50% 
methanol and 10% acetic acid and then dried between two pieces of cellophane.  
Co-Immunoprecipitation of GST-Lamin A with BAF 
In order to assess the interaction of BAF with the Ig Fold of Lamin A, in vitro co-
immunoprecipitation was performed. Crude GST-Lamin A (WT, R453C or R527H) lysates 
were incubated with Glutathione sepharose beads (GE Healthcare #52-2303-00 AK) for 
two hours at 4°C with end over end rotation in PBS containing the protease inhibitors 
described above. Samples were washed twice and then 2ug of purified BAF WT or BAF 
A12T were added to the samples. Samples were re-incubated for two hours at 4°C with 
end over end rotation. Samples were boiled in sample buffer containing: 1% SDS, 1% b-
Mercaptoethanol, 50mM Tris (pH 6.8), 6.5% glycerol, and bromophenol blue. Eluate was 
subjected to SDS-PAGE alongside inputs, and samples were either subjected to silver 
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staining or transferred on to nitrocellulose membrane and subjected to immunoblot 
analysis to detect GST or BAF.  
Cell Biology Methods 
Growth curve assay and doubling time 
Cells were detached from their dishes using 0.05% Trypsin EDTA and collected in 
an equal amount of complete medium, then spun at 673xg for 5 minutes at room 
temperature. The trypsin-containing media was then aspirated and the cells were flicked 
to dissociate the pellet and resuspended into a single cell suspension in 1-2mL of 
complete media. An aliquot of cells was taken and diluted 1:1 with 5% Trypan Blue. The 
number of live cells in each of the outer quadrants of a hematocytometer were counted 
and the average cell number per quadrant was taken. This number was multiplied by the 
dilution factor of Trypan blue and the number of cells per mL was determined. Equal 
densities of cells were plated in a 24-well plate in technical triplicate for each desired time 
point. Cells were then counted using the same method described above at each desired 
time point. The number of cells was plotted against the time elapsed, generating a growth 
curve. To assess the apparent doubling time, cells were plated at equal densities and 
counted 48h after plating. To determine the number of doublings, the equation 
2x=nfinal/ninitial, where x equals the number of doublings and n equals the number of cells. 
The apparent doubling time is then determined by h/x where h equals the number of hours 
after seeding and x is the number of doublings calculated in the previous formula.  
MTT Assay and Cell Titer Glo Assay 
In order to generate a growth curve based on the metabolic activity of cells, an 
MTT assay, a colorimetric assay based on the formation of insoluble formazan in viable 
cells, was used.  Cells were plated at a density of 5×103 cells per well of a 96-well dish 
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and incubated for a desired period of time (usually 0, 24, 48, 72 and 96 hours). At each 
desired time point, tetrazolium dye MTT 3-(4,5-dimethylthiazol-2-yl)-
2,5,diphenyltetrazolium bromide (MTT) was added to a final concentration of 250ug/mL 
per well, and incubation continued for three additional hours at 37°C. After three hours, 
the plate was removed and 100uL of Stop Solution containing 20% Sodium dodecyl sulfate 
(SDS) and 50% dimethylformamide (DMF) in dH2O was added to each well and the plate 
was rocked at room temperature for one hour. After one hour, the plate was read on a 
multi-well spectrophotometer at 570nm. The absorbance was plotted against the elapsed 
time to generate a growth curve.  
An alternative method to assess cell viability is the use of Cell Titer Glo (Promega 
#G9241). Cell Titer Glo is a luminescent assay that measures ATP. The mono-
oxygenation of luciferin by luciferase in the presence of Mg2+, molecular oxygen and ATP, 
which is contributed by viable cells, results in a luminescent signal that is measured on a 
spectrophotometer. Cells were plated at a density of 5×103 cells per well of a black walled, 
clear bottom, 96-well dish and incubated for a desired period of time (usually 0, 24, 48, 72 
and 96 hours). Cell Titer Glo reagent was added to each well and incubated for 10 minutes 
at room temperature. Luminescence was measured on a multi-well spectrophotometer 
and was plotted against the elapsed time to generate a growth curve. 
Preparation of Cell Lysates and Immunoblotting 
Medium was aspirated from dishes and cells were washed twice with ice cold 
1xPBS, then lysed directly in the dish using “phospho-lysis buffer” (PLB) containing: 0.01M 
NaPO4 (pH7.4), 0.1M NaCl, 1% Triton X-100, 2% SDS and 0.5% Deoxycholate 
supplemented with protease and phosphatase inhibitors at a concentration of 1ug/mL of 
Pepstatin, 1ug/mL of Leupeptin, 1mM PMSF, 1mM NaF, 5nM Calyculin A and 25 U/mL of 
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Benzonase (Sigma Aldrich #E1014). Cells were scraped in the lysis buffer and transferred 
to 1.5mL tubes and incubated on ice for 30 minutes. Lysates were cleared by spinning at 
600xg at 4°C for 15 minutes. The supernatant was collected into a fresh tube. Protein 
concentration was quantified using a Thermo Pierce BCA assay (#PI23227). 25-50ug of 
protein was resolved by SDS-PAGE at 1W/cm between electrodes and then transferred 
onto nitrocellulose membranes. Antibodies used in this study are described in Table 2-1. 
Immunoblots were developed using Super Signal West Pico Chemiluminescence 
Substrate (Thermo Pierce #PI34578) and developed on a FluorChem HD2 Imaging 
Platform from Protein Simple.  To quantify signal, densitometry was performed using the 










Table 2-3- Table of Antibodies 
Antibody Manufacturer Product 
Number 














MabTech 3715-3-250 Mouse Human -- 1:500 
ATR  Santa Cruz 
Biotechnology 
sc-515173 Mouse Human, 
Mouse 
-- 1:200 
BAF (A-11) Santa Cruz 
Biotechnology 
 Mouse Human -- 1:1000 
BAF  Abcam ab129184 Rabbit Human 1:200 1:1000 







Chk-1 Santa Cruz 
Biotechnology 

















NB300-269 Mouse Human, 
Mouse 
1:50 1:500 
Flag (M2) Sigma Aldrich F1804 Mouse -- 1:200 1:2000 
GAPDH 
(EPR6256) 
Abcam ab128915 Rabbit Human -- 1:1000 
GFP 
(EPR14104) 
Abcam ab183734 Rabbit -- 1:200 1:1000 
GST       
H2B       







sc-374229 Mouse Human, 
Mouse 
-- 1:500 










Antibody Manufacturer Product 
Number 












14574S Rabbit Human, 
Mouse 
1:100 1:1000 
p53 (DO-1) Santa Cruz 
Biotechnology 














9532S Rabbit Human, 
Mouse 
-- 1:1000 
p-Chk1 Cell Signaling 
Technologies 












3031S Rabbit Human, 
Mouse 
-- 1:1000 
RPA   Mouse Human, 
Mouse 
-- 1:1000 
V5 Invitrogen R960-25 Mouse -- 1:100 1:1000 
Vimentin Abcam ab92547 Rabbit Human, 
Mouse 
1:200 1:1000 







2577S Rabbit Human, 
Mouse 
-- 1:1000 




Co-Immunoprecipitation of Flag-Tagged Proteins 
Cells were harvested by lysing directly in the dish using “flag-lysis buffer” 
containing: 150mM NaCl, 25mM Tris pH 7.4, 50mM EDTA, 0.1% Triton X-100, 0.01% 
NP40 and 0.1% Tween. Protease and phosphatase inhibitors were supplemented in the 
lysis buffer at a concentration of 1ug/mL of Pepstatin, 1ug/mL of Leupeptin, 1mM PMSF, 
1mM NaF, 5nM Calyculin A and 25 U/mL of Benzonase (Sigma Aldrich #E1014). Cells 
were incubated with magnetic Flag-conjugated beads (Sigma Aldrich #M8823) according 
to the manufacturer’s instructions. Lysates were incubated with beads for four hours at 
4°C with end over end rotation. Elution was performed by boiling samples for 10 minutes 
in sample buffer containing: 1% SDS, 1% b-Mercaptoethanol, 50mM Tris (pH 6.8), 6.5% 
glycerol, and bromophenol blue. Eluant was subjected to SDS-PAGE alongside inputs, 
transferred on to nitrocellulose membrane and immunoblots against Flag and the protein 
of interest were performed according to the specifications in Table 2-3.   
Immunofluorescence 
Cells were plated at equal densities on either four- or eight-well chamber slides 
(NUNC Inc. #154526 or #154534 respectively) or 35mm (20mm imaging area) glass 
bottom culture dishes (Mattek Corporation #NC9650104) either in the presence or 
absence of a substrate coating of gelatin or Matrigel described above. If no substrate was 
present, a Poly L-Lysine (Simga Aldrich #P8920) layer was coated on the glass. Cells 
were treated as desired and then fixed for 15 minutes with 4% paraformaldehyde in PBS 
(Electron Microscopy Sciences #15710) in dH2O on ice. Following PBS washes, cells were 
permeabilized with 0.2% Triton-X 100 for five minutes on ice or, using “Hetzer Buffer” 
containing: 0.1% Triton-X 100, 0.02% SDS and 10mg/mL of bovine serum albumin (BSA), 
for 30 minutes at room temperature. The latter was only used when nucleolar structures 
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were under investigation. Samples were then incubated for one hour at room temperature 
with antibodies in 3% BSA (w/v), (or Hetzer buffer when appropriate) at concentrations 
outlined in Table 2-3. Cells were then washed and incubated for one hour at room 
temperature with secondary antibodies conjugated to Alexa Fluor 488 or 596 (Life 
Technologies, 488: #A11034, 594: #A11037), or, when visualizing actin, phalloidin 
conjugated to rhodamine (Life Technologies #A12381) was used. DNA was visualized by 
staining with 4’,6’-diamidino-2-phenylindole (DAPI). Cells were then imaged on a Nikon 
Eclipse Ti microscope.  
Analysis of Nuclear Morphology  
In order to define nuclear morphology, cells were analyzed by 
immunofluorescence as described above. Specifically, Lamin A/C was used to visualize 
the nuclear envelope and DAPI to visualize the nucleus. Based on previously published 
scoring methodologies (T. P. Molitor & Traktman, 2014) in each population of cells, the 
nuclear envelope morphology was ascribed a score from one to six. Normal nuclei= 1, 
invaginated= 2, highly invaginated= 3, pinched off= 4, blebbed= 5 and multi-nucleated= 6.  
Live Imaging for Nuclear Rupture 
Flow Cytometry to Assess Mesenchymal Stem Cell Surface Markers 
Mesenchymal stem cell surface marker expression was assessed by flow cytometry using 
an MSC Phenotyping Kit (Miltenyi Biotec #130-125-285). Samples were fixed using 4% 
paraformaldehyde (Electron Microscopy Sciences #15710) at room temperature for 15 
minutes. Cells were washed with PBS and then resuspended in “FACS Buffer” containing 
0.5% BSA and 2mM EDTA in PBS, and the phenotyping cocktail provided by the kit. The 
phenotyping cocktail contains positive surface markers: anti-CD73 conjugated to 
allophycocyanin (APC), anti-CD105 conjugated to phycoerythrin (PE), anti-CD 90 
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conjugated to fluorescein isothiocyanate (FITC); and negative surface markers: anti-CD 
34, anti- CD45, anti-CD20, anti- CD14 all conjugated to PerCP-Cy5.5. Cells were 
incubated with the phenotyping cocktail for 15 minutes at 4°C. Cells were analyzed on a 
BD Fortessa X-20 Analytical Flow Cytometer. 10,000 events for each sample were 
collected, and only live, individual cells were gated on. Samples were analyzed using the 
FACSDiva software (BD Biosciences).   
Metabolic Labeling of Cells to Assess Protein Synthesis 
Cells were plated at a density of 1.5x105 cells in a 35mm culture dish. 48 hours 
later, cells were washed with methionine free media, and then labeled with 100uCi/mL of 
35S-methionine (Perkin Elmer #NEG709A500UC) for 45 minutes. As a control, cells were 
pre-treated with cycloheximide for 20 minutes at a concentration of 50ug/mL. Cells were 
harvested by scraping in ice cold PBS and lysed in lysis buffer containing 1% SDS, 1% b-
Mercaptoethanol, 50mM Tris (pH 6.8), 6.5% glycerol, bromophenol blue and 2.5U of 
Benzonase. Samples were incubated on ice for 30 minutes and then boiled for 5 minutes. 
10% (for autoradiography) and 50% (for western blotting) of each sample was loaded and 
run on a 7%-17% SDS-PAGE. For autoradiography: the gel was fixed in a solution of 50% 
Methanol, 10% Acetic Acid and 40% dH2O, then dried between two sheets of cellophane. 
The dried gel was then exposed on a phosphor-screen overnight and exposed on a 
Typhoon for quantification. For western blotting: the gel was transferred overnight on to a 
nitrocellulose membrane at 4°C at 35V then subjected to western blotting. 
Senescence Associated b-Galactosidase Staining 
Senescence associated b-galactosidase was used in order to detect β-
galactosidase activity at a pH of 6, a characteristic of senescent cells. This was done by 
examining the hydrolysis of 5-bromo-4-chloro-3-indolyl-b-d-galactopyranoside (BCIG or 
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X-gal) by β-galactosidase yielding an insoluble blue byproduct visible to the naked eye 
and by microscopy. A b-galactosidase staining kit from Cell Signaling Technology (Cell 
Signaling Technology # 9860) was used. Cells were plated on four-chamber microscopy 
slides (NUNC Inc. #154526) or 35mm (20mm imaging area) glass bottom petri dishes 
(Mattek Corporation #NC9650104). Growth media was removed from the dishes and cells 
were washed with PBS then fixed in situ using a proprietary fixative solution provided in 
the components of the kit. Next, cells were washed and then overlayed with a β-
galactosidase staining solution containing proprietary buffers and 10mg/mL of X-gal. Cells 
were incubated at 37°C overnight and then imaged by phase microscopy. Quantification 
of β-Galactosidase staining was performed by generating a scoring mechanism where 0= 
absence of blue staining in the cell, 1= partial blue staining of the perinuclear area of the 
cell and 2= complete blue staining of the perinuclear area and cytoplasm of the cell. 
Senescence was reported as the number of cells falling into one of the three categories 
described above divided by the total number of cells per condition.  
Detection of Reactive Oxygen Species 
The accumulation of reactive oxygen species (ROS) generates an oxidative 
environment within the cell. 2’,7’-Dichlorofluorescin diacetate (DCFDA), a non-fluorescent 
probe, is permeable across the plasma membrane. In the presence of oxidative 
conditions, DCFDA is de-esterified and becomes highly fluorescent and trapped within the 
cell. Cells were plated in 96-well tissue culture dishes. Cells were washed with serum free 
media prior to the addition of DCFDA (Sigma #D6883). A solution of 2.5uM of DCFDA in 
serum free media was added to the cells and incubated for 30 minutes at 37°C. Cells were 
then washed and then analyzed for fluorescence intensity at 488nm on a 
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spectrophotometric plate reader. As a positive control, cells were treated with 10uM 
hydrogen peroxide (H2O2) for 30 minutes prior to the addition of DCFDA.  
Comet Assay  
Cells were plated at an equal density in 60mm dishes and incubated for 48h. Cells 
were then treated with 50uM Etoposide for one hour. Samples were collected by scraping 
gently in 1mL PBS and then counted on a hematocytometer and diluted to 1x105 cells/mL. 
Comet assays were performed according to the Comet Assay Kit from TREVIGEN (2350-
050-K). Briefly, cells were combined with low-melt agarose and spread on a microscope 
slide by using the side of a pipet tip. Slides were then gently immersed in the provided 
lysis solution overnight in the dark. The next day slides were then aligned equidistant from 
electrodes and subjected to electrophoresis at a voltage of 1 volt/cm (between electrodes) 
at 4°C. The DNA was then ethanol precipitated in situ, then dried and stained with DAPI. 
Slides were imaged at 10X magnification and comet moment was quantified by measuring 
the vector length from the center of the comet head to the end of the comet tail.  
Assessment of Lineage Differentiation Using Histologic Stains 
In order to assess efficiency of lineage differentiation from mesenchymal stem cells 
to osteoblasts and pre-adipocytes histologic stains against a specific cell types were used. 
All samples were fixed in situ using 4% paraformaldehyde (Electron Microscopy Sciences 
#15710) for 15 minutes at room temperature. Samples were plated in duplicate in order to 
be stained with Crystal Violet as a positive stain for all cells, and to be used to calculate 
the percentage of cells that stain positive for the lineage specific markers. For osteoblasts, 
Alizarin Red (abcam #146374) was used at a concentration of 40mM. Pre-adipocytes were 
stained with Oil Red O (Simga Aldrich #O0625) at 0.5% in methanol. All samples were 
stained for 30 minutes at room temperature and then washed with dH2O and imaged on a 
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light microscope. Following microscopy, samples were solubilized for quantitative 
analysis. Samples stained with Crystal Violet were solubilized with 100% methanol, 
samples stained with Alizarin Red were solubilized with 10% Cetylpyridinium chloride 
(CPC) and samples stained with Oil Red O were solubilized with 100% Isopropanol. 
Solubilized samples were then transferred to a clear-bottom 96-well dish in triplicate and 
read on a spectrophotometer at 590mm absorption for Crystal Violet, 570mm absorption 
for Oil Red O and 540mm absorption for Alizarin Red.  
ATAC-Seq 
ATAC-Seq is a method for mapping chromatin accessibility throughout the 
genome. ATAC-Seq employs the use of hyperactive transposases that insert adapter 
sequences into accessible areas of the genome; the presence of these integrated 
adapters can then be assessed by sequence analysis (Buenrostro, Wu, Chang, & 
Greenleaf, 2015). Cell pellets prepared from in duplicate for ATAC-Seq analysis at Active 
Motif. Three analyses were used to assess differences in the accessibility of chromatin in 
these cells. The preliminary analysis was performed by using a genome browser and 
manually identifying peaks that exhibited at least a two-fold difference between the 
samples. Secondly, we examined whether there were observable differences in chromatin 
accessibility specifically at any of the following regions: distal intergenic, intronic, exonic, 
3’UTR, 5’UTR, or any promoters ranging from <1kb to 5kb. These analyses were 
performed on raw sequencing files. Following this, we filtered our reads and used Partek 
Flow Software to call peaks that specifically align at transcription start sites.  
Electron microscopy.  
Confluent 60mm dishes of confluent cells were washed with Sorensen’s buffer 
containing: 133mM Na2HPO4, 133mM KH2PO4 pH7.2, and fixed in situ with 1% 
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glutaraldehyde in Sorensen’s buffer for 30min at room temperature. Cells were collected 
by centrifugation at 800 x g for 7min and fresh fixative was added. Cells were then 
processed for conventional electron microscopy and embedded in Embed 810 resin 
(Electron Microscopy Sciences, Hatfield, PA). Thin sections were examined on a JEOL 
JEM-1010 microscope and images were taken using a Hamamatsu camera. 
Mouse Methods 
All animal procedures were performed in accordance with the protocols approved 
by the Medical University of South Carolina Institutional Animal Care and Use Committee 
(IACUC).  
Generating BANF1 A12T/+ mice 
To generate a BANF1 A12T/+ mice, Applied Stem Cell generated an allele which 
replaced a single codon in the second exon of the BANF1 gene. The codon encoding 
Alanine 12, GCA, was replaced using CRISPR/Cas9 technology, and the resultant codon, 
ACC, gave rise to a Threonine at position 12, thereby generating an A12T mutation in the 
BAF protein.  
Applied Stem Cell generated a six-mouse colony comprising three heterozygous (A12T/+) 
females and three heterozygous males. Subsequent colony expansion was performed in-
house.  
Genotyping BANF1 A12T Mice 
In the WT BANF1 allele, the codon for the 12th amino acid, alanine, is GCA. To 
generate the A12T amino acid substitution in our mice, the codon was changed from GCA 
to ACC. This codon substitution generates two de novo restriction enzyme sites. The 
BANF1 WT coding sequence contains two HPY 188III and one TSP 45I restriction enzyme 
sites whereas the mutant allele generates a novel HPY 188III and TSP 45I restriction 
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enzyme proximal to the mutation. We utilized the introduction of this unique restriction 
enzyme site in order to genotype the mice.  
Tail clips were obtained from mice at weaning by restraining the mouse in one 
hand, introducing an ear tag, and using a fresh razor, cutting 1mm from the tip of the tail, 
caudal to the end of the tail vein.  Tail clips were maintained in 1.5mL tubes on ice until all 
clips were complete.  
Tail clips were subjected to an alkaline DNA extraction by incubating them in of 
Alkaline Lysis Buffer containing: 25mM NaOH and 0.25mM EDTA in dH2O for 45 minutes 
at 100°C. Extracted DNA was subjected to polymerase chain reaction (PCR) to amplify 
exon two of the BANF1 coding sequence. Forward and reverse primers were designed 
against the flanking regions of Exon 2. Once PCR was complete, restriction enzyme 
digestion was performed on the PCR products. HPY 188III (NEB #R0622) and TSP 45I 
(NEB #R0583) were individually incubated with the amplified BANF1 Exon 2 PCR product 
for 2h according to the manufacturer’s instructions. Undigested and digested DNA were 
electophoretically resolved using a 20% polyacrylamide gel cast in TBE at 250V. Bands 
were subsequently visualized by staining with SYBR Gold (Life Technologies #S11494). 
Genotypes were analyzed based on the banding patterns described in Figure 5-2.  
X-Ray Imaging and Analysis of Mouse Skeleton 
Mice were subjected to anesthesia using 20% Isoflurane by nose cone inhalation. 
Mice were then laid on their left lateral side inside the imaging chamber of a Faxitron LX-
60 Cabinet X-Ray System. Mice were subjected to 40 kV of energy or 40 seconds and 
then x-rays were developed. Mice were revived from anesthesia spontaneously under a 
warming lamp. Skeletal measurements were taken based on anatomical landmarks. 
Measurements taken include: length of nasal bone, distance between nasomaxillary point 
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to superior incisor point, mandible length, menton to mandibular condyle, cranial length, 
occipital bone to coronal suture, coronal suture to tip of nasal bone, body length (from 
nose to anus), femur length, tibia length, humerus length, the height and width of the fifth 
lumbosacral vertebra, the distance between the top of the fourth lumbosacral vertebra to 
the bottom of the sixth lumbosacral vertebra, and the kyphosis index which is measured 
by taking the distance between the bottom of the sixth cervical vertebra to the bottom of 
the sixth lumbosacral vertebra (line AB) and the distance from the highest point in the 
curvature of the spine down to line AB, generating line CD. The ratio of line AB to line CD 
is deemed the kyphosis index. Figure x depicts the measurements made for each x-ray 
taken.  
Full Body Mouse Necropsy and Histologic Analysis 
In order to perform histopathologic studies on the mice, full body necropsies were 
performed by euthanizing mice using CO2 inhalation followed by secondary cervical 
dislocation. All organs were harvested and maintained in 10% neutral buffered formalin 
(Sigma Aldrich #HT501128). Samples were then submitted to the Division of Laboratory 
Animal Resources, Veterinary Pathology Services at the Medical University of South 
Carolina. Briefly, samples were subjected to either Hematoxylin & Eosin staining or 




Chapter 3: The Effect of BAF and BAF A12T Overexpression in Mammary 
Epithelial Cells 
Introduction 
 As discussed extensively in Chapter 1, the nuclear envelope is a highly-organized 
structure which provides a barrier between the cytoplasm and the nucleus while still 
allowing for highly regulated communication between the two cellular compartments 
(Hetzer, 2010). BAF acts as a bridge between the nuclear lamina and chromatin and 
creates an interface between the two. In addition to regulating nuclear structure, BAF is 
involved in the disassembly and reassembly of the nuclear envelope in mitosis. It is also 
thought to play a unique role in gene expression in two ways: the first is through 
transcriptional regulation, and the second through epigenetic organization of chromatin. 
At the transcriptional level, BAF has been shown to associate with multiple transcription 
factors, pointing at a potential for regulating gene expression. At the epigenetic level, BAF 
has been shown to bind histones and chromatin, thereby modifying overall chromatin 
organization. Although BAF binds dsDNA in a sequence independent manner, it also binds 
histones H3 and H1.1, and affects accessibility to chromatin through these interactions (T. 
Chandra et al., 2015; R. Montes de Oca, Lee, & Wilson, 2005; Ronglang Zheng et al., 
2000). These findings indicated to us that BAF has the capacity to influence 
chromatin organization and epigenetic regulation of gene expression. 
Rationale 
BAF is an essential protein that bridges the nuclear lamina and chromatin and 
regulates nuclear structure. Phosphorylation of BAF by VKR1 regulates its interactions 
with dsDNA, and LEM-D proteins and alters its subcellular localization (R.J. Nichols et al., 
2006).  Molitor and Traktman demonstrated in 2014 that the depletion of VRK1 resulted in 
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nuclear dysmorphia in MCF-10a cells and decreased the fraction of mobile BAF (T. P. 
Molitor & Traktman, 2014). Molitor and Traktman also published that the depletion of 
VRK1 slowed the doubling time of breast cancer cells and reduced the instances of distal 
metastases in a breast cancer model (T.P. Molitor & Traktman, 2013). Moreover, the 
homozygous inheritance of a missense mutation in BAF from Alanine 12 to Threonine 
results in a premature aging syndrome termed NGPS; patient-derived cells exhibit 
aberrant nuclear envelope structure, thereby designating it as a laminopathy (Puente et 
al., 2011). We hypothesized that the hypophosphorylation of BAF contributed to the 
nuclear envelope defect observed in VRK1-depleted cells and that the discovery of the 
A12T mutation could further inform the model generated by Molitor and Traktman and help 
elucidate the molecular mechanisms underlying these observations.  
 The BAF A12T mutation is not predicted to alter in the overall secondary structure 
of the protein: A12 is not localized in the dimerization interface of BAF, and dimerization 
is not disrupted in vitro (Nicolas Paquet et al., 2014). Furthermore, A12T mutation did not 
compromise binding to known protein partners such as Emerin, Lamin and histone H3 
protein, however purified protein exhibited decreases DNA binding (Nicolas Paquet et al., 
2014). Before the publication of the paper identifying the binding interface between BAF 
and Lamin A, the surface was thought as being important in chromatin condensation and 
histone binding (R. Montes de Oca et al., 2005; Samson et al., 2018; Segura-Totten, 
Kowalski, Craigie, & Wilson, 2002). We posited that the mutation had implications in 
chromatin structure and organization. Knowing that BAF may be involved in the regulation 
of higher order chromatin organization, we hypothesized that the spatial organization 
of the nucleus would be disrupted and that there might be an overall loss of 
heterochromatin. We further hypothesize that the loss of higher order structure in the 
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nucleus would cause a shift in gene expression profiles, which is a contributing 
factor the development of the disease phenotype.  
Chromatin conformation is tightly orchestrated spatially and temporally within the 
nucleus (Harr, Gonzalez-Sandoval, & Gasser, 2016). In an extensive review (Harr et al., 
2016), a compilation of the histone associated proteins of the nuclear envelope revealed 
the extent to which the INM proteins participated in the coordination of chromatin 
organization through histone modifications. Although BAF has been fairly well 
characterized, the role it plays in higher order chromatin organization has not yet been 
well parsed out in interphase nuclei. Given what is known about tissue-specific chromatin 
organization, we aimed to characterize the role of WT BAF and BAF A12T on higher order 
chromatin structure. Chromatin can be classified in two compartments, open, 
euchromatin, and closed, heterochromatin. Whether the overall chromatin 
organization in NGPS is altered has yet to be seen and characterizing the structural 
differences of chromatin in BAF A12T cells will provide insight into the contribution 
of higher order chromatin organization to the disease phenotype.  
Results 
Generating a Stable Mammary Epithelial Cell Line That Constitutively Expresses 3XF-
BAF or 3XF-BAF A12T Depleted for Endogenous BAF 
The clinical manifestation of NGPS results from the homozygous inheritance of the 
BAF A12T allele (Puente et al., 2011). To examine the impact of the BAF A12T mutation 
in a close-to homozygous setting, we generated MCF-10a cells that constitutively 
overexpress 3XF-BAF or 3XF-BAF A12T through a lentiviral transduction system, while 
also introducing shRNA that targets endogenous BAF. Control cells were transduced with 
a corresponding empty lentiviral vector. In order to silence endogenous BAF but not the 
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BAF introduced by the lentiviral expression system, the 3XF-BAF and 3XF-BAF A12T 
constructs had mutations introduced into the shRNA recognition sites in the 3’ 
untranslated region (UTR). Lentiviral mediated transduction of MCF-10a cells with both 
expression vectors resulted in modest overexpression of 3XF-BAF to an average of two-













Figure 3-1. Generating a Stable Mammary Epithelial Cell Line That Constitutively 
Expresses 3XF-BAF or 3XF-BAF A12T Depleted for Endogenous BAF. The first lane 
represents parental MCF-10a cells, unmodified by lentiviral transduction, the vector 
control lane represents MCF-10a cells transduced with an empty pHM vector that does 
not encode for any mammalian protein, the remaining two lanes represent MCF-10a cells 
transduced with lentiviruses encoding shRNA resistant 3XF-BAF or 3XF-A12T in order to 
introduce exogenous BAF protein. Endogenous BAF was then depleted using lentiviral 
mediated-transduction of shBAF targeting the endogenous (but not exogenous) protein. 
This model achieves near homozygous expression of either WT BAF or A12T, allowing 





















The Expression of Wild Type 3XF-BAF or 3XF-BAF A12T Does Not Alter the Doubling 
Time or Growth of Cells Compared to Vector Control 
When MCF10a cells are depleted of VRK1, the kinase responsible for 
phosphorylating BAF, the apparent doubling time increases (T.P. Molitor & Traktman, 
2013). In order to ask the question whether MCF-10a cells expressing 3XF-BAF or 3XF-
BAF A12T in a close-to homozygous background also have an altered doubling time, we 
performed four different assessments: analysis of apparent doubling time, growth by 
counting cells on a hemocytometer, MTT assay and Cell Titer Glo assay. In all cases, 
proliferation between vector control cells and cells overexpressing 3XF-BAF or 3XF-BAF 
A12T showed no significant difference. Statistical significance was determined by 
performing a student’s t-test for the assessment of apparent doubling time and non-linear 































Figure 3-2. Assessment of Proliferation in 3XF-BAF or 3XF-A12T Expressing Cells. 
(A) Apparent doubling time of vector control cells is approximately 18h, whereas cells 
expressing either 3XF-BAF or 3XF-A12T have a doubling time of approximately 20h, an 
apparent doubling time of 2h greater than vector control, but not different between the 
homozygous expression of WT 3XF-BAF and 3XF-A12T as described in Chapter 2. (B) 
Cells were seeded at equal densities and counted every day for 4 days by staining with 
Trypan Blue and counting live cells. This was repeated in 5 independent experiments and 
cell number was plotted against time to generate a growth curve. (C) Cells were plated at 
equal densities and then subjected to MTT analysis across 4 days as described in Chapter 
2. This represents 6 independent experiments. 570nm absorbance was measured on a 
spectrophotometer and plotted against time to generate a growth curve. There was no 
significant difference between the rate of proliferation  of 3XF-BAF expressing cells and 
3XF-A12T expressing cells. (D) Cells were plated at equal densities and then subjected 
to Cell Titer Glo analysis as described in Chapter 2. This represents 6 independent 
experiments. Luminescence was   measured by spectrophotometer and plotted against 
time to generate a growth curve.  Statistical analysis revealed no significant difference 
between the growth curves of cells expressing 3XF-BAF or 3XF-A12T.   
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The Homozygous Expression of 3XF-BAF A12T Results in Aberrant Nuclear Morphology 
Cells derived from patients afflicted with NGPS display a clear change in nuclear 
morphology that is characteristic of all premature aging syndromes arising from mutations 
in the components of the nuclear periphery. Expression of 3XF-BAF A12T results in the 
deformation of the shape of the nucleus. Cells were stained using a Lamin A antibody and 
were assessed by fluorescence microscopy as described above. Approximately 50% of 
the cells expressing 3XF-BAF A12T display some amount of nuclear envelopathy.  
Furthermore, using the scoring scheme described in Moltior & Traktman 2014 (T. P. 
Molitor & Traktman, 2014) the distribution of the severity of the nuclear dysmorphia was 
analyzed. Whereas vector control cells and cells overexpressing 3XF-BAF WT displayed 
normal nuclei at a frequency of 83% and 79% respectively, only 51% of cells expressing 
3XF-BAF A12T displayed a normal nuclear morphology. 35% of 3XF-BAF A12T 
expressing cells had nuclei that were assigned a score of 2 and 8% were assigned a score 



















Figure 3-3. Homozygous Expression of 3XF-A12T Results in Aberrant Nuclear 
Morphology. (A) Cells were analyzed by immunofluorescence of Lamin A to for nuclear 
morphology abnormalities. Normal nuclei were defined by a score of 1 based on the scale 
defined in Molitor & Traktman 2014, and aberrant nuclei were defined by a score >1. 50% 
of the cells expressing 3XF-A12T exhibited dysmorphic nuclei. (B) Cells expressing 3XF-
BAF  appear to have well rounded, smooth nuclei when analyzed by immunofluorescence 
of Lamin A; meanwhile, cells expressing 3XF-A12T exhibit dysmorphic nuclei that contain 
invaginations, blebs and in some cases multinuclei. (C) Using the scoring scheme defined 
in Molitor and Traktman 2014, cell nuclei were assigned a score of 1-6, with 1 defined as 
smooth round nuclei, and 6 as multinucleated and blebbed. Vector expressing cells and 
3XF-BAF expressing cells both exhibited approximately 80% normal nuclei, whereas cells 




The Homozygous Expression of 3XF-BAF A12T Does Not Alter the Steady State Levels 
of Proteins of the Nucleus 
BAF interacts with many different binding partners within the nucleus, including the 
nuclear lamins and proteins with a conserved LEM domain. We used immunoblotting and 
band analysis, in order to ask whether the steady state levels of components of the nuclear 
periphery were altered during 3XF-BAF A12T expression. The proteins of the nuclear 
lamina, together with BAF, organize the nuclear periphery to provide structure and 
modulate the functions of the nucleus. Any alterations in the steady state levels of these 
proteins could point at a loss of interaction or organization at the nuclear periphery and 
may be a contributing factor to the formation of dysmorphic nuclei in the presences of a 
homozygous expression of 3XF-A12T. Using immunoblotting and immunofluorescence, 
we assayed steady state levels and distribution of Emerin, Lamin A/C and Lamin B, and 
found that they were unchanged in the presence of homozygous 3XF-BAF A12T.  
Additionally, cells that exhibit premature aging phenotypes have an increased 
amount of heterochromatin and as such, an increase in the amount of tri-methylated 
histone 3 at lysine 9 (H3K9me3). H3K9me3 is found at sites of physiologic 
heterochromatin but also is a component of senescence associated heterochromatin foci 
(SAHF) in the context of cellular aging (Romero-Bueno, de la Cruz Ruiz, Artal-Sanz, 
Askjaer, & Dobrzynska, 2019). While senescent cells can exhibit dynamic signaling 
changes such as the upregulation of senescence associated secretory phenotype (SASP) 
components, once SAHFs have been formed, the heterochromatic structures are largely 
static and organized into repressive layers that are spatially distinct from transcriptionally 
active chromatin (Tamir Chandra & Narita, 2013). The use of H3K9me3 for analysis by 
immunofluorescence to analyze distribution and by immunoblotting to assess steady state 
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levels are, therefore, straightforward methodologies to ask whether SAHF are being 
formed in association with cellular senescence. Steady state levels of H3K9me3 were 
unaltered in the presence of homozygous expression of 3XF-A12T, and the distribution of 


















Figure 3-4. Nuclear Protein Expression and Distribution Is Unaltered by The 
Expression of 3XF-A12T. (A) Steady state levels of Lamin A/C, Lamin B and Emerin 
were analyzed by immunoblotting. Band analysis and quantification revealed no 
significant differences between the steady state levels of these NP proteins in 3XF-BAF 
expressing cells compared to 3XF-A12T expressing cells. This experiment is 
representative of 4 independent experiments. Statistical analysis was done by individual 
student’s T-tests between conditions (B) Immunofluorescence for H3K9me3 was 
performed to compare the distribution of heterochromatin foci in cells expressing 3XF-BAF 
or 3XF-A12T. The number of foci and fluorescence intensity were no different between 
cells expressing 3XF-BAF and 3XF-A12T indicating no changes in the formation of SAHF. 
(C) Immunoblot analysis of the steady state levels of H3K9me3 further indicate that the 
expression of 3XF-A12T does not result in the accumulation of H3K9me3 in the nucleus. 
Band analysis and Student’s T-tests were used to determine no significant differences 
between samples.  
79 
 
The Homozygous Expression of 3XF-BAF A12T Results in Minor Alterations in the 
Nucleus 
The nucleolus is a nuclear substructure in which the transcription of ribosomal RNA 
(rRNA) occurs. The nucleolus is a dynamic structure that responds to cellular signaling, 
stress, and metabolism.(Boulon, Westman, Hutten, Boisvert, & Lamond, 2010).  Previous 
studies have shown that in normal cells, nucleolar size and function are tightly regulated 
by the Lamin A meshwork, whereas in the context of HGPS, the Lamin A meshwork is lost 
and in turn nucleolar expansion and rRNA production increases. These phenomena result 
in an increase in nascent protein synthesis. (Buchwalter & Hetzer, 2017). Furthermore, 
nucleolar size inversely correlates with longevity. Tiku et al. demonstrated that C. elegans 
longevity mutants have reduced ribosome biogenesis, smaller nucleoli, and decreased 
protein synthesis (Tiku et al., 2017). Owing to the idea that nucleolar size can indicate 
changes in rRNA synthesis and in turn nascent protein synthesis, we asked whether 
steady state levels of a nucleolar marker, nucleolin, were altered and whether nucleolar 
number or size were altered in the context of 3XF-A12T homozygous expression. 
Measuring these nucleolar parameters was performed by fluorescence microscopy. 
Nucleoli were visualized by immunostaining for nucleolin, and DAPI was used to 
counterstain the DNA. The area of the nuclei and nucleoli were measured based on DAPI 
staining and nucleolin staining respectively and the area and the number of nucleoli were 
quantified.  
Whereas cells expressing 3XF-BAF A12T had a slightly increased nuclear area, 
the nucleolar area was decreased, and the number of nucleoli was not altered. These data 
suggest that the area occupied by the nucleoli within the nucleus is significantly smaller in 
cells expressing 3XF-BAF A12T as compared to cells with wild type BAF expression. The 
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decreased occupancy of the nucleolus within the 3XF-A12T nucleus could imply variations 
in the amount of rRNA production and overall nascent protein synthesis. The inversion of 
the phenotype, however, is intriguing. While HGPS cells exhibit nucleolar expansion, the 
homozygous expression of 3XF-A12T leads to a decrease in nucleolar area and nuclear 
occupancy. Whether these slight variations have a biological influence on the behavior of 
the cells would be determined by the overall protein turnover as assessed by metabolic 
labeling and analysis of nascent protein synthesis.  
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Figure 3-5. Assessment of Nucleoli in 3XF-BAF and 3XF-A12T Expressing Cells. (A) 
Cells were immunostained with antibodies directed against Fibrillarin, a marker of the 
fibrillar component of the nucleolus and Nucleolin, a nucleolar marker, and counterstained 
with DAPI (for DNA). Representative images are shown;  3 independent experiments were 
performed and approximately 10 fields/experiment were analyzed. (B) Nuclear size was 
analyzed by taking the total area of positive DAPI staining per cell; approximately 500 cells 
from 3 independent experiments were analyzed. Statistical significance was determined 
by multiple Student’s T-tests. The average area of vector and 3XF-BAF expressing cells 
is approximately 500um2 , whereas the average nuclear area of 3XF-A12T-expressing 
cells is approximately 600um2. (C) Nucleolar area was determined by measuring the total 
area of Nucleolin staining that is delimited by a strong outer ring, and that colocalizes with 
Fibrillarin staining. The nucleolar area is the measurement of each nucleolus in the cell, 
not the average nucleolar area per cell. Approximately 1000 nucleoli were analyzed from 
3 independent experiments and statistical significance was determined by multiple 
Students T-tests. The average nucleolar area of 3XF-BAF expressing cells and vector 
control cells is 30um2, whereas the average nucleolar area of 3XF-A12T expressing cells 
is 20um2. (D) The number of nucleoli per cell was counted by indexing any structures that 
contained were delimited by a strong outer ring of Nucleolin and that co-localized with 
Fibrillarin. The number of nucleoli per cell was taken by analyzing 50 nuclei from 3 
independent experiments. There are approximately 3 nucleoli per cell in all conditions. In 
all measurements, the mean and standard error of the mean were plotted. (E) Immunoblot 
analysis of the steady state levels of Nucleolin reveal no alterations between any of the 
conditions. Band analysis reveals no significant differences in the relative expression 
levels of Nucleolin.   
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Nascent Protein Synthesis Was Unaltered in Cells Expressing 3XF-BAF A12T 
Based on the observation that the nucleolar area was significantly smaller in cells 
expressing 3XF-BAF A12T, we asked whether the rate of nascent protein synthesis was 
altered. One of the nine hallmarks of aging is the loss of proteostasis, with a concomitant 
increase in nascent protein synthesis (Buchwalter & Hetzer, 2017; Lopez-Otin et al., 
2013). To ask whether there were alterations in protein synthesis in cells expressing 3XF-
BAF A12T, we performed metabolic labeling using 35S-methionine/cysteine. Protein 
synthesis remained unaltered in cells expressing 3XF-BAF A12T as compared to cells 
expressing wild type BAF. Therefore, even though we observed differences in nucleolar 
















Figure 3-6. Nascent Protein Synthesis is Unaltered in Cells Expressing 3XF-A12T. 
The production of nascent proteins was analyzed by pulsing the cells with 35S-
methionine/cysteine. Samples were resolved by SDS-PAGE and subjected to 
phosphorimager analysis (left). Protein synthesis was unaltered in cells expressing 3XF-
A12T compared to 3XF-BAF or vector control. These data are representative of 3 
independent experiments. Band analysis was performed, and statistical analysis was 



























Cells Expressing 3XF-BAF A12T Exhibited an Increase in the Accumulation of DNA 
Double Strand Breaks, but Do Not Accumulate Reactive Oxygen Species as a Measure 
of Cellular Stress 
The accumulation of DNA damage is one of the hallmarks of aging (Lopez-Otin et 
al., 2013). The accumulation of dsDNA breaks results in genomic instability and in some 
cases, a subsequent arrest in cell proliferation (Efeyan & Serrano, 2007). To measure 
DNA damage, we assessed the levels of RPA, p53 and gamma-H2AX steady state levels 
in cells expressing 3XF-BAF A12T as compared to those expressing wild type 3XF-BAF 
or vector controls. As a positive control, cells were treated with the DNA damaging agent 
Etoposide at a concentration of 100µM for one hour. Interestingly, cells expressing 3XF-
BAF A12T exhibited an increase in the steady state levels of gamma-H2AX in the absence 
of any exogenous DNA damaging agents, whereas the steady state levels of RPA and 
p53 remained unaltered. These results were intriguing, since the constitutive 
phosphorylation-mediated activation of histone H2AX normally leads to the activation of 
the DNA damage response pathway, and to the resolution of dsDNA breaks or cell cycle 
arrest (Itahana, Dimri, & Campisi, 2001; Jakob et al., 2011). However, as indicated by 
figure 3-2, proliferation was unaltered in these cells, indicating an ability for these cells to 
bypass the presumed accumulation of DNA damage. To further assess whether the 
activation of H2AX was truly a result of the accumulation of dsDNA breaks, we performed 
a comet assay. Single cell DNA electrophoresis indicated that there was, in fact, an 
increase in the number of DNA double strand breaks per cell in cells expressing 3XF-BAF 
A12T, as indicated by the vector length of the comet tails generated by resolved dsDNA 
on slides coated with agarose and then stained with DAPI. The presence of “basal” DNA 
damage in 3XF-A12T cells is clear, what remains unclear is the biological significance. 
The cells do not exhibit slowed proliferation, nor do they have increased levels of p53. 
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 To assess whether the genotoxic stress present in these cells results in the 
accumulation of other stress responses, we next asked whether there was an 
accumulation of reactive oxygen species. We posited that cells may accumulate reactive 
oxygen species as a result of cellular stress. Furthermore, one of the nine hallmarks of 
aging is mitochondrial dysfunction (Lopez-Otin et al., 2013). The accumulation of genomic 
stress and reactive oxygen species is also a phenomenon observed in prematurely aged 
cells. In order to measure whether cells accumulated reactive oxygen species, they were 
treated with DCFDA. ROS lead to the esterification of the substrate DCFDA, which can be 
measured by the emission of light at 488nm. As a positive control, cells were treated with 
hydrogen peroxide for one hour prior to the assay. Cells expressing 3XF-BAF A12T did 
not have a noticeable accumulation of ROS as compared to cells expressing 3XF-BAF 
WT, and both conditions had a negligible accumulation of ROS as compared to cells 
treated with H2O2. Therefore, even though genomic instability was present in these cells, 
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Figure 3-7. DNA Damage Analysis of Cells Expressing 3XF-A12T. (A) Immunoblot 
analysis of DNA damage response proteins RPA and p53 in the presence and absence 
of 100uM Etoposide for 1h. Steady state levels of RPA and p53 were not different between 
cells expressing 3XF-BAF or 3XF-A12T, nor were there differences in the response to 
exogenous DNA damage (increased levels). (B) Immunoblot analysis of γH2AX in the 
presence and absence of 100uM Etoposide was performed. The steady state level in the 
absence of exogenous DNA damage is 2-fold higher in cells expressing 3XF-A12T BAF 
in comparison to cells expressing 3XF-BAF or Vector control cells. The level of γH2AX 
increases approximately 2-fold in the presence of etoposide in control cells, whereas it 
appears that there is no further induction of this damage response in 3XF-A12T 
expressing cells. (C) A comet assay was performed on cells expressing 3XF-BAF or 3XF-
A12T in the absence and presence of 100uM Etoposide. Single cell electrophoresis was 
followed by DAPI staining to visualize DNA. Vector tail lengths were measured and plotted. 
This image is representative of approximately 25 fields per experiment, 3 independent 
experiments. Quantification was performed on approximately 500 cells, and multiple 
Students T-tests were used for statistical analysis. In each cell line the vector length of 
each comet tail increased in the presence of Etoposide, however the comet tail vector 
length was significantly greater in cells expressing 3XF-A12T in the absence of Etoposide 














Figure 3-8. DCFDA Analysis of ROS. Cells were treated with DCFDA in order to measure 
the accumulation of reactive oxygen species in the cells. Vector control cells were treated 
with H2O2 as a positive control prior to DCFDA treatment. Vector control cells, 3XF-BAF 
and 3XF-A12T cells alike had a fluorescence intensity of about 300 A.U. whereas H2O2 
treated cells had a fluorescence intensity of greater than 1500 A.U., a massive increase 





ATAC-Seq Analysis Reveals No Overall Alterations in Gene Accessibility in Cells 
Expressing BAF A12T 
ATAC-Seq is a method for mapping chromatin accessibility throughout the 
genome. ATAC-Seq employs the use of hyperactive transposases that insert adapter 
sequences into accessible areas of the genome; the presence of these integrated 
adapters can then be assessed by sequence analysis (Buenrostro et al., 2015). Proteins 
of the nuclear periphery participate directly in chromatin organization, and in the context 
of HGPS, the expression of Progerin results in differences in gene accessibility and altered 
gene expression. BAF, which directly binds to dsDNA, acts as an organizational hub at 
the nuclear periphery. We therefore posited that chromatin conformation might be altered 
in cells expressing BAF A12T, and that such changes might result in altered gene 
accessibility. As a first test of this hypothesis, cells were subjected to ATAC-Seq. Cell 
pellets prepared from our vector control, 3XF-BAF wild type or 3XF-BAF A12T cell lines 
were submitted in duplicate for ATAC-Seq analysis. After ATAC-Seq was performed (see 
Chapter 2 for details) three analyses were used to assess differences in the accessibility 
of chromatin in these cells. The preliminary analysis was performed by using a genome 
browser and manually identifying peaks that exhibited at least a two-fold difference 
between the samples. At the time of this preliminary analysis, we did not ask whether 
these peaks fell within exonic, intronic, genic, intergenic, proximal or distal promoter 
regions or other regulatory regions within the genome. Our preliminary analysis indicated 
that there were no overall differences in the accessibility the genome. In order to ask 
whether differences might be revealed with a more precise analysis, we examined whether 
there were observable differences in chromatin accessibility based on specifically 
annotated chromatin regions. When organized into these categories, we were unable to 
observe gross alterations in chromatin accessibility at any of the following regions: distal 
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intergenic, intronic, exonic, 3’UTR, 5’UTR, or any promoters ranging from <1kb to 5kb. 
Knowing that these categories did not necessarily encompass all the important regions for 
gene accessibility and expression, we further asked whether there might be alterations in 
accessibility specifically at transcription start sites. Mapping these regions and peak 
annotations revealed no gross alterations in the accessibility of chromatin at transcription 
start sites overall. Taken together, these data, ranging from broad analysis down to 
detailed annotation, indicate no changes in the accessibility of chromatin based on the 






Figure 3-9. ATAC Seq Analysis on 3XF-BAF and 3XF-A12T Expressing Cells. (A) 
Schematic of ATAC Seq methodology taken from (Buenrostro et al., 2015) depicting 
transposes attacking accessible areas of the genome that insert adapter sequences in 
open chromatin that are then amplified and sequenced. (B) Analysis of peaks of open and 
accessible chromatin organized by their genome designation. There are no differences 
between the accessibility of chromatin in cells expressing 3XF-BAF or 3XF-A12T 
regardless of their location in the genome. (C) Analysis of accessibility at the average of 
all transcription start sites. Vector control cells had a lower accessibility at transcription 
start sites in comparison to 3XF-BAF or 3XF-A12T expressing cells, however there is no 
marked difference between the accessibility at transcription start sites between 3XF-BAF 
and 3XF-A12T expressing cells. 
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Overall Heterochromatin and Euchromatin Distribution is Unaltered in Cells Expressing 
BAF A12T 
Another measure of overall chromatin organization and compaction is the ratio of 
heterochromatin to euchromatin within the cell and the amount of heterochromatin at the 
nuclear periphery. Chromatin that is associated with the lamina is often times compacted 
into foci of heterochromatin that are directly bound to Lamin A or to other components of 
the nuclear periphery; these are called Lamina Associated Domains (LADs). While cells 
expressing 3XF-BAF and 3XF-A12T did not exhibit variations in the levels and distribution 
of H3K9me3, nor were there observable differences in overall chromatin accessibility, the 
use of electron microscopy offers a unique and direct visualization of the chromatin within 
the nucleus. MCF-10a cells expressing Vector control, 3XF-BAF, or 3XF-BAF A12T were 
subjected to glutaraldehyde fixation and processed for electron microscopy. The area of 
the nucleus was analyzed at 2,000x magnification and the respective areas of 
heterochromatin and euchromatin were measured. The ratio of heterochromatin to 
euchromatin was calculated, revealing that the overall distribution of heterochromatin to 
euchromatin was largely unchanged in cells expressing 3XF-A12T compared to vector 
control. The heterochromatin at the nuclear periphery is associated with lamina associated 
domains, which, as discussed above, are generally sites of silenced genes tethered to the 
nuclear lamina. The thickness of heterochromatin was measured, and the average 
thickness of the heterochromatin at the NP was 0.002 um (+/- 0.001). There were no 
significant differences in the overall thickness of the heterochromatin at the nuclear 
periphery indicating no gross changes in the quantity of lamina associated domains in 




































































Figure 3-10. Electron Microscope Analysis of 3XF-BAF and 3XF-A12T Expressing 
Cells. (A) Cells pellets were processed for transmission electron microscopy; images were 
taken at a magnification of 2,000x. Approximately 5 fields per condition were analyzed. 
(B) The ratio of heterochromatin to euchromatin was analyzed by taking the overall nuclear 
area, and using automated measurement of heterochromatin area vs euchromatin area 
based on the pixel density. (C) Peripheral heterochromatin was measured by measuring 
the vector length between the edge of the nucleus and the end of any peripheral 




Here, we have demonstrated that the expression of BAF A12T causes a nuclear 
envelopathy in MCF10a cells. Since the BAF A12T allele is associated with a premature 
aging syndrome, our goal was to determine if this envelopathy was correlated with  
agreed-upon hallmarks of cellular aging. As described in detail in Chapter 1, the hallmarks 
of aging are: genomic instability, telomere attrition, epigenetic alterations, loss of 
proteostasis, deregulated nutrient signaling, mitochondrial dysfunction, cellular 
senescence, stem cell exhaustion and altered intercellular communication (Lopez-Otin et 
al., 2013). We asked about epigenetic alterations and the alteration of nuclear 
substructures and found that there were no significant changes in the steady state levels 
of the nuclear periphery proteins, histone modifications, or the substructures of the 
nucleus. We did find a decreased area occupied by the nucleoli; however, this was not 
met with any changes in de novo protein synthesis, indicating that there were no gross 
alterations in protein synthesis. We addressed the question of cellular senescence and 
exhaustion by asking whether the growth curves or doubling times were altered in BAF 
A12T expressing cells and found no variation in cell proliferation. We asked whether there 
was genomic instability in these cells by examining the cells for double strand break 
accumulation. While we did see an increase in the accumulation of double strand breaks, 
the remaining data indicate that these double strand breaks did not result in an increase 
in cellular stress responses. We addressed the question of mitochondrial dysfunction by 
examining the accumulation of ROS and found that cells did not accumulate ROS nor did 
they accumulate other cellular stress responses.  
Furthermore, we asked whether premature aging in this model might manifest with 
gross alterations at the level of euchromatin and heterochromatin organization. By using 
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two high resolution methodologies: electron microscopy and ATAC-Seq, we were unable 
to distinguish changes in overall nuclear organization.  
All these data together highlight that while the homozygous expression of BAF 
A12T causes a human premature aging disease, the expression of BAF A12T in an 
epithelial cell line does not recapitulate the hallmarks of cellular premature aging. It also 
highlights that while BAF A12T causes a nuclear envelopathy, nuclear envelopathies are 
not sufficient to result in a model of cellular aging and dysfunction. While on the surface 
this may appear to be a limitation, we find that a model of nuclear envelopathies lacking a 
premature aging phenotype actually presents itself as a powerful tool for the 
understanding of nuclear envelope dynamics without the downstream sequalae that arise 
from cellular stress responses.  
We posited that, since the BAF A12T-associated progeria primarily affects tissues 
of mesenchymal origin, the use of a mammary epithelial cell line might not recapitulate 
some of the cellular features of the disease. Furthermore, the model of lentiviral 
transduction to overexpress shRNA resistant 3XF-BAF or 3XF-A12T followed by the 
depletion of endogenous BAF is a somewhat complex approach to modeling a 
homozygous expression system. Therefore, we sought to address these limitations by 
generating a CRISPR/Cas9 mouse model that introduces A12T into the endogenous BAF 
locus. Generating a mouse model allows for the examination of different tissue to ask 
about cell type specificity, and the impact of the disease at the organismal level. 
Importantly, primary cells derived from these mice may also provide valuable insight into 
the etiology of the disease phenotype.  




Chapter 4: The Characterization of a Novel NGPS Mouse Model  
Introduction 
Background on Murine Models of Progeria 
Aging at the cellular level is defined by nine hallmarks (outlined in Chapter 1). At 
the organismal level, aging is characterized by the loss of function of physiologic systems 
over time, and the inability to maintain homeostasis (Blair, 1990). Clearly, the 
accumulation of cellular aging culminates in organismal aging and the sites of age-related 
pathologies are also the sites of the accumulation of senescent cells (Jeyapalan & Sedivy, 
2008). Several studies have identified genes in which mutations arise that either 
accelerate or delay the effects of aging, indicating a genetic component to this physiologic 
phenomenon (Liao & Kennedy, 2014).  
Mouse models for accelerated aging, or progeroid models, are not defined solely 
by a shortened life span, but rather must encompass the accumulation of age-associated 
pathologies. As of 2014, nine categories of genes whose alteration result in premature 
aging and/or shortened life span were established: Lamin A processing, the somatotropic 
axis, DNA repair, DNA replication, oxidative stress, sirtuins, hormones, genes involved in 
inflammation, and tumor suppressor genes. The existing mouse models for premature 
aging syndromes arising from nuclear envelopathies (see Chapter 1) all fall under the 
category of Lamin A processing mutations, thereby mirroring human HGPS (Liao & 
Kennedy, 2014). Patients with HGPS exhibit accelerated aging that involves the 
degeneration of tissues of mesenchymal origin including osteolysis and joint contracture, 
musculoskeletal disorders, severe craniofacial deformities, lipodystrophy, alopecia, 
thinning skin. Interestingly, HGPS patients also exhibit cardiovascular defects which  
ultimately  results in heart attack or stroke and death, with the lifespan of HGPS patients 
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averaging merely 13 years  (Tsiligiri, Fekos, Theodoridou, & Lavdaniti, 2014). A range of 
murine models of LMNA derived mutations have been generated in order to study the 
mechanisms of disease progression and to generate novel therapies. As detailed in 
Chapter 1, HGPS arises from a mutation in Lamin A resulting in a mutant protein termed 
Progerin.  Progerin is unable to undergo cleavage by the endopeptidase ZMPTSE24, 
resulting in Progerin’s permanent farnesylation and accumulation at the NE (Goldman et 
al., 2004). Mice with mutations in, LMNA or  the deletion of ZMPTSE24 both recapitulate 
the phenotypes observed in HGPS in humans including failure to thrive, loss of adipose 
tissue, craniofacial defects, musculoskeletal abnormalities, nuclear envelopathies, and 
premature death as a result of dilated cardiomyopathy (Navarro et al., 2004; Pendás et 
al., 2002). Interestingly, while HGPS is associated with a heterozygous mutation in LMNA, 
specifically LMNA G608G/+, in order to recapitulate the progeria syndrome in mice, the 
paralogous LMNA G609G mutation is best modeled using a homozygous LMNA 
G609G/G609G model of inheritance, highlighting an important difference between human 
manifestation of HGPS and the murine model (Fernando G. Osorio et al., 2011).  
Werner’s syndrome is a progeria syndrome arising from mutations in the WRN 
gene (Oshima, Martin, & Hisama, 1993), which encodes a protein involved in DNA repair. 
The Werner’s helicase contributes to the resolution of double strand breaks through 
homologous recombination and non-homologous end joining (NHEJ) (Thompson & 
Schild, 2002). To recapitulate this premature aging syndrome using a mouse model, 
Lombard et al. generated a WRN knockout mouse; however the WRN -/- mouse does not 
exhibit the features or clinical phenotypes of premature aging (Lombard et al., 2000). 
However, when WRN -/- mice were crossed with mice deficient for Terc, a component of 
the telomerase complex, the mice began to develop key premature aging phenotypes at 
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the organismal level, such as alopecia and osteoporosis, and at the cellular level such as 
replicative senescence and accumulation of genotoxic stress (Chang et al., 2004). This 
model is highlighted because it required a “double hit” model to capture the premature 
aging syndrome in mice, whereas the human disease results from a “single hit”.  
There are key differences between the clinical manifestation of human progeria 
syndromes and the parallel mouse models aiming to recapitulate these diseases. These 
differences highlight the complexity of developing a mouse model in order to study a 
disease state at the organismal level. 
The Study of Progeroid Primary Cells  
 Organismal aging is the culmination of cellular aging and replicative senescence 
(Campisi, 1998). The use of primary cells is therefore a useful methodology for the study 
of premature aging at the molecular and cellular levels. The first studies of HGPS patient-
derived dermal fibroblasts revealed a reduced capacity for proliferation due to a steady 
decline of the fraction of proliferating cells over time with each passage (Kill, Faragher, 
Lawrence, & Shall, 1994; Martin, Sprague, & Epstein, 1970). The presence of abnormal 
nuclei is characteristic of cells expressing mutant Lamin A, and the discovery of these 
dysmorphic nuclei pointed at the molecular etiology of the disease phenotype (Annachiara 
De Sandre-Giovannoli et al., 2003; Eriksson et al., 2003). Further, another study indicated 
that the fraction of cells with dysmorphic nuclei increases with both cellular and organismal 
age (Bridger & Kill, 2004). Together these data helped inform the subsequent studies that 
revealed the molecular pathways of cellular aging, especially those arising from insults to 
the nuclear envelope. Furthermore, the study of fibroblasts from elderly patients compared 
to HGPS-derived fibroblasts has been an excellent method of comparison between 
102 
 
physiologic and pathologic aging (Cao, Capell, Erdos, Djabali, & Collins, 2007; Scaffidi & 
Misteli, 2006).  
 While the study of patient-derived cells has been valuable in the analysis of 
premature aging syndromes, especially in the context of treatment prospects, the use of 
reprogrammed patient cells has been an important tool in analyzing the differences 
between normal cellular aging and premature cellular aging as well (Carrero et al., 2016). 
Induced pluripotent stem cells (iPSCs) derived from patient fibroblasts have provided a 
mechanism to understand the process of differentiation and the upstream mechanisms 
leading to cells prone to premature aging phenotypes. For example, in the case of 
Werner’s syndrome (WS), patient-derived fibroblasts that were reprogrammed to iPSCs 
had telomere length elongation, and restoration of cellular function, whereas when they 
were differentiated to mesenchymal stem cells they exhibited the hallmarks of premature 
aging once again (Cheung et al., 2014; Shimamoto et al., 2014).   
 In parallel to patient derived cells, primary cells derived from mouse models have 
also been valuable for the study of premature aging syndromes at the cellular level. The 
study of cells derived from ZMPTSE24 null mice established that the accumulation of 
Progerin damages the nuclear envelope, a critical and central feature of HGPS (Varela et 
al., 2005). Analysis of these cells also revealed other pathways involved in the pathologic 
aging phenotype including upregulation of p53 signaling, stem cell dysfunction and DNA 
repair defects (Liu et al., 2005; Fernando G. Osorio et al., 2011; Varela et al., 2005).  
Measuring Aging in Mice 
Premature aging syndromes arising from components of the nuclear lamina 
manifest at the cellular level with nuclear morphology defects, as outlined in Chapter 1. 
However, based on this study and others (T. P. Molitor & Traktman, 2014) a nuclear 
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envelopathy is not sufficient to generate a premature aging phenotype. Therefore, the 
measurement of premature aging in mice must rely on the accumulation of tissue 
degeneration and organ system dysfunction. Previous models of mouse aging syndromes, 
both arising as a result of LMNA mutations or other etiologies, use an array of 
measurements to assess the progression of premature aging.  
Clearly, as defined by shortened lifespans, published characterizations of 
premature aging syndrome report survival. For example, the LMNA G609/G609 murine 
model of HGPS has an average lifespan of 125 days, approximately four months, 
compared to 242 days, approximately 8 months in LMNA G609G/+ mice and the 24 month 
life span of a healthy mouse (Flurkey, Currer, & Harrison, 2007; Fernando G. Osorio et 
al., 2011). Consistent with human phenotypes, mice expressing progeria-inducing genetic 
mutations exhibit reduced growth rates and significantly lower weights compared to their 
wild type counterparts (Navarro et al., 2004; F. G. Osorio et al., 2011; Pendás et al., 2002; 
Santiago-Fernández et al., 2019).  
As mentioned previously, premature aging syndromes specifically target the 
degeneration of tissues of mesenchymal origin. Importantly, these include the bones, 
cartilage, muscle and adipose tissue. Skeletal aging specifically is defined by the 
progressive loss of function in the bone and articular cartilage. The most common clinical 
manifestations include osteoporosis and osteoarthritis (Hambright, Niedernhofer, Huard, 
& Robbins, 2019). Osteoporosis is characterized by reduced bone mass resulting from a 
loss in the balance between bone formation and resorption resulting in increased porosity, 
trabecular erosion and an increased incidence in fractures (Demontiero, Vidal, & Duque, 
2012). The many murine models of HGPS all exhibit skeletal aging features including 
osteoporosis, kyphosis, and spontaneous fractures resulting in craniofacial defects due to 
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inappropriate healing (Bergo et al., 2002; Kuro-o et al., 1997; Pendás et al., 2002).  X-ray 
analysis of the entire skeleton elucidates overall skeletal defects such as kyphosis, and 
fractures whereas micro-computed tomography (uCT) is used to assess bone density and 
volume, trabeculae number and other high-resolution analyses (Shazeeb et al., 2018). On 
the histological level, murine progeria syndromes arising from a LMNA processing 
mutation, and cells exhibit a classic nuclear envelopathy as expected, but also exhibit an 
increase in nuclear stress and cellular senescence markers, and defects at the 
microscopic level in structures of the skin, muscle, bone, cartilage and the aortic arch.  
Nestor Guillermo Progeria Syndrome: Clinical Manifestation 
As previously described above, the discovery of the BAF A12T mutation in patients 
provided insight into BAF’s role in aging. The clinical manifestations closely mirror those 
of HGPS with one marked difference: patients expressing BAF A12T do not suffer from 
the cardiovascular defects that results in the premature death of HGPS patients. As 
addressed before, the clinical manifestations of NGPS do not begin until approximately 
two years of age. Patients present with failure to thrive, skin atrophy, general lipoatrophy 
and severe osteoporosis with marked osteolysis (Puente et al., 2011). Craniofacial 
abnormalities result from the atrophy of the facial subcutaneous fat and osteolysis of the 
maxilla and mandible and incomplete closure of the cranial sutures, see figure 4-1. 
Diverging from HGPS, NGPS patients retain eyebrows and eyelashes and, importantly do 
not exhibit cardiac dysfunction, ischemia, atherosclerosis or metabolic syndromes (R. 
Cabanillas et al., 2011; H. G. Fisher et al., 2020; Puente et al., 2011). The index patient 
suffered of severe secondary pulmonary hypertension and subsequent heart failure as a 




Patients with NGPS had progressive and dramatic skeletal degeneration. Studies 
of murine models have been used to elucidate fundamental mechanisms of disease 
progression in a tissue-specific, systems-based approach. Based on the ability to replicate 
progeria syndromes in mice, albeit with some limitations and shortcomings, we aimed to 












Figure 4-1. Craniofacial Defects in Patients with NGPS. Adapted from R. Cabanillas et 
al. 2011 (Rubén Cabanillas et al., 2011). Depicted in photographs and computed 
tomography reconstructions, patients with the homozygous inheritance of BAF A12T have 
severe craniofacial defects: the skull retains open cranial sutures, the facial bones 
undergo osteolysis with complete mandibular resorption, and they exhibit a marked loss 





The Generation of a BANF A12T/+ Mouse Colony and Genotyping BANF1 Mice 
 To generate a BANF1 A12T/+ mice, Applied Stem Cell generated an allele 
which inserted the NGPS associated mutation into the second exon of the BANF1 gene, 
see Figure 4-2. Applied Stem Cell generated a six-mouse colony comprised of three 
heterozygous (A12T/+) females and three heterozygous males in a C57/B6 background. 
Subsequent colony expansion was performed in-house by mating heterozygous sires and 
dams. The colony was subsequently inbred and maintained over 6 generations and 
resulted in approximately 330 mice. Genotyping was performed at weaning. 
In the WT BANF1 allele, the codon for the 12th amino acid, alanine, is GCA. To 
generate the A12T amino acid substitution in our mice, the codon encoding Alanine 12 
was changed from GCA to ACC. This codon substitution generates two de novo restriction 
enzyme sites. The BANF1 WT coding sequence contains two HPY 188III and one TSP 
45I restriction enzyme sites, whereas the mutant allele generates a novel HPY 188III and 
a novel TSP 45I restriction enzyme proximal to the mutation (Figure 4-3 C). We took 
advantage of the introduction of this unique restriction enzyme site in order to genotype 
the mice. Genotyping PCR amplified exon two of the BANF1 coding sequence followed 
by restriction enzyme digestion of the PCR products using HPY 188III and TSP 45I. 
Undigested and digested DNA were resolved on a 20% polyacrylamide gel. Genotypes 









Figure 4-2. Alignment of human BAF and mouse BAF protein sequences. BAF is 
highly conserved between human and murine BAF sequences. Only 3 of the 89aa differ 
(blue and green). Ser4, the predominant phosphorylation site is underlined in red.  A12 














Banding Pattern Based on Genotype Using Restriction Enzyme Digest 
Restriction 
Enzyme 
Product Size (bp) Corresponding Genotype 
Uncut 222 -- 
HPY 188III 132 and 90 Wild Type (+/+) 
  132, 57 and 33 Homozygous Mutant (A12T/A12T) 
  132, 90, 57 and 33 Heterozygous (A12T/+) 
TSP 45I 140 and 82 Wild Type (+/+) 
  140, 49 and 33 Homozygous Mutant (A12T/A12T) 



























Figure 4-3. Genotyping BAF A12T Mice. The BANF1 WT coding sequence contains two 
HPY 188III and one TSP 45I restriction enzyme sites. The BANF1 A12T mutant allele 
generates a novel HPY 188-III and TSP 45-I restriction enzyme site that digests six base-
pairs downstream of the mutation. (A) DNA electrophoresis of uncut or restriction enzyme 
digested samples reveal a unique banding pattern based on mouse genotype. Lanes 4 
and 7 indicate a WT genotype based on the appearance of 2 distinct bands at 132bp and 
90bp in HPY188-III digested and at 140bp mutant allele, giving rise to new bands of 33bp 
and 57bp in the presence of HPY 188-III and bands of 49bp and 33bp in the presence of 
TSP45-I. The heterozygous mice have the appearance of all the bands due to the 
existence of one WT allele and one A12T allele. (B) Table describing the banding patterns 
based on genotype (C) Primer target for PCR amplification of exon 2 of BAF. The amplified 
PCR product in the WT allele contains pre-existing HPY188-III and TSP 45-I restriction 
enzyme digest sites. However, in the mutant allele, GCA (blue box top) is mutated to ACC 
(blue box bottom) to give rise to the A12T mutation which generates a de novo restriction 







Distribution of Phenotype and Analysis of Fertility 
 We first sought to characterize the distribution of males and females, and to 
determine whether the distribution of the mutation followed Mendelian patterns of 
inheritance. Matings were maintained between heterozygous mice, and the distribution of 
male and female mice was evenly distributed at an approximate ratio of 1:1 (Figure 4-4 
A). Furthermore, the distribution of wild type, heterozygous and homozygous mutant mice 
was distributed at approximately 25:50:25 as predicted by Mendelian patterns of 
inheritance. Next, we test-mated homozygous mutant males and females by mating 
A12T/A12T males with WT females or A12T/A12T females with WT males followed by 
crossing A12T/A12T females with A12T/A12T males, in order to ask whether they were 
fertile. Data from our lab have shown that VRK1 hypomorphic mice are infertile as a result 
of the progressive loss of spermatogonia in the testes and defects in oocyte maturation 
(Wiebe, Nichols, Molitor, Lindgren, & Traktman, 2010) and (Traktman unpublished). 
Therefore, it was an important question to ask whether a mutation in VRK1’s target, BAF, 
also resulted in defects in fertility. We assessed 15 litters per group, and we found that 
heterozygous and homozygous females both produced an average litter size of 
approximately 5 mice per litter as compared to an average of 7 pups per litter in their wild 
type counterparts (Figure 4-4 B). Pups from all groups grew and weaned appropriately 
and there was no increase in the pre-weaning mortality of heterozygous or homozygous 
mutant pups. Therefore, there were no detectable defects in fertility as a result of A12T 
expression, and A12T/+ and A12T/A12T distribution is based on classic genetic ratios.  
 To the best of our ability, we counted the number of pups born at day p=0-1 and 
then matched the number of pups at weaning. This information indicated to us that there 
was no death previous to weaning, however the loss of any pups before detection of 
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parturition could be a confounding factor since mothers scavenge dead pups. Taken 
together, these data indicate that heterozygous and homozygous A12T mice do not have 














Figure 4-4. Distribution of Genotype and Analysis of Litter Size. (A) The distribution 
of genotypes among BANF1 mouse colony. There was a similar distribution of 
heterozygous and homozygous mice among males and females alike. (B) Average litter 
































































Characterization of Lifespan and Growth 
 The average lifespan for C57/B6 mice 18-22 months, or 540 to 660 days. In HGPS 
mice, LMNA G609G/+ and G609/G609 mice have dramatically shorter lifespans of 
approximately 250 days and 100 days respectively (Fernando G. Osorio et al., 2011; Villa-
Bellosta et al., 2013). The lifespan of A12T/A12T mice is equal in length to wild type mice 
(Figure 5-5 A). We allowed the lifespan study to continue for 670 days before euthanizing 
the mice for endpoint analysis. Necropsy of the mice revealed no gross anatomical 
differences or gross abnormalities in either WT or A12T/A12T mice.  
 HGPS mice exhibit failure to thrive and exhibit body weights approximately 1/3 of 
their wild type counterparts (Zaghini et al., 2020). Therefore, we next measured the body 
weight of mice consistently between 3 and 12 weeks of age (Figure 4-6 A). No significant 
difference was observed in the growth rate between wild type and mutant mice. 
Furthermore, body weight was re-measured at 9 months of age and no significant 
difference was observed between wild type and mutant mice see Figure 4-6 A. During 
necropsy at end point analysis at 9 months of age, weights of heart, spleen, kidneys, liver, 
and lungs were all measured. No statistical significance was observed in organ weight, 
including liver weight, between wild type and mutant mice. Further, when liver weights 
were normalized to body weights, the differences between the groups was even smaller. 
These data suggest that there is no growth defect between in A12T/A12T mice and that 
















Figure 4-5. Survival Curve of BAF A12T Mice. Litter mates were maintained in a survival 
study across 670 days. The end point of this study was 22 months of age. The mice were 
then euthanized for further analysis. The p value between the survival curves is >0.9999.  
 
  
























Figure 4-6. Analysis of BAF A12T Mice Growth. (A) Mouse body weight was measured 
over time from 3 weeks of age to 12 weeks of age (left panel) n=6 per group. No significant 
difference was observed in the growth rate between wild type and mutant mice (p=0.572). 
Body weight between mice was taken at 9mo of age and no significant difference was 
observed between wild type and mutant mice (right panel) n=3 per group. (B) Liver weights 
were taken at 9mo of age after end point euthanasia. No statistical significance was 
observed between wild type and mutant mice. Further, when liver weights were 
normalized to body weights, the differences between the groups was even smaller. We 







Radiographic Analysis of BANF A12T/A12T Mice 
Mice that exhibit premature aging syndromes such as HGPS exhibit severe 
skeletal defects such as osteoporosis, craniofacial defects, and severe kyphosis (F. G. 
Osorio et al., 2011; Zaghini et al., 2020). In order to ask whether the mice expressing 
A12T/A12T developed craniofacial or skeletal defects we used radiographic analysis to 
measure different skeletal parameters. At 9 months of age, mice were anesthetized using 
isoflurane and laid on their left lateral side inside the imaging chamber of a Faxitron LX-
60 Cabinet X-Ray System. Skeletal measurements were taken based on anatomical 
landmarks. Measurements taken include: length of nasal bone, distance between 
nasomaxillary point to superior incisor point, mandible length, menton to mandibular 
condyle, cranial length, occipital bone to coronal suture, coronal suture to tip of nasal bone 
(Figure 4-8), and body length (from nose to anus), femur length, tibia length, humerus 
length, the height and width of the fifth lumbosacral vertebra, the distance between the 
top of the fourth lumbosacral vertebra to the bottom of the sixth lumbosacral vertebra, and 
the kyphosis index (Figure 4-7) which is measured by taking the distance between the 
bottom of the sixth cervical vertebra to the bottom of the sixth lumbosacral vertebra (line 
AB) and the distance from the highest point in the curvature of the spine down to line AB, 
generating line CD. The ratio of line AB to line CD is deemed the kyphosis index. There 
were no obvious defects in the living animals and the radiographic analysis revealed no 
significant differences between the measurements of the skeleton indicating that there 









































































































































Figure 4-7. Radiographic Analysis of the Skeleton. (A) Full body x-ray imaging was 
performed on 9mo old mice (n=3 per group) by irradiating at 60kV for 60 seconds. (B) 
Body length, tibia, humerus, femur and cranial lengths were all measured. No significant 
differences were observed between wild type and mutant mice except femur length  
(p=0.0335). (C) The kyphosis index is measured by taking the distance from the C7 
vertebra to the wing of the ilium (line AB); and the distance from the point of maximum 
curvature of the spine to the intersection of line AB (line CD); The kyphosis index (KI) is 
the ratio of line AB to line CD: (KI=AB/CD). No significant difference in the KI was found 
between wild type and mutant mice. Other spinal measurements such as the distance 
from L4-L6 and the height and width of L5 were assessed and no differences in these 






















































































































































































































































































Figure 4-8. Radiographic Analysis of the Head. X-ray analysis was performed on the 
heads using cranial landmarks. (A) Close up images from the full body x-rays seen in 
figure 5. (B) The ratio of cranial length normalized to body length was not significantly 
different between wild type and mutant mice, nor were the lengths of the mandible, nasal 
bone or the ratio of the mandible to the cranial length. (C) No differences were observed 
in any of the cranial structures and distances including the distance between the sutures 





































































































































Histologic Analysis of BANF A12T/A12T Mice  
 Histologic analysis of LMNA G609G/G609G mice reveals a loss of subcutaneous 
adipose tissue, reduced  hair follicle distribution and thinning of the dermal layer (S. H. 
Yang et al., 2006; Zaghini et al., 2020). Tissues derived from mesenchymal origin are 
preferentially affected by both HGPS and NGPS; therefore, we recovered tissue from the 
same mice on which radiographic analysis was performed.  Tissue samples from skin, 
long bone, and joints were sectioned and stained with H&E as described in Chapter 2. 
Histologic analysis of skin sections from A12T/A12T mice were assessed by measuring 
the subcutaneous fat thickness and the dermal thickness. There were no measurable 
differences in the distribution of the layers of the skin. Further, while there were no gross 
skeletal abnormalities between wild type and A12T/A12T mice, we looked at the structures 
of the bone and cartilage at the microscopic level. The thickness of the epiphyseal line 
was also measured alongside other bone parameters including overall organization of 
trabeculae, compact bone, and cartilage distribution. There were no differences in the 
overall histology of the long bones between wild type and A12T/A12T mice.  
 The overall histologic analysis of tissues derived from A12T mice revealed no 
abnormalities compared with wild type mice (Figure 4-9 A). This was not wholly surprising 
based on the normal skeletal architecture, normal growth rate and lifespan, and the 
absence of any gross visible anomalies between the groups of mice. From the study of 
HGPS mouse models, we know that a dominant mutation in the context of the human 
syndrome requires homozygous expression system to be recapitulated in a mouse model. 
Furthermore, in the case of WRN null mice, mice do not exhibit a premature aging 
phenotype that mimics WS until the mice are bred with Terc -/- mice. This implies that 
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generating a mouse model that mirrors human NGPS has not been as precise as modeling 















Figure 4-9 Histologic Analysis of select BAF A12T/A12T Tissue. (A) Skin section 
stained with H&E at 10x magnification in wild type and BAF A12T/A12T mice; the 
subcutaneous fat and dermal thicknesses were measured. 3-5 fields were analyzed, and 
statistical significance was determined by students T-test. (B) Section of epiphyseal line 
of the tibia stained with H&E at 40x magnification in wild type and A12T/A12T mice; the 
epiphyseal thickness was measured. 5 fields were analyzed, and statistical significance 




Analysis of Primary Dermal Fibroblasts from BAF A12T/A12T Mice 
As mentioned in the introduction to this chapter, the use of primary cells derived 
from mouse models of premature aging have been informative in dissecting some of the 
molecular mechanisms underlying disease etiology and progression. In order to generate 
a primary fibroblast cell line from WT and A12T/A12T mice, 1mm ear biopsies were 
harvested, and explant cultures were established from the outgrowth of the dermal 
fibroblasts. Our hope was that the study of these cells would reveal important pathways 
affected by homozygous inheritance of the BAF A12T mutation. The first parameter that 
we aimed to study was the proliferation of these primary dermal fibroblasts once they were 
in culture. The apparent doubling time of WT cells was approximately 25.5h, whereas the 
doubling time of mutant cells was approximately 24.3h, a negligible difference in doubling 
times between the two conditions. Furthermore, the growth curves were analyzed by 
plating cells at equal densities and counting live cells for three days after (Trypan blue 
staining). The growth curves were very similar between all the cell lines and we can 
conclude from these data that there are no differences in the proliferation of A12T/A12T 
fibroblasts compared to wild type.  
Furthermore, since the expression of A12T results in a nuclear envelopathy (Figure 
3-3), we analyzed the nuclear morphology of primary dermal fibroblasts. Cells were 
analyzed by immunofluorescent staining of Lamin A and scored based on the scoring 
schema described above. Greater than 50% of the A12T/A12T cells had an aberrant 
nuclear morphology with a score of 2 or greater. To complement this analysis, we used 
automated imaging software analysis to assess the nuclear circularity of both wild type 
cells and A12T/A12T cells. The departure from circularity in A12T/A12T expressing cells 
was significantly greater than wild type cells, as expected.  This was an excellent proof of 
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concept and solidified the data that the inheritance of homozygous A12T results in 
dysmorphic nuclear envelopes.  
However, as discussed in Chapter 3, nuclear envelopathy is strongly associated 
with a premature cellular aging phenotype. Our next analyses were therefore focused on 
whether A12T/A12T dermal fibroblasts accumulate the hallmarks of premature aging. 
While there were no differences in the rates of proliferation between wild type or 
A12T/A12T fibroblasts, we still aimed to analyze whether there was a fraction of senescent 
cells that might contribute to a premature cellular aging phenotype. We performed SA-β-
galactosidase staining on primary dermal fibroblasts and quantified the proportion of 
positively stained cells. Less than 10% of the primary dermal fibroblasts exhibited SA-β-
galactosidase positive staining, indicating that neither wild type nor A12T/A12T expressing 
cells undergo replicative senescence. Furthermore, as discussed in Chapter 3, cells that 
exhibit premature aging phenotypes usually contain an elevated  of the histone variant 
H3K9me3, which marks areas of SAHF (Romero-Bueno et al., 2019). We measured 
H3K9me3 intensity by immunofluorescence to analyze its distribution and steady state 
levels, in order to ask whether SAHF are being formed in these cells. The levels and 
distribution of H3K9me3 were unaltered in the dermal fibroblasts derived from A12T/A12T 
mice.  
To measure the induction of the DNA damage response pathway, cells were 
treated with Etoposide at a concentration of 100µM for one hour and the induction of 
gamma-H2AX was monitored. Wild type and A12T/A12T fibroblasts both appropriately 
induced the DNA damage response in the presence of etoposide and neither displayed 
any basal DNA damage. Lastly, we assayed the accumulation of ROS in primary dermal 
fibroblasts by treating cells with DCFDA. As a positive control, cells were treated with 
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hydrogen peroxide for one hour prior to the assay. There was no noticeable difference 
between wild type and A12T/A12T dermal fibroblasts in the basal level of ROS, but H2O2 































































Nuclear Envelope Score of Primary Mouse Ear Fibroblasts




Figure 4-10. Analysis of Growth and Nuclear Envelopathy in Primary Dermal 
Fibroblasts. (A) Apparent doubling of primary fibroblasts established from the outgrowth 
of dermal biopsies from two wild type mice and two A12T/A12T mice. N=15, significance 
determined by students T-tests. (2) Cells were seeded at equal densities and counted 
every day for 3 days by staining with Trypan Blue and counting live cells. This was 
repeated in 5 independent experiments and cell number was plotted against time to 
generate a growth curve. (C) Cells were analyzed by immunofluorescence of Lamin A for 
nuclear morphology abnormalities. Normal nuclei were defined by a score of 1 based on 
the scale defined in Molitor & Traktman 2013, and aberrant nuclei were defined by a score 
>1. 50-60% of the cells expressing A12T/A12T exhibited dysmorphic nuclei compared to 
wild type. Cells from four different mice WT mice and four A12T/A12T mice were analyzed. 
(D) Nuclear circularity was assessed by immunofluorescence of Lamin A, and then an 
automated software program assessed the nearness of the nucleus to a perfect circle, 
defined as 1, and the departure from a circle defined as 0>x<1. Approximately 250 cells 
were analyzed from fibroblasts cultures derived from one wild type mouse and one 
A12T/A12T mouse in 2 independent experiments. Statistical significance was determined 
by students T-test. (E) Using the scoring scheme defined in Molitor and Traktman 2013, 
cell nuclei were assigned a score of 1-6, with 1 defined as smooth round nuclei, and 6 as 
multinucleated and blebbed. WT primary dermal fibroblasts exhibited 87% normal nuclei, 
whereas only 56% of A12T/A12T dermal fibroblasts had normal nuclei, and 30% had 






















4-11. Assessment of Premature Aging Hallmarks in Primary Dermal Fibroblasts. (A) 
SA β-galactosidase staining of primary dermal fibroblasts were imaged by phase 
microscopy and then quantified. N=3 independent experiments from cultures derived from 
3 wild type mice and 3 A12T/A12T mice. (B) H3K9me3 levels in primary fibroblast nuclei 
were analyzed by immunofluorescence intensity. Cultures derived from 3 WT mice and 4 
A12T mice were analyzed in 3 independent experiments. (C) Cells were treated with 
100uM Etoposide for 1h and then subjected to immunoblotting for γH2AX as a marker of 
the induction of the DNA damage response pathway. This is representative of 3 
independent experiments using cultures derived from 1 wild type mouse and 1 A12T/A12T 
mouse. (D) Cells were treated with DCFDA in order to measure the accumulation of 
reactive oxygen species in the cells. All cells were treated with H2O2 as a positive control 
prior to DCFDA treatment. H2O2 treated cells had a fluorescence intensity of greater than 
between 250-300 A.U., a massive increase compared to the untreated cells which have a 
fluorescence intensity of less than 100 A.U. with no variations between wild type and 










 In generating a CRISPR/Cas9 A12T/A12T mouse, we were aiming to recapitulate 
some of the clinical manifestations of NGPS in mice. Taking the previous data from murine 
models of HGPS and other premature aging syndromes, we hypothesized that a novel 
NGPS mouse model would be a valuable tool used to elucidate the fundamental 
mechanisms of disease progression in a tissue-specific, systems-based approach.  
 Mouse models of premature aging have been able to recapitulate some of the 
clinical manifestations of the disease including skeletal abnormalities, failure to thrive, 
alopecia and other severe phenotypes. NGPS patients suffer from progressive and 
dramatic skeletal degeneration, scoliosis, adipolysis and alopecia. The A12T/A12T mice 
that we developed do not present a premature aging syndrome. Their lifespan is 
comparable to wild type C57/B6 mice, they grow and thrive appropriately, they do not have 
skeletal defects or abnormalities, and at the histologic level, A12T/A12T derived tissue is 
healthy and free of the hallmarks of NGPS. However, primary dermal fibroblasts derived 
from A12T/A12T mice do exhibit nuclear morphology defects, and in fact almost 60% of 
these cells display some amount of nuclear dysmorphia. This envelopathy, though, is not 
accompanied by the induction of stress responses or the onset of replicative senescence.  
 Similarly to the, WRN null mouse model, the BAF A12T/A12T mice may need to 
be stressed by “second hit”. Crossing A12T/A12T mice with mice that are deficient in 
another gene that contributes to premature aging or that is involved in mesenchymal stem 
cell maintenance or bone remodeling may begin to elucidate mechanisms of organismal 
aging involving A12T/A12T expression. In the case of HGPS, a dominant disease, mice 
expressing LMNA G609G/+ do not exhibit a severe phenotype compared to LMNA 
G609G/G609G mice. NGPS arises from the homozygous expression of BAF A12T, 
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therefore it in not possible to increase the severity of the inheritance. These complexities 
between the clinical manifestation of human progeria syndromes and the parallel mouse 
models aiming to recapitulate these diseases highlight the challenges of developing a 
mouse model to study a disease state at the organismal level. 
In Chapter 3, we hypothesized that the homozygous expression of BAF A12T 
would result in an overall loss of heterochromatin, which in turn would alter gene 
expression profiles through alterations in gene accessibility. We next asked whether we 
could recapitulate the disease phenotype with the development of an NGPS mouse model 
to assess the impact of the A12T mutation on aging at the organismal level, while also 
establishing a primary cell line to assess the cellular phenotype too. The data shown in 
both Chapters 3 and 4 clearly indicate that the primary effect of the BAF A12T mutation is 
unlikely to be at the level of chromatin organization and architecture, and that epithelial 
cells in the context of MCF-10a cells, and primary fibroblasts derived from an A12T/A12T 
both do not exhibit the effects of premature aging despite exhibiting a severe nuclear 
envelopathy. 
 In continuing to ask how BAF A12T contributes to premature aging, we shifted our 
focus from epigenetic modulation to other ways that BAF A12T may be affecting the 
nuclear envelope and why the clinical manifestations preferentially impact tissue of 
mesenchymal origin. As we were completing our analysis of the work described in this 
chapter, a publication from the Zinn-Justin lab (Samson et al., 2018) revealed a key finding 
that shifted our paradigm of BAF function. Samson et al. presented the first ternary 
structure of Emerin, BAF and the IgG fold of Lamin A. Residue ala12 of BAF is found on 
the surface of BAF that binds to Lamin A, and indeed is buried in the interface. This 
indicated to us that our assessment of BAF function would not be complete if we did not 
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integrate binding to Lamin A in our future analyses. Therefore, to continue to assess how 
BAF A12T affects the structure and function of the nucleus, our subsequent studies were 
performed using iPSCs that carried +/+ or A12T/A12T alleles at the endogenous BANF1 
locus. These isogenic, pluripotent cells can be further differentiated to different cell types 
to assess the impact of the mutation.   
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Chapter 5: The Assessment of BAF A12T Expression in Mesenchymal Stem 
Cell Maintenance 
Introduction 
 The use of patient-derived cells as a method to study premature aging syndromes 
has been a historically powerful method to study the molecular mechanisms behind the 
disease state. The ability to reprogram patient cells in to pluripotent cells provides the 
opportunity to model disease development and progression through the differentiation 
program. As reviewed in Carrero et al in 2016, several studies have been able to 
demonstrate upon reprogramming somatic cells taken from progeria patients, there was 
a reversal in age-related phenotypes reversal in age-related phenotypes including 
increased telomere length, loss of senescence and a restoration of mitochondrial fitness 
(Carrero, Soria-Valles, & López-Otín, 2016). The modeling done by previous labs in the 
study of HGPS have helped frame and inform subsequent studies of premature aging 
syndromes at the cellular level. 
 Human iPSCs resemble human embryonic stem cells in that they have the ability 
to differentiate into all somatic cells of the body (Bellin, Marchetto, Gage, & Mummery, 
2012). Studying iPSCs is particularly important in the case of premature aging, where cells 
are difficult to culture and study as a result of their replicative senescence. The limitation 
arising from the use of reprogrammed patient cells is the unavailability of matched control 
cells with identical genetic background; therefore, the study of patient cells compared to 
control cells is not a direct comparison. While this is an accepted methodology, the use of 
CRISPR/Cas9 technology to generate iPSCs with a homozygous BAF A12T mutation and 
a matched isogenic control is a more direct method of studying the contribution A12T to 
cellular aging.  
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Patients with NGPS do not begin to exhibit symptoms until approximately two 
years of age, highlighting that this is not a developmental disorder but rather a 
degenerative one. Patients suffer from severe osteolysis, adipolysis and craniofacial 
defects indicating that tissue arising from mesenchymal origin are preferentially affected 
(R. Cabanillas et al., 2011; Puente et al., 2011).  
 At the onset of our study of BAF and A12T’s roles at the nuclear periphery, we 
initially hypothesized that the contribution of A12T to premature cellular aging would result 
from alterations in chromatin organization and changes in overall gene accessibility and 
gene expression. The data indicated that the impact of A12T was not on the level of 
chromatin architecture. However, data from the Zinn-Justin lab indicate that Alanine 12 is 
found on the surface of BAF that binds to the Ig Fold of Lamin A, and that the A12T 
mutation is buried in this binding surface (Samson et al., 2018). Furthermore, since the 
BAF A12T-associated progeria primarily affects tissues of mesenchymal origin, we shifted 
from the use of mammary epithelial cells to performing our studies using iPSCs that carried 
+/+ or A12T/A12T alleles at the endogenous BANF1 locus. These isogenic, pluripotent 
cells can be further differentiated to different cell types to assess the impact of the 
mutation. 
Rationale   
 Progerias offer a pathologic model that mirrors accelerated physiologic aging. The 
study of these models has been instrumental in identifying and characterizing genetic 
mutations that perturb NE structure and function. The tissue-specificity of NGPS is poorly 
understood, but the impact on tissues of mesenchymal origin has led to the hypothesis 
that survival, proliferation or differentiation of mesenchymal stem cells (MSCs) is 
perturbed. Patient fibroblasts exhibit dysmorphic nuclei, however the molecular 
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mechanisms behind premature cellular aging in A12T -expressing cells is still unclear.  
 The homozygous expression of A12T causes dysmorphic nuclei in all cells, but the 
impact of the envelopathy varies between cell types. Using isogenic WT and A12T/A12T 
iPSCs, we aimed to differentiate them to induced MSCs (iMSCs). Using this model and 
the data from Samson et al. 2018, we hypothesize that defective BAF-Lamin A 
interactions compromise the structural network of the nuclear lamina and weaken 
the nuclear envelope.  
Results 
Generating iMSCs and hepatocytes from iPSCs 
 HGPS also preferentially affects cells of mesenchymal origin, and through the 
study of reprogrammed patient derived cells and genetically manipulated stem cells that 
express Progerin, the cell-type specific pathologies have been attributed to stem cell 
exhaustion and differentiation defects (Halaschek-Wiener & Brooks-Wilson, 2007; Scaffidi 
& Misteli, 2008). NGPS preferentially affects tissues arising from mesenchymal origin (R. 
Cabanillas et al., 2011). In order to ask whether the mesenchymal stem cell defects 
observed in HGPS are mirrored in the case of NGPS, we sought to generate a 
mesenchymal stem cell line derived from iPSCs expressing A12T. Applied Stem Cell 
generated two BAF A12T/A12T cell lines (derived from ASE-9203 iPSCs) using 
CRISPR/Cas9 technology to change the codon sequence encoding Alanine 12 in Exon 2 
of the endogenous BANF1 gene locus. iPSCs must be cultured and passaged on Matrigel 
coated dishes and do not express Lamin A, and as such, do not exhibit nuclear envelope 
dysmorphia (Dan Constantinescu, Heather L Gray, Paul J Sammak, Gerald P Schatten, 
& Antonei B Csoka, 2006). In order to address the tissue specificity behind NGPS, we 
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differentiated iPSCs to induced mesenchymal stem cells, and to a cell type that is 
unaffected by NGPS such as hepatocytes.  
 To generate iMSCs, iPSCs were plated on Matrigel coated dishes and cultured in 
FBS-containing media for 21 days in a protocol developed from Zhang et al. who 
generated iMSCs and vascular smooth muscle cells from iPSCs to study the contribution 
of Progerin expression in these models (Zhang et al., 2011). After the 21st day, cells were 
passaged onto dishes coated with 0.1% gelatin, and after three passages, cells were 
plated on uncoated tissue culture dishes. The success of this protocol is measured by the 
ability of the cells to continue to proliferate on uncoated culture dishes. When iPSCs are 
cultured on Matrigel, they appear circular and grow in colonies, with no observable 
differences between WT and A12T cells. When the cells transition into FBS-containing 
media, they begin to grow in a tightly packed monolayer and develop a lenticular shape 
until they are passaged on gelatin, where they elongate and become spindle-shaped and 
maintain tight packing between the cells. Once on plastic, wild type cells maintain a similar 
phenotype as when they are cultured on gelatin. However, when A12T expressing cells 
are cultured on plastic, they lose the spindle shape and the cytoplasm spreads to form a 
circular shaped cell. This is the first key difference that we observed between wild type 
cells and A12T expressing cells (Figure 5-1 A-B).  
 Pluripotent stem cells do not express Lamin A, whereas differentiated cells do. 
Lamin A/C is thought to play a role in the maintenance of differentiated cells.  It is also 
acts as an important factor in stem cell differentiation and plays a role in the differentiation 
of MSCs into osteoblasts and adipocytes (Bermeo, Vidal, Zhou, & Duque, 2015; Dan 
Constantinescu et al., 2006). Lamin B, is present in all cell types, and Lamin B expression 
is highest in pluripotent stem cells (D. Constantinescu, H. L. Gray, P. J. Sammak, G. P. 
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Schatten, & A. B. Csoka, 2006). The expression of Lamin B is required for proper 
organogenesis and cells that are deficient in Lamin B have misshapen nuclei and undergo 
premature cellular senescence (Y. Kim et al., 2011; Vergnes, Péterfy, Bergo, Young, & 
Reue, 2004). WT and A12T iPSCs express Emerin at equal steady state levels across 
differentiation. As expected, iPSCs do not express do not express Lamin A, and express 
Lamin B1. Once iPSCs are differentiated into iMSCs, Lamin A steady state levels increase 
and Lamin B1 levels decrease; however there is no significant difference between the 
levels of Lamin A or Lamin B steady state levels between WT iMSCs and A12T iMSCs 
(Figure 5-1 C).  
 The further characterization of the iMSCs will be discussed in upcoming sections, 
however we first wanted to demonstrate that any differences we observed in A12T 
expressing iMSCs were a direct result of the cell type specificity.  Therefore, in order to 
ask whether the phenotypes observed in A12T iMSCs are cell type specific, examined the 
effect of A12T expression in a cell type that is not affecting in NGPS patients. Hepatocytes 
are terminally differentiated epithelial cells of the liver which express Lamin A (Barboro, 
D'Arrigo, Repaci, Patrone, & Balbi, 2010). Using a well-defined differentiation protocol 
established by our MUSC colleague Stephen Duncan’s lab, WT or A12T iMSCs were 
differentiated into hepatocytes (Si-Tayeb et al., 2010). Of note, when iPSCs are 
differentiated into hepatocytes, they remain on a Matrigel substrate throughout 
differentiation. Furthermore, induced Hepatocytes are quiescent and unable to be further 
cultured once they are terminally differentiated. 
When iPSCs were differentiated into hepatocytes (kindly performed by our 
collaborator Ray Liu), the overall cellular morphology between wild type and A12T 
expressing cells was indistinguishable. Moreover, the ability of A12T iPSCs to differentiate 
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into hepatocytes and express hepatocyte specific markers was just as efficient at wild type 
(Figure 4-2 A). WT iHepatocytes and A12T iHepatocytes exhibited similar steady state 
levels of Apolipoprotein B (Apo B) and HNF4α, two functional markers of hepatocytes. 
iHepatocytes were then subjected to SA-β-Gal staining. The great majority of WT and 
A12T-expressing hepatocytes were overwhelmingly negative for SA-β-Gal staining, with 
only ~10% of the population staining partially positive or positive with Blue-Gal (Figure 5-
2 B). Lastly, we examined whether A12T-expressing hepatocytes exhibited a nuclear 
envelopathy. Nuclear dysmorphia was scored as described previously. A12T expressing 
hepatocytes exhibited a mild nuclear envelopathy, reinforcing the fact that A12T 
expression in any cell type results in aberrant nuclear envelope architecture.   
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Figure 5-1. Principal Characterization of iMSCs. (A) Phase microscopy images at 20x 
magnification of WT and A12T iMSCs in their first passage on plastic. As evidenced by 
the inlaid images, WT iMSCs exhibit elongated, spindle shaped morphology, whereas 
A12T expressing iMSCs exhibit lenticular shaped nuclei and a more rounded cell body. 
(B) Phase microscopy images at 40x magnification p.3 on plastic. The shape of the cells 
is divergent between WT iMSCs and A12T iMSCs. Where WT iMSCs are elongated and 
spindle-shaped and pack in a tight monolater, A12T expressing cells are circular and the 
cytoplasm is spread out. Furthermore, A12T iMSCs form clusters on the culture plastic 
rather than a cohesive monolayer. (C). The steady state levels of Lamin A, Lamin B1 and 
Emerin were analyzed by immunoblotting. The steady state levels of Emerin do not 
change between WT and A12T expressing cells, nor did they differ between iPSC and 
iMSCs. Lamin A is not expressed in iPSCs, and is expressed in high levels in MSCs, 
however there is no difference in the steady state levels of Lamin A between WT and A12T 
expressing iMSCs. Lamin B1 is highly expressed in pluripotent cells and diminishes in  
differentiated cells. WT and A12T iPSCs express Lamin B at similar steady state levels 
and Lamin B1 levels diminish after differentiation to iMSCs in both A12T and WT 
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Figure 5-2. Assessment of A12T Expressing Hepatocytes. WT and A12T expressing 
iPSCs were differentiated into hepatocytes. (A) Immunoblot analysis of two hepatocyte 
markers, Apolipoprotein B (ApoB) and HNF4α, reveals that there is no significant 
difference in the steady state levels of these proteins n=4. (B) SA-β-Gal treatment of 
hepatocytes was performed n=3 and cells were designated “negative”, “partial” or “full” for 
Blue-Gal staining as described above. 90% of these cells exhibited no Blue-Gal staining, 
indicating that BAF A12T-expressing hepatocytes do not become senescent. (C) Nuclear 
envelope score was determined by using the scoring scheme from Molitor & Traktman 
2014. A12T expressing hepatocytes exhibited a nuclear envelopathy compared to WT 
hepatocytes as expected n=4.   
150 
 
Characterizing A12T expressing iMSCs by Flow Cytometry and Differentiation Potential 
 Mesenchymal Stem Cells (MSCs) are multipotent stromal-like cells that are 
derived from the mesoderm (Pittenger et al., 1999). They are found in a variety of tissue 
including bone marrow, adipose tissue, bone, cartilage and the umbilical cord and are able 
to differentiate into the associated cell types to repair damaged tissue (C. Chen & Hou, 
2016; Divya et al., 2012). In 2006, the International Cellular Therapy Society established 
the minimal criteria to define mesenchymal stem cells: 1) They must adhere to and 
proliferate on tissue culture plastic 2) They must express CD73/CD90 and CD105 and 
must not contain CD45, CD45, CD20 or CD14 and 3) they must maintain their ability to 
differentiate into adipocytes, osteoblasts and chondrocytes (Dominici et al., 2006). While 
MSCs are derived from the mesoderm and are defined by their ability to differentiate into 
adipocytes, osteoblasts and chondrocytes, studies have also shown that they exhibit 
plasticity in their potency and are able to differentiate into cells of the ectodermal layer 
such as neurons, and cells of the endodermal layer such as myocytes (C. Chen & Hou, 
2016; Divya et al., 2012). Importantly, mesenchymal stem cells exhibit a homing capacity, 
in which they migrate to damaged tissue where they mitigate the immune response at the 
site of damage, and contribute to the healing process through tissue regeneration and the 
inhibition of fibrosis (Klopp, Gupta, Spaeth, Andreeff, & Marini III, 2011).  
 To continue our analysis of the iMSCs we generated, we sought to examine the 
functional characteristics of the cells. Building on the minimal requirements of defining an 
MSC, we characterized iMSCs as cells that are able to adhere to, and proliferate on, tissue 
culture plastic.  By extrapolation from the literature regarding bone marrow-derived 
mesenchymal stem cells, we postulated that our iMSCs should express the surface 
markers CD90, CD73 and CD105, and should be negative for CD34, CD45, CD20 and 
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CD14 (Dominici et al., 2006). Finally, and importantly, our iMSCs should be able to 
differentiate into cells of mesenchymal lineage such as osteoblasts and pre-adipocytes. 
We used commercially available mesenchymal stem cells as a positive control, this 
presented a caveat because these cells are derived from the adipose tissue of patients 
undergoing liposuction, and therefore, these commercial MSCs are considered hASCs, 
human adipose-derived MSCs. It is important to highlight this difference, because human 
mesenchymal stem cells arise from within the niche of the bone marrow or resident tissue 
and are exposed to a variety of signaling molecules that inform the surface markers of 
human-derived primary cells. Furthermore, conventionally MSCs are derived from the 
bone marrow (BMMSCs), a site of residence of hematopoietic stem cells (HSCs), 
therefore the importance of the surface markers is a method to distinguish HSCs from 
BMMSCs. 
 We first performed flow cytometry on commercial MSCs and wild type iMSCs by 
staining cells with surface marker-specific antibodies conjugated to different fluorophores: 
CD90-FITC, CD73-APC and CD105-PE, while the negative surface markers were all 
conjugated with –PerCP. We gated on live, individual cells to conduct our analyses and 
asked whether there were variations in the staining of any of these surface markers. As 
expected, neither the commercial MSCs nor our iMSCs expressed 
CD34/CD45/CD20/CD14. Both commercial MSCs and wild type iMSCs stained positive 
for both CD90 and CD73; however, our wild type iMSCs did not express CD105.  (Figure 
5-3 D). While Domincini et al. defined the three positive surface markers that must be 
present in mesenchymal stem cells, other studies have shown that a subpopulation of 
CD105- mesenchymal stem cells are refractory to TGF-β signaling and that have an 
increased capacity for osteogenic differentiation (Levi et al., 2011).  
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Building on these data, we performed lineage differentiations in which commercial 
MSCs and iMSCs were cultured in adipogenic-defined or osteogenic-defined media to 
generate pre-adipocytes and osteoblasts respectively. Commercial MSCs and wild type 
iMSCs both effectively differentiate into pre-adipocytes and osteoblasts as assessed by 
Oil-Red-O staining for adipocytes or Alizarin Red for osteoblasts (Figure 5-3 B). In fact, 
wild type iMSCs differentiated into osteoblasts at a greater efficiency than commercial 
MSCs, confirming the finding from Levi et al. that CD105 negative mesenchymal stem 
cells function effectively as mesenchymal stem cells. Cumulatively, these data gave us 
the confidence that our mesenchymal stem cell differentiation protocol was effective and 
resulted in functional MSCs (Figure 5-3 B).  
We therefore moved next to the differentiation and characterization of A12T-
expressing iPSCs into iMSCs in order to assess the impact of A12T on mesenchymal stem 
cells. We performed flow cytometry on wild type and A12T iPSCs and iMSCs in order to 
observe the shift from iPSC-associated surface marker expression to iMSC-associated 
surface marker expression (Figure 5-4). We found that WT and A12T iPSCs all expressed 
CD90 (expected, as CD90 is a marker of stem cells) to similar levels, and they were all 
negative for the expression of CD73/CD105 and CD34/CD45/CD20/CD14. When 
differentiated into mesenchymal stem cells, and assessed at their first three passages on 
plastic, A12T expressing iMSCs expressed CD90 to a similar level as WT iMSCs.  
Whereas WT iMSCs expressed CD73, A12T iMSCs did not. Additionally, and as expected 
from the data shown below (Figure 5-4), neither WT iMSCs nor A12T iMSCs expressed 
CD105, or CD34/CD45/CD20/CD14. Over time, A12T iPSCs begin to express one of the 
negative CD34/CD45/CD20/C14 markers (although we are unable to distinguish which 
one since they are all conjugated with the same fluorophore).  
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These data indicate that A12T iMSCs are have a reduced capacity to differentiate 
into mesenchymal stem cells compared to WT iMSCs. This was further confirmed during 
a differentiation assay in which WT iMSCs and A12T iMSCs were cultured in adipogenic-
defined or osteogenic-defined media on plastic tissue culture dishes. While WT iMSCs 
differentiated into pre-adipocytes and osteoblasts, A12T iMSCs all detached from the 
culture surface and died (data not shown). These data suggested that A12T expressing 
cells exhibited defects in differentiating into functional mesenchymal stem cells however, 
we noticed that the defect occurred over time, during passaging on plastic culture dishes. 
This lead us to believe that: either A12T iMSCs might functionally arrive at iMSCs but are 
unable to withstand culture conditions, or are unable to differentiate into iMSCs at all. We 
aimed to investigate this question further and sought to understand the etiology of the 
A12T iMSC phenotype.   
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Figure 5-3. Characterization of iMSC Phenotype (A) 10,000 cells were analyzed by flow 
cytometry. Live, individual cells were gated on and the histograms of expression of CD90, 
CD73, CD105 and CD34/CD45/CD20/CD14 were plotted. Monkey kidney epithelial cells, 
BSC40s, (Bs-Black) were used as a negative control for MSCs Commercial MSCs 
(LaCells-yellow) highly express CD90/CD73/CD105 and do not express 
CD/34/CD/45/CD20/CD14 as expected. Normal, human derived bone marrow stem cells 
were analyzed (Px-Purple) as well; however their expression profiles indicate that they are 
CD73 negative subpopulation but they were not used for further experimentation. (B) 
Absorbance of Oil Red O staining for Pre-Adipocyte staining and of Alizarin Red for 
Osteoblast staining. Samples were stained on day 23 of differentiation and then stain was 
solubilized and quantified by spectrophotometer at the appropriate wavelengths for the 
stain. Crystal Violet staining was used to normalize for cell number, and the absorbance 
was graphed. N=2 independent experiments, each performed in triplicate. Statistical 












Figure 5-4. Flow Cytometry Analysis of iPSC and iMSC Surface Markers. 10,000 cells 
were analyzed by flow cytometry. Live, individual cells were gated on and the histograms 
of expression of CD90, CD73, CD105 and CD34/CD45/CD20/CD14 were plotted. Monkey 
kidney epithelial cells, BSC40s, (Bs-Black) were used as a negative control for MSCs (A) 
iPSCs were analyzed for their surface marker expression prior to differentiation. WT iPSCs 
(iPSC 197-green) and A12T  iPSCs (iPSC CB6-pink & iPSC C1535-blue) both express 
CD90 but do not express CD73, CD105 or CD34/CD45/CD20/CD14. (B) iMSCs were 
analyzed by flow cytometry at passages 1, 2 and 3 (representative image of p.2 iMSCs). 
WT iMSCs (WT-green) express CD90 and CD73. They do not express CD105, nor do 
they express CD34/CD45/ 
CD20/CD14. A12T iPSCs (CB6-pink & C1535-blue) express CD90, but do not express 
CD73 or CD105, nor do they express CD34/CD45/CD20/CD14.   
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BAF A12T iMSCs Have Dysmorphic Nuclei 
 The homozygous expression of A12T in all cell types results in a dysmorphic 
nuclear envelope. To begin to address the impact of A12T expression on iMSC function, 
we examined nuclear envelope morphology. Cells were stained using a Vimentin antibody 
as a positive marker for mesenchymal stem cells or stromal cells, and a Lamin A antibody 
to delineate the nuclear envelope and were assessed by fluorescence microscopy as 
described above (Figure 5-5 A).  
 Approximately 60% of the A12T-expressing iMSCs display some amount of 
nuclear envelopathy (Figure 5-5 B).  Using the scoring scheme described in Molitor & 
Traktman 2014(T. P. Molitor & Traktman, 2014), the distribution of the severity of the 
nuclear dysmorphia was analyzed. Wild type iMSCs displayed uniformly normal nuclei 
(90%), whereas only 40% of A12T-expressing iMSCs exhibited normal nuclei. Highly 
dysmorphic nuclei with scores of 3 and above were seen at a frequency of approximately 
20-25% (Figure 5-5 C). The nuclear envelopathy is more severe in iMSCs than what we 
observed in the MCF-10a model. Furthermore, A12T iMSCs exhibited a greater frequency 
of micronuclei compared to WT iMSCs (Figure 4-6). Micronuclei are a post- mitotic 
phenomenon in which whole or fragmented chromosomes that were not incorporated 
during nuclear envelope reassembly are packaged into micronuclei (Luzhna, Kathiria, & 
Kovalchuk, 2013). Nuclear envelopathies are thought to arise in two ways, either through 
interphase tension within the nucleus or as a result of inappropriate nuclear envelope 
reassembly. Therefore, the presence of a severe envelopathy in A12T iMSCs could be an 
interphase phenomenon or a post mitotic phenomenon (or both), whereas the presence 









Figure 5-5. Analysis of Dysmorphic Nuclei in A12T iMSCs. (A) WT iMSCs have 
rounded, smooth nuclei when analyzed by immunofluorescence of Lamin A; in contrast, 
A12T iMSCs exhibit dysmorphic nuclei that contain severe invaginations, blebs and 
multinucleation (B) Cells were analyzed by immunofluorescence of Lamin A to for nuclear 
morphology abnormalities. Normal nuclei were defined by a score of 1 based on the scale 
defined in Molitor & Traktman 2014, and aberrant nuclei were defined by a score >1. 60% 
of the iMSCs expressing A12T exhibited dysmorphic nuclei.  (C) Using the scoring scheme 
defined in Molitor and Traktman 2014, cell nuclei were assigned a score of 1-6, with 1 
defined as smooth round nuclei, and 6 as multinucleated and blebbed. WT I MSCs 
exhibited 90% normal nuclei, whereas 20-25% of A12T iMSCs had nuclei with a score of 
3 or greater. These experiments were repeated in biological triplicate and statistical 


















Figure 5-6. Analysis of Micronuclei. WT and A12T iMSC cells were analyzed by 
immunofluorescence of Lamin A to assess for the presence of micronuclei. WT iMSCs 
only had an incidence of micronuclei at a rate of approximately 5%, whereas A12T iMSCs 
exhibited a frequency of micronuclei of 25-35%. Data shown represent 3 independent 
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BAF A12T Expressing iMSCs Exhibit Altered Actin Distribution and Nuclear Herniation 
and Rupture 
 The inner nuclear envelope contains transmembrane proteins such as the LEM 
domain proteins, but also SUN proteins that interact with Nesprins which, together form 
the LINC complex that bridges the cytoskeleton to the inner nuclear skeleton by interacting 
with Lamin A as described in Chapter 1 (Crisp  et al., 2005). The connection between the 
cytoskeleton and the nucleoskeleton influences many aspects of cellular structure and 
function, including nuclear positioning and mechanotransduction (Tapley & Starr, 2013). 
MSCs are mechanosensitive cells and their mechanotransduction and actin cytoskeleton 
arrangement are regulated by shear stress (Kuo et al., 2015). Based on the morphological 
differences we observed in the cells under phase microscopy (Figure 5-1 A&B), we sought 
to examine the actin cytoskeleton organization in WT and A12T iMSCs. Assessment of 
the actin cytoskeleton was achieved by staining cells with a Lamin A antibody and with 
Phalloidin conjugated to rhodamine to visualize the nuclear lamina and the actin 
cytoskeleton. We then quantified the actin fiber length (Figure 5-7 B), the classification of 
actin distribution (cortical actin vs stress fibers) and whether there were changes in the 
amount of actin over the nucleus. Actin fiber length corresponds to the morphological 
differences we observed under phase microscopy: WT iMSCs had elongated, spindle-like 
cell bodies, and as such had long, parallel actin fibers running the length of the cell. A12T 
iMSCs on the other hand, exhibited shorter actin fibers that crisscrossed throughout the 
cell rather than being organizing into parallel bundles. WT iMSC actin cytoskeleton was 
predominantly arranged into stress fibers, with cortical actin bundles present in the cell 
edges. A12T expressing iMSCs exhibited an increase in the distribution of cortical actin 
as opposed to stress fibers (Figure 5-7 D). Any disruptions in cell polarity may cause 
alterations in the distribution of  focal adhesions and may result in the organization of the 
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actin network into radial arcs that contain a dense meshwork of peripheral actin filaments 
and few stress fibers (McHardy, Warabi, Andersen, Roskelley, & Roberge, 2005). We 
hypothesized that the radial distribution of actin in A12T iMSCs may have altered the 
proportion of actin that passes over the nucleus. The distribution of actin “on” the nucleus, 
termed actin caps, play an important role in protecting it from external forces. Actin caps 
are longitudinal actin fibers that run parallel with the stress fibers and terminate at focal 
adhesions (Davidson & Cadot, 2021; J.-K. Kim et al., 2017). Conversely, nuclear 
confinement as a result of contractile rings surrounding the nucleus and interacting with 
the LINC complex, are responsible for insults to the nuclear envelope and are a direct 
cause of nuclear rupture and chromatin herniation in mechanosensitive cells or cells with 
compromised nuclear envelope integrity (Hatch & Hetzer, 2016). We quantified the actin 
caps on the nucleus and found that there was a decrease in the distribution of actin over 
the nucleus in A12T iMSCs compared to WT iMSCs (Figure 5-7 C). Taken together, the 
transition of parallel stress fibers to short, radial cortical fibers and the loss of actin caps 
on the nucleus in A12T expressing iMSCs, indicate that the actin network within the iMSCs 
is caging the nucleus and could in turn be causing mechanical stress on the nuclear 
envelope.  
Next, we asked whether there were gross changes in the arrangement of the actin 
cytoskeleton based on the hardness of the culture substrate. Since the diversion of the 
cellular morphology between WT and A12T expressing iMSCs was dependent on whether 
they were being cultured on Matrigel, gelatin or plastic, we cultured WT iMSCs on these 
three substrates. We then stained these cells with rhodamine-phalloidin and measured 
actin fiber length (Figure 5-7 D). Actin fiber length significantly decreased with increasing 
hardness of the substrate on which the cells were cultured. This led us to postulate that 
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mechanosensitive iMSCs begin to exhibit the deleterious effects of the A12T mutation 
once they are subcultured on plastic and the actin cytoskeleton is shortened.  Actin fiber 
shortening may result in the loss of actin caps, imparting mechanical stress on the already 
aberrant nuclear envelope.  
 Using immunofluorescence analysis of Lamin A distribution within iMSCs, we 
asked whether the radial conformation of the actin cytoskeleton was causing nuclear 
herniation and rupture as reported by Hatch in 2016 (Hatch & Hetzer, 2016). Cells were 
defined as having undergone a rupture or chromatin herniation if the DAPI staining of the 
DNA extruded beyond the Lamin A border of the nucleus. We found that 15-20% of A12T 
iMSCs exhibited instances of nuclear rupture, see Figure 5-8. This was a striking finding, 
because the leaking of nuclear material into the cytoplasm can trigger stress responses in 
the cell, including the induction of the senescence associated secretory phenotype (SASP) 
and eventual replicative senescence (Dou et al., 2017; Glück & Ablasser, 2019). The 
implication that there may be an induction of replicative senescence as a consequence of 
the expression of A12T in iMSCs points at a potential molecular etiology for the preferential 
decay of MSCs in the context of NGPS. It also highlights a newly described role for BAF 
in the context of cytoskeletal arrangement, the effects on the nuclear Lamin meshwork, 















































Figure 5-7. Actin Distribution in A12T Expressing iMSCs.  (A) Immunofluorescence 
analysis of WT and A12T iMSCs to assess actin distribution after staining with rhodamine-
phalloidin and anti-Lamin A to evaluate the nuclear envelope. WT iMSC cells had long, 
parallel actin fibers running the length of the cell. A12T iMSCs on the other hand, exhibited 
shorter actin fibers that crisscrossed throughout the cell rather than organizing in parallel 
bundles. (B) Actin fiber length was quantified and the average actin fiber length per cell of 
approximately 50 cells from 3 independent experiments was plotted. Significance was 
determined by Student’s T-Test. (C) We quantified the actin caps on the nucleus and found 
that there was a significant decrease in the distribution of actin over the nucleus in A12T 
iMSCs compared to WT iMSCs. N=3 independent experiments, statistical significance 
was determined by Student’s T-Test. (D) 75% of the actin in WT iMSCs was organized 
into stress fibers. Whereas only 30% of the actin in A12T iMSCs was distributed into stress 
fibers, and about 50% organized into cortical actin. (E) Actin fiber length was measured 
and quantified and the average actin fiber length per cell of approximately 100 cells and 2 





Figure 5-8  
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Figure 5-8. Assessment of Nuclear Rupture and Chromatin Herniation. 
Immunofluorescence of Vimentin (red), Lamin A (green) of iMSCs and DNA staining using 
DAPI (blue).  Rupture was defined as DAPI staining that extends beyond the Lamin A 
border of the nucleus. 15-20% of A12T iMSCs exhibited nuclear rupture compared to 
approximately 2.5% of WT iMSCs. n= 150 cells from 3 independent experiments and 




Premature Cellular Aging is a Result of Stress Signal Accumulation and Senescence 
 As previously mentioned, the leakage of DNA into the cytoplasm elicits a cellular 
stress response that may lead to the induction of the SASP pathway and in turn increase 
the incidence of replicative senescence (Campisi, 2013). Cellular senescence is defined 
as a cellular effector program that can be triggered in response to various stressors 
including genotoxic stress, oxidative stress, and mitochondrial dysfunction through the 
induction of the p53/p21 pathway or the p16/RB pathway (Glück & Ablasser, 2019). The 
activation of the SASP and the induction of replicative senescence is accompanied by the 
increase in senescence-associated β-galactosidase activity (a key marker used to identify 
senescent cells), as well as the hallmarks of aging described in Chapter 1 (Lopez-Otin et 
al., 2013).  
 To ask whether the incidence of nuclear ruptures result in the induction of 
replicative senescence and other cellular stress responses, we first asked whether there 
was an accumulation of ROS, measured by the intensity of DCFDA as described 
previously. A12T iMSCs cultured for just 1 passage on plastic exhibited the accumulation 
of ROS to a greater extent than wild type iMSCs treated with H2O2. This indicates that 
A12T iMSCs undergo oxidative stress, a hallmark of prematurely aged cells (Figure 5-9 
A). Next, we analyzed the steady state levels of p53, to measure whether A12T iMSCs 
had an increase in the induction of this stress response pathway. A12T iMSCs have a 4-
fold increase in the steady state levels of p53 as compared to WT controls, indicating that 
iMSCs not only accumulate ROS but also p53 in response to cellular stress (Figure 5-9 
B).  
 Lastly, we measured the presence of senescence-associated β-galactosidase in 
WT and A12T iMSCs over a period of multiple passages. This was accomplished by 
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treating cells with X-gal and measuring the amount of X-gal cleavage by β-galactosidase 
to produce Blue-Gal: a blue colored insoluble compound visible in the cell. Cells were 
classified as “negative” if they contained no blue color in the cytoplasm, “partial” if the area 
of cytoplasm was less than 50% Blue-Gal, and “positive” if the area of cytoplasm was 
greater than 50% Blue-Gal staining. As a positive control, wild type iMSCs were treated 
with 10μM H2O2 for one week leading up to the assay. During their first passage on 
plastic, only approximately 20% of A12T iMSCs exhibited any evidence of senescence. 
After just one additional passage on plastic, approximately 80% of the cells exhibited 
either partial or complete senescence. Of the 80%, only about half of these cells exhibited 
complete senescence, and with subsequent passages both the proportion of cells 
exhibiting senescence, and the ration of complete: partial senescence, increased. In 
contrast, WT iMSCs maintained a proportion of non-senescent cells of greater than 80% 
across the span of passages assessed. On the other hand, by passage 5, approximately 
70% of the A12T expressing cells and the cells treated with H2O2 exhibited complete 
senescence, and the remainder exhibited partial senescence. By this point, the iMSCs 
were no longer able to be passaged. Meanwhile, WT iMSCs were able to be passaged 
continually without a loss of proliferation capacity for at least 40 passages. These data 
supported our hypothesis that the survival and proliferation of mesenchymal stem cells 




























   






























Figure 5-9. Assessment of the Accumulation of Cellular Stress Responses and 
Senescence. (A) Cells were treated with DCFDA in order to measure the accumulation 
of reactive oxygen species in the cells. WT iMSCs cells were treated with H2O2 as a 
positive control prior to DCFDA treatment. A12T iMSCs exhibited a DCFDA intensity level 
equal to or greater than the positive control cells, indicating that A12T iMSCs were 
accumulating ROS. N=3 independent experiments, statistical significance was determined 
by Student’s T-Test. (B) Immunoblot analysis of p53 steady state levels between WT and 
A12T iMSCs exhibited that p53 steady state levels are 4-fold greater in A12T iMSCs 
compared to WT iMSCs. N=3 independent experiments. (C) SA-β-Gal staining of WT 
iMSCs, WT iMSCs treated with H2O2 and A12T iMSCs across 5 passages. Cells were 
classified as “negative” if they contained no blue color in the cytoplasm, “partial” if the area 
of cytoplasm was less than 50% Blue-Gal, and “positive” if the area of cytoplasm was 
greater than 50% Blue-Gal staining.   
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A12T BAF Exhibits Defective Binding to Lamin A  
 Data from the Zinn-Justin lab indicate that Alanine 12 of BAF is found on the 
surface of BAF that binds to the Ig Fold of Lamin A, and that the A12T mutation is buried 
in this binding surface (Samson et al., 2018). By revealing the interface between the BAF 
dimer and the Lamin A Ig Fold domain, Samson et al mapped several residues found on 
the Lamin A Ig Fold that are frequently mutated in atypical progerias (Figure 5-10 A). Their 
preliminary data indicated that there was diminished binding between Lamin A and BAF 
A12T, suggesting that the complex between BAF and Lamin A/C is destabilized in the 
context of NGPS and other progeroid syndromes. We posited that this data could be the 
puzzle piece that tied together the phenotypes seen in the mechanosensitive iMSCs and 
the etiology of the loss of the structural integrity of the nucleus. Furthermore, taking what 
was shown in Chapter 1 about the biochemical analysis of BAF A12T, the previously 
known functions of BAF were unaffected by the mutation. With LEM-domain binding, DNA 
binding, phosphorylation by VRK1 and intracellular half-life all appearing to behave similar 
to WT BAF, we were perplexed by how the mutation was affecting BAF function. The 
surface on which A12T appears on the BAF dimer originally piqued our interest as a 
binding surface. Previous reports had mapped that surface as being involved in histone 
binding and chromatin compaction- which helped inform the hypothesis we established in 
Chapter 3 (R. Montes de Oca et al., 2005). Given our data (Chapter 3) indicating that 
A12T’s effect on the cell is not at the level of chromatin organization, and using this data 
from Samson et al. 2018 study, we hypothesized that the loss of the BAF-Lamin A 
interaction in the presence of A12T destabilizes the Lamin A meshwork within the nucleus, 
causing mass cytoskeletal rearrangements which in turn cause nuclear rupture, chromatin 
herniation and ultimately replicative senescence.  
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 To test the BAF: Lamin A interactions directly, we performed in vitro co-
immunoprecipitation assays.  Lysates prepared from bacteria programmed to express 
recombinant GST-Lamin A Ig fold  (WT, R453C or R527H) were applied to Glutathione-
sepharose beads, and then purified BAF WT or BAF A12T were added to the beads 
containing the immobilized GST-Lamin A-IgF. After binding was allowed to occur, beads 
were washed carefully and both inputs and eluates were resolved electrophoretically and 
subjected to immunoblot analysis to visualize both GST-Ig Fold Lamin A and BAF.  
 WT BAF readily bound to GST-Lamin A WT, and as demonstrated by the Zinn-
Justin lab, did not bind to Lamin A R435C or R527H. These two mutant alleles are 
implicated in atypical progerias that are buried in the BAF: Lamin A interface. While 
Samson et al. observed diminished binding of A12T to Lamin A, in our hands we saw a 













Figure 5-10. In Vitro Binding Assay of Lamin A with BAF. (A) Binding surface between 
Lamin A Ig fold (gray) and BAF dimer (green) taken from (Samson et al., 2018). 
Highlighted in red are the residues that cause atypical progeria when mutated. Highlighted 
in blue are the residues on BAF that are involved in the BAF:Lamin binding interface. G47 
between the BAF dimers (purple) is required for dimerization. (B) GST-tagged Ig fold of 
Lamin A (either WT, R435C or R527H) was immobilized on glutathione sepharose beads 
and then incubated with purified recombinant WT or A12T BAF. WT BAF readily bound 
the Ig fold of Lamin A, but did not bind to the two LA-IgF mutants shown to abrogate 
binding, R435C and R527H. On the other hand, A12T was unable to bind WT Lamin or 
any of the mutant Lamins at all. N=4 independent experiments.  (Purified BAF proteins 





 The study of progerias offers a pathologic model that provides insight into 
accelerated physiologic aging and has been a valuable tool for characterizing the 
molecular mechanisms of premature aging, specifically in the context of perturbations to 
the nuclear envelope.  
Patients that are affected by premature aging syndromes exhibit degeneration of 
tissue derived from mesenchymal origin. Studies examining the tissue specificity in the 
context of HGPS led to the hypothesis mesenchymal stem cell survival and proliferation, 
and it is thought that patient MSC reservoirs are depleted as a result. We sought to identify 
the molecular mechanisms behind NGPS’s tissue specificity and to understand whether 
the homozygous expression of A12T preferentially impacted mesenchymal stem cells.    
 A12T expressing iMSC cellular morphology diverges greatly from WT iMSCs and 
instead of elongated cell bodies with spindle-like morphology, they are circular with spread 
out cytoplasms and lenticular nuclei. In order to understand these functional and 
morphological differences, we assessed the actin cytoskeleton of these cells and found 
that iMSCs exhibit changes in actin arrangement. WT iMSC actin is organized into 
elongated, parallel stress fibers running the length of cell, whereas A12T iMSCs exhibit 
shorter fiber length, organized in radial arcs around the nucleus. The confinement of the 
nucleus by these radial bundles and loss of actin caps causes an increase in the 
mechanical stress on the nucleus, and in turn results in an increased incidence of nuclear 
rupture.  
 The downstream effects of these morphological differences and nuclear rupture 
includes the leakage of DNA into the cytoplasm results the accumulation of reactive 
oxygen species, increased p53 signaling and eventual complete replicative senescence. 
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Knowing that these cells do not exhibit these phenotypes when cultured on Matrigel or 
gelatin, we posit that the mechanosensitive nature of mesenchymal stem cells, coupled 
with A12T’s effect on the nuclear envelope leads to nuclear rupture in A12T expressing 
cells, where WT expressing iMSCs are able to withstand the mechanical forces. 
Furthermore, BAF’s interaction with the Lamin A meshwork of the nucleoskeleton may be 
a stabilizing force within the nucleus. A12T is unable to bind the Ig fold of Lamin A and in 
turn destabilizes the nucleoskeletal meshwork. Since the nucleoskeleton is bridged to the 
cytoskeleton through the LINC complex’s direct interaction with Lamin A, the 
destabilization of the Lamin A:BAF interaction results in an inability to withstand 
mechanical forces arising from the mechanotransduction of mechanical forces along the 
actin network. See Figure 5-11. 
 Through the understanding that the mechanosensitive nature of iMSCs 
predisposes these cells to nuclear deformation when cultured on hard substrates, and that 
the expression of A12T in these cells exacerbates nuclear deformity and induces nuclear 
rupture and DNA leakage, it became clearer why A12T iMSCs exhibit stem cell 
dysfunction. While the pre-iMSCs are cultured on softer substrates such as Matrigel and 
gelatin, the actin cytoskeleton exerts less force on the nuclei. Once moved to a harder 
substrate, A12T nuclei are prone to catastrophic mechanical stress and as such are 
unable to proliferate efficiently on plastic. Flow cytometry and differentiation assays were 
performed on iMSCs that had already been subcultured on plastic, undergone nuclear 
deformation by the actin cytoskeleton and may have already begun to undergo replicative 
senescence. While it’s easy to dismiss these cells as not falling under the classification of 




 Importantly, these data are specific to iMSCs and none of these effects are 
observed in hepatocytes derived from A12T expressing iPSCs. This leads us to believe 
that the effects seen are a result of the mechanosensitive nature of MSCs and that the 
deleterious effects of the A12T mutation on tissue derived from mesenchymal origin in 
patients are a result of the direct effect the A12T mutation has on mesenchymal stem 
cells. 
 By elucidating the contribution of BAF to the stabilization of the Lamin A meshwork 
and its novel role in mechanotransduction, we have gotten closer to understanding the 
molecular mechanisms of A12T’s contribution of premature cellular aging in mesenchymal 
stem cells. However, in order to strengthen these findings, we must establish whether the 
loss of Lamin A binding to BAF through other mutations on the BAF binding interface 
results in nuclear envelopathy and premature cellular senescence as well. Furthermore, 
we would benefit from examining whether we are able to reverse these effects by moving 
A12T iMSCs from a hard surface, like plastic, onto a softer substrate such as Matrigel; or 
by relieving the stress imparted by the actin cytoskeleton through treatment with either a 
pharmacologic agent such as Blebbistatin, or through the genetic manipulation of the LINC 

























Figure 5-11. Model of A12T Contribution to iMSC Dysfunction. Pink= Matrigel, 
gray=gelatin, red= actin cytoskeleton dark blue= nucleus inlay= Lamin A and BAF binding 
interface (A) When WT iMSCs are cultured on varying substrates, their in-tact nuclear 
envelope is able to withstand the actin rearrangement that occurs on harder substrates 
and the cells do not exhibit any functional differences. (B)  A12T iMSCs exhibit nuclear 
envelope defects regardless of the substrate on which they are cultured, however when 
they are cultured on a hard substrate such as plastic, the actin rearrangement results in 
radial actin bundles caging the nucleus and including nuclear rupture and chromatin 
herniation. The reason the nuclear envelope is unable to withstand these forces falls back 
on to the loss of BAF-Lamin A binding in A12T expressing cells. The destabilization of this 
interaction in turn destabilizes the Lamin A meshwork within the nucleus and the cells are 
unable to withstand mechanical forces transduced along the actin network on a hard 
substrate such as plastic. As a result, DNA leaks into the cytoplasm causing the 




Chapter 6: Discussion 
The studies emerging about the complexity and dynamic nature of the nuclear 
envelope have been garnering the attention of more and more research groups in recent 
years. The categorization of a subset of diseases associated with components of the 
nuclear lamina, laminopathies, has elucidated the contribution of the nuclear lamina to the 
maintenance of cell homeostasis, nuclear structure and function and cellular aging.  
BAF is an essential protein that bridges the nuclear lamina and chromatin and 
regulates nuclear structure. Phosphorylation of BAF by VKR1 regulates its interactions 
with dsDNA, and LEM-D proteins and alters its subcellular localization (R.J. Nichols et al., 
2006).  Molitor and Traktman demonstrated in 2014 that the depletion of VRK1 resulted in 
nuclear dysmorphia in MCF-10a cells and decreased the fraction of mobile BAF (T. P. 
Molitor & Traktman, 2014). Molitor and Traktman also published that the depletion of 
VRK1 slowed the doubling time of breast cancer cells and reduced the instances of distal 
metastases in a breast cancer model (T.P. Molitor & Traktman, 2013). Moreover, the 
homozygous inheritance of a missense mutation in BAF from Alanine 12 to Threonine 
results in a premature aging syndrome termed NGPS; patient-derived cells exhibit 
aberrant nuclear envelope structure, thereby designating it as a laminopathy (Puente et 
al., 2011). We hypothesized that the hypophosphorylation of BAF contributed to the 
nuclear envelope defect observed in VRK1-depleted cells and that the discovery of the 
A12T mutation could further inform the model generated by Molitor and Traktman and help 
elucidate the molecular mechanisms underlying these observations.  
At the onset of this study, we hypothesized that the surface on which the A12T 
mutation occurred was important in chromatin condensation and histone binding (R. 
Montes de Oca et al., 2005; Samson et al., 2018; Segura-Totten et al., 2002). We posited 
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that the mutation had implications in chromatin structure and organization. To examine 
the contribution of BAF A12T on the spatial organization within the nucleus, we generated 
a model in MCF-10a cells wherein we modestly overexpress shRNA resistant 3XF-BAF 
or 3XF-A12T while depleting endogenous BAF in order to approach near homozygous 
expression.  
We demonstrated that the expression of A12T causes a nuclear envelopathy in 
MCF10a cells and sought to examine the different aspects of cellular aging such as 
genomic instability, epigenetic alterations, alterations in protein synthesis, cellular 
senescence, and the accumulation of reactive oxygen species (Lopez-Otin et al., 2013). 
We determined there were no significant changes in the steady state levels of the nuclear 
periphery proteins, histone modifications, or the substructures of the nucleus; nor were 
there alterations in de novo protein synthesis. A12T expressing cells did not exhibit 
accumulation of cellular stress responses, nor did we observe and variation in cell 
proliferation. Furthermore, we asked whether premature aging in this model might 
manifest with gross alterations at the level of euchromatin and heterochromatin 
organization. Using electron microscopy and ATAC-Seq, we were unable to distinguish 
changes in overall nuclear organization. The data show that there were no gross 
alterations in chromatin compaction, indicating that alterations in gene accessibility and 
severely altered gene expression are unlikely to be responsible for the defects seen at the 
nuclear envelope and eventual premature cellular aging phenotype. 
The data generated from addressing questions of premature aging in MCF-10a 
cells indicates that this model does not mirror the hallmarks of premature cellular aging.  
However, we learned from these analyses that while BAF A12T causes a nuclear 
envelopathy, nuclear envelopathies are not sufficient to result in cellular aging and 
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dysfunction. This finding presents a unique opportunity to address the contributions of 
BAF to the architecture of the nuclear envelope without the cell suffering the deleterious 
effects of premature aging and eventual replicative senescence.  
Murine models of HGPS and other premature aging syndromes have been able to 
recapitulate some of the clinical manifestations of the disease.  We theorized that 
generating a novel NGPS mouse model would be a valuable tool used to elucidate the 
fundamental mechanisms of disease progression in a tissue-specific, systems-based 
approach. To achieve this, we contracted with Applied Stem cell to generate A12T/+ mice 
using CRISPR/Cas9 technology, with the aim of mirroring the clinical manifestations of 
NGPS.  
While the A12T/A12T mice do not present a premature aging syndrome, primary 
dermal fibroblasts derived from A12T/A12T mice exhibit nuclear morphology defects. At 
the cellular level, this envelopathy, was not accompanied by cellular stress responses or 
replicative senescence. The complexities between the clinical manifestation of human 
progeria syndromes and the parallel mouse models aiming to recapitulate these diseases 
highlight the challenges of developing a mouse model to study a disease state at the 
organismal level. The reasons why some murine models are unable to recapitulate the 
disease model or require more severe patterns of inheritance is unclear. While there are 
most certainly differences between human and mouse physiology, it remains unknown 
why the inheritance of A12T/A12T in mice does not cause a premature aging syndrome. 
Unknown redundancy mechanisms in the mice may be masking the contributions of the 
A12T to protect the cell and organism from its deleterious effects. Crossing A12T/A12T 
mice with other mouse models of premature aging, or mice with defects in the tissues of 
mesenchymal origin may aid in revealing the ways in which A12T contributes to the 
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process of organismal aging and mesenchymal stem cell maintenance. Mesenchymal 
stem cells are found in many tissue types and behave as the reservoir for tissue 
regeneration after injury. They also exhibit homing capabilities and immuno-modulatory 
functions (Pittenger et al., 1999). Therefore, while A12T expressing mice do not exhibit 
defects in premature aging, we have not examined whether the expression of A12T results 
in defective wound healing or tissue regeneration after injury such as bone breaks. 
Additionally, harvesting bone marrow from these mice to ask whether the proportion of 
BMMSCs is different over time as the mice age, or characterizing whether they exhibit 
premature cellular aging similar to the iMSCs generated from iPSCs would answer the 
question of cell type specificity vs species specificity as well.  
Dermal fibroblasts derived from A12T/A12T mice exhibited nuclear envelope 
dysmorphia but did not exhibit markers of premature cellular aging. In the same way that 
stressing the mouse model with a “second hit” through genetic or injury, future studies of 
the primary dermal fibroblasts with additional stress might reveal differences between WT 
and A12T expressing cells that would have remained undetected in an “unstressed” 
model. BAF has been shown to play an important role in the recognition and repair of 
nuclear ruptures by binding to herniated chromatin and recruiting INM proteins and their 
associated membranes with the help of ESCRT-III machinery (Halfmann et al., 2019; 
Young et al., 2020). Using microfluidics chambers as a model for confined migration BAF 
and A12T expressing dermal fibroblasts could be examined for differences in the ability to 
withstand confinement and mechanical stress (how quickly it ruptures in confined spaces) 
and assess the repair efficacy in A12T expressing cells.  
Our initial hypothesis relied on the idea that surface of BAF on which the A12T 
mutation occurs was a result of altered interactions with chromatin and histones. 
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Furthermore, we posited that generating a model system for the analysis of A12T’s impact 
on organismal aging, and cellular aging through an expression system that introduced 
A12T in the endogenous locus would provide us with clearer insight on the disease 
etiology. Moreover, the causes for the tissue-specificity of NGPS are unclear, but the 
impact on tissues of mesenchymal origin led us to the hypothesis that survival, 
proliferation or differentiation of mesenchymal stem cells is perturbed.  
Therefore, to examine the effect of A12T expression on MSCs we transitioned from 
the use of MCF-10a cells to isogenic iPSCs that carried +/+ or A12T/A12T alleles at the 
BANF1 locus. W differentiated the iPSCs into induced mesenchymal stem cells (iMSCs), 
or a cell type unaffected by NGPS. We were able to establish that there were no functional 
defects in A12T iPSCs differentiated into hepatocytes. While A12T hepatocytes exhibit a 
mild nuclear envelopathy, they express hepatocyte markers at similar levels to WT 
hepatocytes, and do not exhibit cellular senescence.  
We established a differentiation protocol from iPSCs to iMSCs and were able to 
show that WT iMSCs were functional as stem cells and efficiently differentiated into 
osteoblasts and pre-adipocytes. The first distinction we observed between WT and A12T 
iMSCs was a notable morphological difference. To examine this further, we analyzed the 
actin cytoskeleton using immunofluorescence. We observed that the actin cytoskeleton of 
WT iMSC is organized into elongated, parallel stress fibers running the length of cell, 
whereas A12T iMSCs exhibit shorter fiber length, organized in radial arcs around the 
nucleus. The radial distribution of actin and confinement of that imparts mechanical stress 
on the nucleus, resulting in an increased incidence of nuclear rupture and the leakage of 
the components of the nucleus into the cytoplasm.  The downstream effects of the leakage 
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of DNA into the cytoplasm results the accumulation of reactive oxygen species, increased 
p53 signaling and eventual complete replicative senescence.  
The dependence of these phenotypes on substrate hardness was intriguing to us. 
Knowing that these cells do not exhibit these phenotypes when cultured on Matrigel or 
gelatin, we proposed that A12T’s effect on the nuclear envelope leads to nuclear rupture 
in A12T-expressing, mechanosensitive iMSCs on hard substrates, whereas WT 
expressing iMSCs are able to withstand the mechanical forces. Furthermore, the 
publication of the ternary structure of a LEM-D protein, BAF and the IgG fold of Lamin A 
revealed that Alanine 12 is buried in the of BAF-Lamin A interface (Samson et al., 2018). 
Using the data from Samson et al. 2018, we pursued the hypothesis that the A12T 
mutation diminishes the interaction with Lamin A, and the loss of the interaction 
compromises the structural network of the nuclear lamina and weakens the nuclear 
envelope. 
BAF’s interaction with the Lamin A meshwork of the nucleoskeleton is a stabilizing 
force within the nucleus. While WT BAF is able to bind the Ig Fold of Lamin A, A12T is 
unable to bind the Ig fold of Lamin A and in turn destabilizes the nucleoskeletal meshwork. 
Through the interaction of the cytoskeleton with the nucleoskeleton and in turn, Lamin A, 
the destabilization of the Lamin A: BAF interaction results in an inability to withstand 
mechanical forces arising from the mechanotransduction of mechanical forces along the 
actin network. We were able to reveal a novel role for BAF in mechanotransduction and 
the stabilization of the Lamin A meshwork within the nucleus. This observation is relevant 
to one the molecular mechanisms by which the BAF A12T allele contributes to premature 
cellular aging in mesenchymal stem cells.  
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 The elastic modulus of Matrigel is ~0.3kPa, gelatin is ~40-50kPa and tissue culture 
plastic is >1MPa. The increase in substrate hardness from Matrigel to tissue culture plastic 
is greater than 3,000 fold and is not physiologically relevant. While MSCs are exposed to 
different niches in vivo such as bone marrow, fat and bone, the range of mechanical stress 
does not begin to approach the order of MPa. For example, bone’s elastic modulus is 
approximately 50 kPa, similar to the elastic modulus of gelatin; and bone marrow’s elastic 
modulus is ~0.2kPa, similar to the elastic modulus of Matrigel. A12T expressing iMSCs 
clearly have a lower threshold for withstanding mechanical forces applied when cultured 
on plastic, however it would be interesting to examine whether these effects are rescued 
when iMSCs that have been cultured on plastic are moved to softer substrates. By moving 
cells onto substrates 500 fold softer (gelatin) and relieving the stress from the actin 
cytoskeleton, do A12T expressing cells recover from the accumulation of stress responses 
and return to a healthy state? Furthermore, since the mechanical forces are transduced 
along the actin cytoskeleton, would relieving the strain of the actin cytoskeleton on the 
nucleus decrease the frequency of nuclear rupture and in turn reduce the fraction of 
senescent iMSCs? Inhibiting actin dynamics by treatment with Blebbistatin has been 
shown to relieve the stress on the nuclear envelope and in turn improve aberrant nuclear 
envelope morphology (Hatch & Hetzer, 2016). Furthermore, several studies have shown 
that by depleting components of the LINC complex, relieves the tension from the actin 
cytoskeleton on the nucleus. In both these ways we can ask whether the replicative 
senescence observed in the iMSCs are 1) reversible 2) truly a result of the mechanical 
strain imparted by the cytoskeleton.  
 The transduction of mechanical forces from the cell periphery to along the actin 
cytoskeleton initiates a signaling cascade to modify gene expression in an effort to 
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respond to the extracellular environment appropriately. Therefore, understanding the 
pathways involved, such as the YAP/TAZ pathway and whether signaling is altered in the 
presence of the A12T mutation would open a series of potential downstream studies of 
the potential gene expression alterations in WT BAF iMSCs or A12T iMSCs in response 
to mechanical stress. 
Moreover, our observation that A12T does not bind Lamin A implicates the BAF: 
Lamin A as a critical interaction for the structural integrity of the nucleus. To strengthen 
these findings, further examination of the Lamin A-binding interface must be performed to 
determine whether other mutations on the BAF binding interface results in nuclear 
envelopathy and premature cellular senescence as well. Samson et al. mapped residues 
on Lamin A that are buried in the BAF binding interface that are mutated in atypical 
progerias. By identifying previously unknown residues on the surface of BAF that are 
involved in the interaction with Lamin A, we can examine whether their mutation and leads 
to the loss of the BAF: Lamin interaction, and whether, when expressed in iMSCs, results 
in a nuclear envelopathy and premature cellular aging. If, however the envelopathy and 
premature aging syndrome are a result of the loss of the BAF: Lamin A interaction, then 
we must also assess this interaction in the primary dermal fibroblasts. Do A12T dimers 
overcome the binding deficit observed in the iMSCs due to species-related differences in 
the Ig Fold of murine Lamin A? While R435 and R527 are conserved in murine Lamin A 
(the two residues in which mutations to Alanine are unable to bind WT BAF), other 
residues in this region are not conserved. Therefore, to ask whether there is a species-
driven difference in the BAF: Lamin A interaction, or whether the loss of binding is still 
observed, we would perform binding assays between murine BAF and murine Lamin A.  
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 In conclusion, BAF carries out its function through its binding partners, and the 
BAF dimer ties together LEM-D proteins, Lamin A and dsDNA and acts as an organizing 
hub at the nuclear periphery. BAF plays extensive roles in the maintenance of the structure 
and function in interphase and mitosis and this study indicates that the interaction of BAF 
and Lamin at the nuclear periphery plays a central role in stabilizing the entire meshwork 
of the nucleoskeleton Figure (6-1). In summary, the work done in this study has revealed 
the contributions of the BAF A12T mutation to the integrity of the nuclear envelope and 
has elucidated a novel role for BAF in the context of mechanosensitivity, 
mechanotransduction, and the network of the nucleoskeleton and cytoskeleton. We have 
also begun to understand the tissue specificity of NGPS through the study of MSCs and 
have learned that A12T has deleterious effects on mechanosensitive cells but that other 
cell types are more resilient in overcoming insult to the nuclear membrane morphology 
(Figure 6-1). Through the study of three separate models of A12T inheritance, we have 
highlighted the nuances of this mutation’s effect both at the cellular and organismal level. 
Furthermore, this study has generated valuable tools for the study of BAF and A12T 
outside the context of premature cellular aging. The generation of a dermal fibroblast cell 
line from an A12T/A12T mouse offers a toolkit for the analysis of the roles of BAF and 






















Figure 6-1. Summary of BAF Binding Partners. The BAF dimer creates a nuclear 
organizing hub. The BAF dimer creates two binding surfaces at either pole, one that 
creates a LEM-D binding saddle, and the other that binds the Ig fold of Lamin A. On either 
side of the dimer BAF binds dsDNA in a sequence independent manner. BAF is 

















Figure 6-2. Summary of Models. MCF-10a cells and dermal fibroblasts from A12T/A12T 
mice both exhibit nuclear envelope morphology defects without suffering deleterious 
downstream consequences of premature aging. When iMSCs express A12T, they exhibit 
nuclear envelope dysmorphia but also present with premature cellular aging culminating 
from the accumulation of ROS and DNA damage as a result of chromatin herniation due 
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